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General Introduction
1
NeeD for PeDiAtriC reseArCH
In clinical research with children (i.e. pediatric research), there is a tension between what 
is needed for the development of evidence-based drugs and treatments for children 
and what is ethically acceptable concerning the involvement of children in research, 
given that children are legally considered to be unable to give informed consent. While 
children are viewed as being vulnerable and in need of protection against risky and 
discomforting research procedures, withholding them from participation in clinical 
research might be considered unethical and it impedes them from getting access 
to the benefits of clinical research. Research shows that approximately 65% of the 
medicines pediatricians prescribed to children are unregistered or off-label,1 which may 
pose children to an increased risk of an under- or overdose of medication. Without the 
participation of children and adolescents in clinical research, it cannot be adequately 
demonstrated that (new) medicines and treatments are safe and effective for them. Also 
observational research is needed to establish reference values in children (e.g. anatomy, 
metabolism) and to evaluate the outcomes and (long-term) effectiveness of health care 
in everyday life. More pediatric research is therefore urgently needed.1, 2
risk AND DisComfort iN PeDiAtriC reseArCH
An important part of the ethical discussions in pediatric research is about risk and 
discomfort of the research procedures involved. Guidelines, laws and regulations 
regarding pediatric research participation restrict the participation from children in 
clinical research when it involves considerable discomfort and/or risk. In general in 
therapeutic research,a risk and discomfort are accepted as long as the benefits for the 
participant outweigh these. In non-therapeutic research,b risk and discomfort should be 
minimal, although some guidelines and regulations allow a minor increase over minimal 
discomfort in certain situations.3, 4 (Note: in 2016 a new European regulation has been 
passed for clinical trials. An important improvement is that risk and discomfort should 
be minimal compared to the standard treatment of the child.5 To be further elaborated 
on in Chapter 8 ‘General Discussion’).
a Research with potential medical benefits for the participants
b Research without direct medical benefits for the participants
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eVALUAtioN of risk AND DisComfort iN CLiNiCAL reseArCH
Clinical studies have to be reviewed whether they are designed in accordance with regu-
lations and ethics guidelines. Ethics committeesc evaluate the ethical aspects of clinical 
research. One of their responsibilities is to review the balance between discomfort and 
risk of clinical research on the one hand, and its benefits for the participant or study 
population on the other hand. During the informed consent process, a second evalua-
tion takes place in which the children and their legal caretakers evaluate - in consulta-
tion with the researcher/pediatrician - whether discomfort and risk are acceptable for 
this individual child.
emPiriCAL DAtA
A review by Hunfeld and Passchier revealed that empirical research on discomfort of 
children in clinical research is limited.6 Although different ethics reports recommend 
defining and monitoring children’s discomfort during research procedures,2, 7 there are 
only a few small studies published about the self-reported discomfort of children in 
research.8-10 Ethics committees therefore have limited empirical evidence to guide their 
decision-making on what is an acceptable level of discomfort. They have to rely on their 
own subjective assumptions, experiences and observations, and those of other persons 
(e.g. pediatricians, pediatric nurses, ethicists). Literature shows that pediatric healthcare 
professionals and parents likely overestimate children’s discomfort in medical settings, 
although in some cases the opposite occurs.11-13 If discomfort in pediatric research is 
overestimated, it can lead to the rejection of studies because of expected discomfort 
for the children, while in fact the children may think it is acceptable, and vice versa. 
It is therefore crucial to take children´s own perspectives into account when evaluat-
ing discomfort of research. Moreover, it is reflected in article 12 of the United Nations 
Convention on the Rights of the Child that children deserve to give their opinions in 
matters that concern them.14
The need to have empirical data about the experiences of children in clinical research 
is seen, for instance, by the development of the Reactions to Research Participation 
Questionnaire for Children (RRPQ-C)15 and the Pediatric Research Participation Question-
naire (PRPQ).16 These questionnaires give insight in the perceived benefits and barriers 
to pediatric research participation. However, they give limited insight into discomfort 
and do not address children’s experiences during the individual research procedures 
of a study. Since ethics committees often evaluate discomfort of the separate research 
c In the Netherlands, ethics committees are referred to as Medical Ethics Committees (METCs), in the 
United Kingdom as Research Ethics Committees (RECs) and in the United States as Institutional Re-
view Boards (IRBs).
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procedures (in addition to the study as a whole),17, 18 the so-called component-analysis 
approach,19 it is important to have information on discomfort of individual research 
procedures, as such information can be generalized across different research studies 
with similar procedures. So far, there are no instruments to obtain this information.
Aims AND oUtLiNe of tHis tHesis
In this thesis, we support evidence-based decision-making on discomfort in pediatric 
research by providing information on children’s self-reported discomfort. These data are 
an important first step in providing benchmarks for discomfort of various research pro-
cedures in pediatric research. In the absence of an instrument that specifically measures 
discomfort, we developed a short instrument to measure generic forms of discomfort 
applicable to all kinds of pediatric research procedures.
Apart from being helpful to ethics committees, information on children’s self-report-
ed discomfort helps pediatric researchers to get more insight into the experience of 
their studies reported by children in terms of discomfort. It can also help to provide new 
participants with evidence-based information on discomfort based on the reports of 
children who underwent the same procedures in previous research. Moreover, with this 
information, children and their parents will be better informed when making a decision 
for participating in research.
While the focus of this thesis is on discomfort, positive experiences and benefits are 
addressed as well. We did not plan to incorporate these on the first hand, but we noticed 
during our interview study that children were eager to talk about positive experiences 
and benefits. We think that adding these experiences to this thesis give a more balanced 
picture of the overall experiences of children in research.
The main research questions of the thesis were:
1. What is the degree of discomfort of common medical research procedures?
2. Do children experience clinically relevant stress symptoms due to common medical 
research procedures in the long-term?
3. Do age, anxiety-proneness, gender, medical condition and previous experiences 
with the procedures influence discomfort?
4. Are there differences in discomfort of the same medical procedures that are con-
ducted for research purposes versus clinical care?
5. What are children’s suggestions to reduce the discomfort of research procedures?
In Chapter 2 the protocol of our research project is described.
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Although pain, distress and anxiety are often labeled as discomfort, a clear description 
of what constitutes discomfort remains unclear. Chapter 3 gives insight into what can 
be considered as discomfort in clinical research according to the children involved.
Chapter 4 presents the construction of a generic, practical and short instrument to 
measure children’s self-reported discomfort during medical research procedures in 
a quantitative way: the Child’s Discomfort during Research Procedures Questionnaire 
(CDRPQ).
In Chapter 5 children’s self-reported discomfort during common medical research 
procedures is presented from a quantitative point of view. It is explored whether age, 
anxiety-proneness, gender, medical condition and previous experiences with the proce-
dures influence discomfort. Additionally, it was exploratively studied whether there are 
differences between discomfort in medical procedures that are conducted for research 
purposes and for routine clinical care (i.e. purpose of the procedure). This chapter also 
addresses the children’s suggestions for reducing discomfort.
In Chapter 6 the psychological risk of clinical research for children is addressed, which 
is operationalized as clinically relevant stress symptoms. We looked at stress symptoms 
one month and one year after undergoing research procedures.
Chapter 7a and 7b address the positive experiences children report in clinical research, 
and discuss which of these positive experiences could justifiably be seen as benefits 
taken into account into the risk-benefit analysis.
Chapter 8 constitutes a general discussion on the main findings of the studies presented 
in this thesis. It also gives recommendations for practice and future research.
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Hearing the voices of children:  
self-reported information on children’s 
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 a study protocol
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ABstrACt
introduction. In paediatric research, there is a tension between what you can ask from a 
child and what is needed for the development of evidence-based treatments. To find an 
optimal balance in conducting clinical research and protecting the child, it is necessary 
to have empirical data on children’s experiences. Until now, there are scarce empirical 
data on the experiences from the perspective of the child. In this manuscript, we de-
scribe the protocol of a two-phase study measuring children’s self-reported experiences 
during research procedures.
methods and analysis. In the first phase of our study, we aim to interview approxi-
mately 40 children (6–18 years) about their self-reported experiences during research 
procedures. In the second phase, we will develop a questionnaire to measure children’s 
experiences during research procedures in a quantitative way. We will use the inter-
view outcomes for the development of this questionnaire. Next, we will measure the 
experiences of children during seven research procedures with this questionnaire. A 
one-month follow-up is conducted to investigate the emotional impact of the research 
procedures on the children. Children will be recruited from different research studies in 
three academic children’s hospitals in the Netherlands.
ethics and dissemination. The ethics committee of the VU University medical center 
evaluated both studies and indicated that there was no risk/discomfort associated, 
stating that both phases are exempt from getting approval under the Dutch Law. Dis-
semination of results will occur by conference presentations and peer-reviewed publica-
tions. The findings of our project can help Institutional Review Boards and paediatric 
researchers when evaluating the discomforts of research procedures described in study 
protocols or when designing a study. Information on experiences of children involved 
in previous studies may also help children and parents in future research with their 
decision-making about participation in clinical research, or parts thereof.
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iNtroDUCtioN
In paediatric research, there is a tension between what is needed for the development 
of evidence-based drugs and treatments for children and what is ethically acceptable 
concerning the involvement of children in research, given that they are (legally) unable 
to give informed consent. For instance, there are scarce data about the dosage and effect 
of medicines for children, which amount to 65% of all prescribed drugs. More paediatric 
research is therefore needed.1 While children are rightly considered to be vulnerable and 
in need of protection against risky and burdensome research procedures, withholding 
children from participation in clinical research might be considered unethical as well; 
children deserve to get access to the benefits of clinical research.
institutional review Boards
The balance between the burdens and risks of clinical research and its benefits for the 
child plays an important role in the decision-making of Institutional Review Boards 
(IRBs). Since little is known about children’s self-reported experiences of discomfort in 
clinical research,2 IRBs have limited empirical evidence to guide their decision-making, 
which is why they often rely on observations and assumptions of other persons (e.g. 
paediatricians, paediatric nurses, ethicists). Literature shows, however, that paediatric 
nurses, paediatricians, psychologists and parents are likely to overestimate,3, 4 or un-
derestimate,4, 5 children’s discomfort in medical settings. It is therefore crucial to also 
take children’s own perspectives into account when evaluating discomfort of research 
procedures. This argument is also reflected by an advisory council of the Dutch govern-
ment, Committee Doek, that proposed that one of the conditions for clinical research 
in children is to define and permanently monitor children’s discomforts during research 
procedures.6
the measurement of children’s experiences in paediatric research
Hunfeld & Passchier reviewed the literature on discomfort of paediatric research a few 
years ago.7 They concluded: “Several limitations of the present body of knowledge on the 
burden of child participants in medical research can be mentioned. So far no systematic 
research has been conducted covering and comparing the amount and different aspects 
of perceived burden and risks in children, like regular hospital visits, the time needed 
to undergo the medical procedure or the unpleasantness of particular procedures”. In 
addition, they mentioned that there is scarce information on the experiences of research 
procedures based on the perspectives of the children themselves.
The need to have empirical data about the experiences of children in clinical research 
on an international level is seen, for instance, by the development of two questionnaires 
about this topic: the Reactions to Research Participation Questionnaire for Children 
(RRPQ-C)8 and the Pediatric Research Participation Questionnaire (PRPQ).9 The PRPQ 
CHAPTER 2.
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concerns perceived benefits and barriers to paediatric clinical trials participation. The 
RRPQ-C concerns children’s experiences with research studies in general. Since research 
studies vary in the procedures involved and often involve a combination of procedures, 
the outcomes of these questionnaires are difficult to generalise. It is therefore important 
to have additional information about the experiences of the individual research proce-
dures as well as an instrument to measure this.
Current study
In this manuscript, we describe the protocols of a two-phase study: an interview study 
and a questionnaire study. The primary aim of this project is to get insight into the self-
reported experiences of children when undergoing research procedures, in particular in 
relation to discomfort, and the emotional impact of the procedure for the child. Second-
ary aims are to get insight into children’s suggestions to reduce possible discomforts 
of research procedures and whether there are differences in experiences between 
subgroups of children (age, anxiety-proneness and health condition).
Since there is limited information about this topic, the first phase of our project is a 
qualitative study to explore the experiences of children in clinical research in particular 
related to discomfort. We will use the outcomes of the interviews (i.e. the different ex-
periences of the children) for the development of a questionnaire to measure children’s 
experiences in a quantitative way. In the second phase, we will use this questionnaire to 
measure children’s experiences during research procedures in order to get insight into 
the percentages of children who experience certain discomforts and to what extent.
research questions
Primary research questions
1. What are children’s experiences during (common) research procedures, and do these 
differ between different procedures?
2. What is the emotional impact of research procedures for children after 1 month?
Secondary research questions
1. Are there differences in experiences and emotional impact of research procedures 
between (a) healthy children and children with a chronic condition, (b) young (<12 
years) and older children (≥12 years) and (c) between anxiety-prone versus not 
anxiety-prone children?
2. Are there differences in experiences between medical procedures that are conducted 
for research purposes or routine clinical care?
3. What are children’s suggestions to decrease discomfort related to research proce-
dures?
21
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metHoDs AND ANALYsis - iNterVieW stUDY
Design
In the first phase of our study, we will interview a group of children who participate 
in clinical research studies to explore their experiences during research procedures 
and their suggestions to reduce potential discomfort caused by the procedures. The 
primary outcomes of this interview study are the different discomforting aspects during 
research procedures that children experience. These aspects will be categorised into 
themes. Secondary outcomes are children’s positive experiences and their suggestions 
to reduce discomfort.
In addition, for the development of the questionnaire in the second phase of our 
project, children will answer some written questions about their experiences with the 
research procedures. We will ask children to fill in each question on three different re-
sponse options and will ask them which of these options they prefer. The reason why we 
will investigate this is because there is discussion about what the most suitable response 
option is for children. We will use the response option that is most often preferred by the 
children for the questionnaire in the second phase of our project.
Population
The focus of the interviews is to explore the experiences of a diverse group of children. 
We will purposefully select a wide range of children (ages and medical conditions) 
undergoing various types of clinical research procedures to ensure a wide range of 
experiences, influences and attitudes. In qualitative research, this is called a maximum 
variation sample.10 This method is designed to represent a wide range of experiences, 
rather than aiming at numerical representativeness. We will interview children from 6 
years of age because the literature shows that children aged 6 years and older are cogni-
tively capable and have language capacities to accurately verbalise their experiences.11 
We aim to include approximately 40 children, or until saturation is reached. In qualitative 
research, this is the point when additional interviews do not provide new information.12 
The point of saturation will determined by the interviewer (MSS) in consultation with 
other members of the project group (JAMH and JP). Children are eligible to be inter-
viewed if they meet the following criteria: (1) aged between 6 and 18 years, (2) fluent in 
Dutch, (3) no current psychological treatment for pain or anxiety disorders, (4) no severe 
psychosocial problems (such as anxiety disorders and depression), (5) accompanied 
by at least one parent or caretaker and (6) able to express themselves verbally. These 
inclusion criteria will be determined by asking the parent(s) of the children and/or by 
consulting the child’s medical record.
The children will be recruited from research studies at three academic hospitals 
in the Netherlands: Sophia children’s hospital (Erasmus University Medical Center) in 
Rotterdam, the department of Paediatrics of the VU Medical Center in Amsterdam and 
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Emma children’s hospital (Academic Medical Center) in Amsterdam. We aim to include 
children from four different paediatric departments: gastroenterology, pulmonology, 
nephrology and oncology, to cover a large variety of research procedures and to include 
children from a broad range of diseases. We will also include healthy children who par-
ticipate in research studies at these departments.
Procedure
The children and their parents will be approached by the researchers of the studies we 
will cooperate with. If interested, parents and children will receive an information letter, 
which will be adapted for children (6–11 years) and adolescents (12–18 years). Parents 
and children will also have an opportunity to ask the interviewer questions about the 
interview in a face-to-face conversation, which will probably take place on the day of the 
child’s research visit. After agreement, written parent consent and child assent (children 
≥12 years) will be obtained. Children younger than 12 years have to verbally agree to 
participate. The interviews will be conducted by the PhD student of the project (MS, a 
health psychologist) who will receive specific training in interview skills by experts in 
the field of medical and paediatric psychology. Children will receive a gift card (€7.50) 
for being interviewed. Interviews will be conducted in a private room at the hospital, 
directly after the child’s participation in a research study. Parents are allowed to be in the 
room during the interview but will be asked not to intervene as the focus is on the child’s 
perspective. During the interviews, parents will fill in some questions about the child’s 
demographics and medical history. After the interview, children will fill in some written 
questions about their experiences with the research procedures.
instruments
Demographics
We will collect demographics by asking the parent of the child to fill in some questions 
about the child’s gender, date of birth, ethnicity, educational level, paediatric disease 
and medical history. If the parent does not know this information, we will collect the 
data from the child’s medical record.
Interview
The interviews about children’s experiences in clinical research will be semi-structured 
and will focus on the discomforts the child experienced in relation to research proce-
dures. Children will also be asked about positive experiences and suggestions to de-
crease possible discomfort. The interview questions are based on the literature, a review 
about the discomfort of children in clinical research,7 and input from several paediatri-
cians, psychologists and paediatric nurses. The interview will contain questions about 
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children’s experiences during participation, in particular related to discomfort, future 
research participation, preparation for the study and suggestions to reduce discomforts.
Written questions
To find out the most preferred response option, children will fill in five questions about 
their experiences with the research procedures. These questions will be based on input 
from the project group and the literature. We will ask the children to fill in each question 
on three response options: a 5-point Likert scale, a 100 mm coloured visual analogue 
scale (VAS) and a simple 100 mm VAS. Children will be asked which of the three response 
options they prefer.
Analyses
Interview
The interviews will be audio-recorded and transcribed verbatim. The transcripts will be 
analysed using ‘thematic analysis’ in QSR NVivo 10 to identify themes related to chil-
dren’s experiences and their suggestions to reduce discomforts.13 Thematic analysis is 
a method to interpret the findings of qualitative research, in which the transcripts will 
first be coded using open coding. The codes obtained during open coding will then 
be divided into categories covering all relevant information. Finally, the categories will 
merged into main themes. Two researchers (PhD student and supervisor) will inde-
pendently analyze the interviews to ensure interrater-agreement on the relevance of 
the themes derived from the interviews. In case of disagreement, the researchers will 
discuss until consensus about the themes is reached.
Written questions
We will investigate which response option is most frequently preferred by the children.
metHoDs AND ANALYsis - QUestioNNAire stUDY
Design
In the second phase of our study, we will first develop a questionnaire based on the 
information gathered in the interview study (i.e. the themes/categories on children’s 
experiences during research procedures) as well as in expert meetings with different 
healthcare professionals involved in paediatric research (paediatricians, paediatric 
nurses, ethicists, psychologists, pedagogics and parents). This draft questionnaire will 
be pretested in a sample of 25 children. The final questionnaire will be used to measure 
children’s experiences during several research procedures. At two time points, we will 
ask children to fill in questionnaires: directly after undergoing a research procedure and 
1 month later.
CHAPTER 2.
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The primary outcomes of this questionnaire study are children’s experiences, in 
particular related to discomfort, during research procedures and the emotional impact 
of the research procedures on them. Secondary outcomes will be their suggestions to 
reduce discomfort, and possible factors that influence children’s experiences.
Population
Since this study is a first step in systematically investigating children’s experiences dur-
ing research procedures, we cannot say beforehand how many children are needed to 
be included. We plan to include a sample of 50 children for each research procedure. We 
think this number will be reasonable given the duration of our study, and the availability 
of children undergoing the research procedures at the different locations during the 
inclusion period of our study. Recruitment is based on the same criteria as previously 
mentioned for the interview study, except that the lower age limit will be 8 years instead 
of six because we will use two questionnaires that are suitable for children aged eight 
and older. Again, we aim to recruit children from the same three academic children’s 
hospitals in the Netherlands.
In addition, 50 healthy children (8–18 years) will be included to measure their experi-
ences after a check-up visit at the dentist. With this group of children, we aim to measure 
the experiences of a common medical procedure in a child’s ‘daily life’. We will compare 
this outcome with the experiences during the other research procedures.
Procedure
Parents and children will be recruited in the same way as for the interview study. Directly 
after undergoing the research procedure, the child will complete the ‘What do you think 
of …?’-questionnaire, which is the questionnaire we will develop to measure children’s 
experiences during a research procedure. Children also fill in the ‘Zelfbeoordelings Vra-
genlijst voor Kinderen’ (ZBV-K) to measure anxiety-proneness. After 1 month, the child 
receives an email with the link to fill in the two questionnaires online: the ‘What do you 
think of …?’-questionnaire again to investigate whether the moment of measuring may 
influence children’s answers and the Child Revised Impact of Event Scale (CRIES-13) for 
the assessment of the emotional impact of the clinical research procedure. After having 
completed all questionnaires, children will be sent a gift card (€7.50) to their home as 
a token of appreciation for their participation in our study. To send the gift card to the 
children, it is necessary to ask for their addresses. We will delete this information directly 
after sending the gift card.
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instruments
Discomfort - ‘What do you think of …?’-questionnaire.
Children’s experiences during research procedures, in particular related to discomfort 
will be measured using the questionnaire we developed (‘What do you think of …?’-ques-
tionnaire). This questionnaire will contain questions about: (1) experiences during a 
clinical research procedure, both positive and negative experiences; (2) the most bur-
densome part of the research study in which the child participates; (3) whether the child 
would undergo the research procedure again in the future; (4) the child’s experiences 
with the same medical procedure in routine clinical care and (5) an open question to ask 
children about suggestions for decreasing discomfort of the research
procedures. The specific questions of the ‘What do you think of …?’-questionnaire will 
be based on the topics on children’s experiences from the interviews and on input from 
professionals during the expert meetings. The method of answering the questions is 
based on the children’s preferences for response options on the written questions in 
the first phase of the study (i.e. five-point Likert scale, 100 mm coloured VAS or 100 mm 
simple VAS).
Emotional impact - Child’s Revised Impact of Event Scale (CRIES-13)
The emotional (traumatic) impact of the research procedures will be measured by the 
Dutch version of the Child’s Revised Impact of Event Scale (CRIES-13).14 The CRIES-13 
is a child self-report scale about the frequency of event-related (traumatic) distress (in 
our study, we measure the distress caused by the research procedures). The question-
naire consists of 13 items which are divided into three subscales: avoidance, intrusion 
or re-experiencing and arousal. Children have to rate each question on a 4-point Likert 
scale, with the following categories: 0=‘not at all’, 1=‘rarely’, 3=‘sometimes’, 5=‘often’. The 
CRIES-13 demonstrates satisfactory to good psychometric characteristics.15 It has good 
internal consistency for the total scale (Cronbach’s α = 0.80) and satisfactory internal 
consistency for the three subscales: intrusions or re-experiencing (Cronbach’s α = 0.70), 
avoidance (Cronbach’s α = 0.73), and arousal (Cronbach’s α = 0.60), for example, when 
a child has a total score of 30 or above on the CRIES-13, this child is considered to have 
clinically elevated stress response symptoms.16
Anxiety-proneness - Zelfbeoordelings Vragenlijst voor Kinderen (ZBV-K)
Anxiety-proneness of the children will be measured by the Zelfbeoordelings Vragenlijst 
voor Kinderen (ZBV–K).17 The ZBV-K is a Dutch translation of the State–Trait Anxiety 
Inventory for Children (STAI-C)18 and consists of two scales: state and trait anxiety. Each 
scale consists of 20 items. For this study, the trait scale was used, which addresses the 
frequency and intensity of general anxious symptoms. The child was instructed to 
rate the frequency with which he or she experiences anxiety symptoms in general (i.e. 
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anxiety-prone) on a three-point Likert scale (e.g. ‘I worry about school’), with the follow-
ing categories: 1=‘almost never’, 2=‘sometimes’, 3=‘often’. Individuals scoring high on 
this scale tend to interpret situations as more threatening than do individuals with lower 
scores. The trait scale demonstrates good internal consistency in a Dutch norm popula-
tion (Cronbach’s α > 0.80).17 The total ZBV-K score for trait-anxiety ranges between 20 
and 60. Test–retest reliability for both children and adolescents has been found to be 
acceptable (Dutch norm population: r > 0.65).17 Since the manual of the ZBV-K does not 
mention a clinical cut-off score, based on previous studies with the ZBV-K, we consider 
children as anxiety-prone when they have a total score of at least 38 on the ZBV-K.
The ZBV-K is used for children between 8 and 15 years old. However, it has been 
suggested that the child version of ZBV (ZBV-K) may be more useful for adolescent 
populations than the adult version (ZBV), given that even older adolescents may have 
difficulty understanding some of the vocabulary in the adult version.19 Kirisci et al. stud-
ied whether the ZBV-K was also reliable an valid for adolescents (12-18 years old) and 
indicated that the ZBV-K was applicable to this age-group.20 We therefore decided to 
also use the ZBV-K for children between 16-18 years old.
Demographics
Demographics that we will collect include the child’s age, gender, health status, ethnic-
ity, previous experiences with the medical procedure. Since we will include children 
from different hospitals, the research procedures may not be conducted in an identical 
way between those hospitals. Therefore we will also collect data about how the child 
is prepared for the study, who performed the procedure (e.g. paediatrician, lab worker, 
PhD student), the duration of the procedure, and whether the child had local anaesthet-
ics. This information will be asked from the parents, from the researchers of the studies 
and/or derived from the child’s medical record.
research procedures
We will measure children’s experiences during several research procedures: echoscopy, 
faeces testing, MRI-scan, pulmonary function test, buccal swab, skin prick test (allergy 
test), and venepuncture. The research procedures are selected based on an expert 
meeting with paediatricians, paediatric nurses, ethicists, psychologists, pedagogics and 
parents, and on which research procedures are conducted during the timeframe of our 
study at the departments of the three hospitals we cooperate with.
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Analyses
Primary outcomes
Discomfort
Depending on the response option (VAS or Likert scale) of the questionnaire, paramet-
ric or non-parametric tests will be used. The mean respectively median scores of the 
individual questions on the ‘What do you think of…?’-questionnaire will be calculated. 
Differences in outcomes between baseline and one-month follow-up on the ‘What do 
you think of…?’-questionnaire will be tested with paired t-tests respectively Wilcoxon 
matched-pairs tests. Differences in experiences on the different research procedures 
will be tested by one-way between groups ANOVAs respectively Kruskal-Wallis tests. 
For each research procedure, the percentage will be calculated of children willing to 
undergo a similar procedure again in the future.
Emotional impact
We will measure the percentage of children who have elevated stress symptoms caused 
by the research procedure after one month (i.e. total CRIES-13 score of 30 or more). We 
will also study whether there is a relation between emotional impact and the type of 
research procedure by one-way between groups ANOVAs.
Secondary outcomes
Suggestions
Suggestions for reducing discomforts of the research procedures will be coded into 
categories, and frequencies on each category will be measured.
Influencing factors on children’s experiences and emotional impact
Depending on the response option (VAS or Likert scale) of the ‘What do you think of…
?’-questionnaire, parametric (independent-samples t-test) or non-parametric (Mann-
Whitney U test) tests will be used. Possible differences between anxiety-prone children 
(children with a score of 38 or higher on the ZBV-K trait scale) and non-anxious children 
(children who score of 37 or lower on the ZBV-K trait scale) on their experiences will be 
tested. The same tests will be used to study the differences between young children 
(<12 years) and older children (≥ 12 years), and between healthy children and children 
with a chronic condition.
To measure if there are differences on emotional impact between 1) anxiety-prone 
versus non-anxiety-prone children, 2) young children (<12 years) versus older children 
(≥ 12 years), and 3) healthy children versus children with a chronic condition, we will 
perform independent-samples t-tests.
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etHiCs AND DissemiNAtioN
The IRB of the VU Medical Center in Amsterdam (The Netherlands) evaluated both 
studies described in this manuscript and indicated that there was no risk or discomfort 
associated with the interview study (2012/279) nor the questionnaire study (2014/010), 
stating that both phases are exempt from getting approval under the Dutch Law.
Dissemination of results will occur by conference presentations and peer-reviewed 
publications. No identifying participant information will be made available. Only investi-
gators will have access to the raw data of the studies. The outcomes on children’s discom-
fort during research procedures will be available for IRBs and paediatric researchers in 
an online database. These outcomes will not include identifying participant information.
DisCUssioN
In this manuscript, we describe the protocol of a two-phase study to measure children’s 
experiences during research procedures. The findings of this study give insight into chil-
dren’s experiences during some common research procedures, the emotional impact 
of these procedures and suggestions to reduce discomforts of research procedures, as 
seen from the perspective of children themselves. This study also explores whether age, 
health condition and/or anxiety-proneness influence children’s experiences. Finally, 
this study provides an instrument to measure children’s self-reported experiences of 
research procedures.
We will provide the findings of this study on a website which will be accessible for 
parents, children, IRBs, researchers and others who are interested. The findings of our 
project can help IRBs and paediatric researchers when evaluating the discomforts of 
research procedures or when designing a study. Information on experiences of children 
involved in previous studies may also help children and parents in future research with 
their decision-making concerning participation in clinical research, or parts thereof.
Limitations
A limitation of our study is that we cannot acquire a complete overview of the experi-
ences of all research procedures, subgroups of children, and all factors influencing their 
experiences given the limited time and funding.
future research
A future aim is to use our questionnaire to obtain empirical data from other research 
procedures than the ones we investigated in our study. This requires the development of 
a network in which physicians, researchers, IRBs, parents and children are involved. We 
are currently working on the development of this network.
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Next to age, medical condition and anxiety-proneness, other variables may have 
an impact on children’s experiences, such as the interaction of the child, parent and 
researcher during research procedures. Since children’s age, health condition and 
anxiety-proneness are important factors for IRBs to take into account when evaluating 
the discomfort in paediatric study protocols, we decided to focus on these three factors.
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ABstrACt
introduction. There is little empirical evidence on children’s subjective experiences of 
discomfort during clinical research procedures. Therefore, Institutional Review Boards 
have limited empirical information to guide their decision-making on discomforts for 
children in clinical research. To get more insight into what children’s discomforts are 
during clinical research procedures, we interviewed a group of children on this topic and 
also asked for suggestions to reduce possible discomforts.
materials and methods. Forty-six children (aged 6-18) participating in clinical research 
studies (including needle-related procedures, food provocation tests, MRI scans, pulmo-
nary function tests, questionnaires) were interviewed about their experiences during 
the research procedures. Thematic analysis was used to analyze the interviews.
results. The discomforts of the interviewed children could be divided into two main 
groups: physical and mental discomforts. The majority experienced physical discomforts 
during the research procedures: pain, shortness of breath, nausea, itchiness, and feeling 
hungry, which were often caused by needle procedures, some pulmonary procedures, 
and food provocation tests. Mental discomforts included anxiousness because of antici-
pated pain and not knowing what to expect from a research procedure, boredom and 
tiredness during lengthy research procedures and waiting, and embarrassment during 
Tanner staging. Children’s suggestions to reduce the discomforts of the research proce-
dures were providing distraction (e.g. watching a movie or listening to music), providing 
age-appropriate information and shortening the duration of lengthy procedures.
Discussion. Our study shows that children can experience various discomforts during 
research procedures, and it provides information about how these discomforts can be 
reduced according to them. Further research is needed with larger samples to study 
the number of children that experience these mentioned discomforts during research 
procedures in a quantitative way.
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iNtroDUCtioN
Clinical research in children
Pediatric research is necessary to develop safe and effective treatments for children. 
However, children are vulnerable and need to be protected against high levels of risk and 
burden in clinical research. It is an ethical and legal requirement for pediatric research 
that the risks and burdens of research participation are proportionate to the expected 
benefits of participation.1 It is the responsibility of Institutional Review Boards (IRBs) to 
weigh these burdens and risks to establish whether they are acceptable. To be able to 
properly conduct this responsibility, research on the possible discomforts of research 
procedures is required, which involves knowing the perspectives of the participating 
children. For an overview of the terminology used in this article, we refer to Table 1.
table 1. Terminology
term Description
Medical research The over-arching term for all types of medical research, which can be divided 
into primary research and secondary research. Primary research includes basic 
research, clinical research (experimental and observational research) and 
epidemiological research. Secondary research includes meta-analyses and 
systematic reviews.2
Clinical research procedures Medical procedures that are used for clinical research purposes.
Therapeutic research Therapeutic research is clinical research that is likely to directly benefit the 
participant.
Non-therapeutic research Non-therapeutic research is clinical research that is not likely to directly benefit 
the participant but may benefit future patients.
Discomfort: Something that causes one to feel uncomfortable.3
Children’s experiences in clinical research
Since little is known about children’s subjective experiences of discomfort during clinical 
research procedures,4, 5 IRBs have limited empirical information to guide their decision-
making, which is why they often have to rely on the observations and assumptions of 
others. Literature shows, however, that pediatric nurses, pediatricians, psychologists and 
parents are likely to overestimate6, 7 or sometimes underestimate7, 8 children’s discomfort 
in medical settings. It is therefore crucial to also take children´s own perspectives into 
account when evaluating the discomforts of clinical research procedures. This position is 
reflected in Article 12.1 of the Convention on the Rights of the Child 9“States Parties shall 
assure to the child who is capable of forming his or her own views the right to express those 
views freely in all matters affecting the child” as well as Article 3.2.a of the EU Clinical Trials 
Directive (2001/20/EC).10
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empirical data on children’s experiences in clinical research
The experiences of children who participated in research were studied in few studies. 
In two of these studies, children were asked about the worst (and best) parts of the 
study they participated in. Most frequently mentioned were blood work and needles 
because of pain or unpleasantness.4, 11 In another study children were asked to rate 
their level of comfort in relation to IV insertion, Tanner stage assessment, blood draws 
and staying overnight in the hospital after their participation in a research study.12 The 
results indicated low levels of discomfort, although Tanner staging and IV insertion 
were perceived as more discomforting than the other procedures. Some other studies 
in trauma-focused research investigated children’s experiences by using the Reactions 
to Research Participation Questionnaire for Children (RRPQ-C),13 which includes three 
questions on children’s discomforts: feeling bored during the study, feeling upset or sad 
during the study, and feeling sorry for having taken part in the study. Studies that used 
this questionnaire for investigating the discomforts of trauma-focused research showed 
that the majority of the children was not bored, upset/sad or felt sorry about participat-
ing in these research studies.14-16 There is also some literature on the (expected) discom-
forts that children mention in hypothetical research situations.e.g. 17, 18 In these studies 
discomforts mentioned by the children were concerns and worries (e.g. about the safety 
of the procedures or uncertainty that comes with test results), and pain.
Prior literature gives us some insight into discomforts children experience during 
clinical research procedures. Limitations are that these studies focused on the experi-
ences of a homogenous group of children (e.g. only children with asthma or children 
from a limited age-range) during a small number of research procedures, or did not 
distinguish between different kinds of discomforts. In addition, the experiences of chil-
dren in hypothetical situations may not be totally generalizable to the actual experience 
of children because children undergoing a painful procedure often expect to experience 
higher levels of discomfort than they actually experienced.19, 20
Purpose of this study
To get a more complete picture of children’s discomforts during clinical research proce-
dures as described in their own words, we interviewed a diverse group of children about 
the discomforts they experience during a wide range of clinical research procedures. In 
addition, we asked the children for their views on reducing discomfort of the research 
procedures, which as far as we know has not been done in prior research.
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mAteriALs AND metHoDs
subjects
Children (6-18 years) who participated in clinical research studies at two academic pe-
diatric hospitals in the Netherlands (Sophia Children’s Hospital in Rotterdam and Emma 
Children’s Hospital in Amsterdam) were interviewed between November 2012 and June 
2013. We purposefully selected a wide range of children (ages and medical conditions) 
undergoing various types of clinical research procedures to ensure a wide range of 
experiences, influences and attitudes. In qualitative research, this is called a maximum 
variation sample.21 This method is designed to represent a wide range of experiences, 
rather than to aim for numerical representativeness. The age of six was chosen as lower 
age limit because literature shows that children from six years onwards are cognitively 
capable and have language capacities to accurately verbalize their experiences.22
Children were enrolled in one of the outpatient pediatric studies described in Table 
2. The children we interviewed all participated in clinical research studies: in either 
experimental or observational/follow-up studies. We enrolled children until saturation 
was reached. In qualitative research, this is the point when additional interviews do not 
provide new information.23 The point of saturation was determined by the interviewer 
(MS) in consultation with other members of the project group (JH and JP).
Exclusion criteria were 1) children with mental health issues (such as anxiety disor-
ders and depression) to avoid information being biased by their mental condition, 2) 
children who underwent research procedures that are used for both clinical and research 
purposes (e.g. the child´s blood is taken for medical check-up, and some extra tubes 
are taken for research purposes) because this would make it difficult for the children 
to distinguish between procedural aspects for research purposes and those for routine 
clinical care, and 3) children who are not being able to orally express themselves. No 
children however were excluded for these reasons.
Procedure
The researchers of the cooperating studies informed parents and children about our 
interview. Parents and children also received an information letter, which was adapted 
for children (6-11 years) and adolescents (12-18 years). Parents and children had an op-
portunity to ask questions about the interview in a face-to-face conversation with the 
interviewer, which was prior to the start of the study on the day of the child’s research 
visit. Once parents and children agreed to participate, written parent consent and child 
assent (children ≥ 12 years) were obtained. Children younger than twelve years verbally 
agreed to participate. All children received a gift card (€7.50) for being interviewed.
Interviews were conducted in a private room at the hospital, directly after the chil-
dren’s participation in the research studies by the first author (MS), who has a degree 
in health psychology and was trained in interviewing children. The interviews were 
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audio recorded and field notes on the circumstances of the interview (e.g. about be-
ing disturbed during the interview) were taken by the interviewer. Parents were kindly 
requested not to intervene in the interview as the focus was on the child’s perspective. 
During the interview, parents completed a brief survey about the child’s demographics 
and medical history.
table 2. Description of the research studies children participated in
study type study aim Non-therapeutic/
therapeutic study
Health condition
Experimental study 
randomized controlled 
trial (RCT)
To study the efficacy of an 
intervention for the prevention of 
Cystic Fibrosis exacerbations
Therapeutic Cystic Fibrosis
Observational study To study the development of severe 
asthma
Non-therapeutic Mild and severe 
asthma
Observational study To study the development of 
Inflammatory Bowel Disease
Non-therapeutic Inflammatory Bowel 
Disease
Observational Follow-up study to investigate the 
effects of an intervention on atopic 
dermatitis
Non-therapeutic Healthy children
Experimental study: 
double-blind placebo-
controlled trial
To improve the diagnostic methods 
for cashew allergy
Therapeutic Cashew allergy
Observational study To get normative standards of the 
synovial membrane (soft tissue 
between the articular capsule (joint 
capsule) and the joint cavity of 
synovial joints)
Non-therapeutic Inflammatory Bowel 
Disease (children 
were used as a 
control group)
Observational follow-up 
study
To investigate the cognitive and 
physical development of children 
whose mothers participated in a RCT 
for severe preeclampsia.
Non-therapeutic Healthy children
instruments
The interviews were semi-structured. The content of the questions was based on input 
from pediatricians, pediatric nurses and child psychologists as well as literature.4, 11 We 
also consulted literature on interviewing children about their experiences to make the 
questions age-appropriate.24, 25 We started the interviews by asking about the children’s 
general experiences with the research studies, and how they felt before and afterwards. 
Then questions were asked about discomfort experienced during the specific clinical 
research procedures. In line with previous studies,4, 11 we also asked about the children’s 
worst experiences. Previous research had shown that children who are not given (age-)
appropriate information during medical care, are more anxious and consequently expe-
rience more distress.26-29 Therefore we asked the children how they had been prepared 
and whether this was sufficient for them. In line with a previous study by Wagner et 
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al., we asked the children whether they would participate in the study again.11 We also 
asked the children who did not want to participate again, what their concerns were. 
Finally, we asked questions about their suggestions to reduce the discomforts of the 
clinical research procedures. The interview schedule can be found in Appendix A.
Data analysis
Audiotaped interviews and field notes were transcribed verbatim. After initial transcrip-
tion by trained 3rd year psychology students, the transcript was checked for accuracy by 
table 3. Description of the participating children
Age Years
Range 6.3-17.8
Mean 11.9
Standard deviation 3.8
Gender Number of children
Boy 24
Girl 22
ethnic origin Number of children
Dutch 38
Moroccan 3
Surinamese 2
Dutch/Surinamese 1
Dutch/Hindustani 1
Dutch/Nigerian 1
Health condition Number of children
Chronic condition Cashew allergy 7
Crohn’s disease or ulcerative colitis 11
Cystic fibrosis 9
Mild asthma 4
Severe asthma 3
Healthy Mothers had suffered from preeclampsia 7
Atopic dermatitis (AD) as infant 5
Number of visits of the research study Number of children
One visit 23
Two visits 14
More than 2 visits 9
Previous research experience
(participated in another research study before)
Number of children
Yes 38
No 8
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table 4. Clinical research procedures performed on the children
Clinical research procedures Number 
of 
children
Age 
(years)
Health condition of the 
children undergoing this 
procedure
Number of children 
with previous 
experience with 
this procedure
Barostat device (air-filled bag inserted 
into rectum)
1 16 IBD 0/1
Blood pressure 28 6-18 Asthma, cashew allergy, CF, 
Children whose mothers 
suffered from preeclampsia
28/28
Body box pulmonary function test 7 6-16 Asthma 7/7
Buccal swab 4 7-18 IBD 4/4
Cashew provocation test (i.e. eating 
muffins with cashew allergens)
7 6-13 Cashew allergy 4/7
Cognitive capacity 7 12-13 Children whose mothers 
suffered from preeclampsia
7/7
Concentration/focus skills tests 7 12-13 Children whose mothers 
suffered from preeclampsia
7/7
Electronic nose test 7 6-16 Asthma 7/7
Exhaled breath condensate test 9 6-18 CF 9/9
Forced oscillation technique (a 
method to measure respiratory 
mechanics)
7 6-16 Asthma 0/7
Height, weight 46 6-18 All children 46/46
Intra venous procedures 9 6-18 Cashew allergy, IBD 5/9
MRI 8 6-18 IBD 2/8
Nasal brushing 7 6-16 Asthma 0/7
NO testing 7 6-16 Asthma 0/7
Pubertal development examination 
(Tanner staging)
7 12-13 Children whose mothers 
suffered from preeclampsia
0/7
Questionnaires (health status, medical 
history and/or quality of life)
46 6-18 All children 46/46
Regular pulmonary function test 21 6-18 Asthma, CF, AD as infant 21/21
Skin prick test 14 6-18 Asthma, cashew allergy 7/14
Sputum induction 5 11-16 Asthma 5/5
Throat swab test 7 6-16 Asthma 7/7
Urine examination 7 6-16 Asthma 7/7
Venipuncture
(with EMLA©)
26
(3)
6-18
(6-8)
Asthma, AD as infant, IBD
(Asthma, AD as infant, IBD)
26/26
Waist and head circumference 7 12-13 Children whose mothers 
suffered from preeclampsia
7/7
AD: Atopic Dermatitis; CF: Cystic Fibrosis; IBD: Inflammatory Bowel Disease (Crohn’s disease or ulcerative 
colitis)
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MS. Data were analyzed (NVivo 10.0) by MS using ‘thematic analysis’ to identify themes 
related to the discomforts and suggestions of the children.30 First, the transcripts were 
coded using open coding. The codes obtained during open coding were divided into 
categories covering all relevant information. Finally, the categories were merged into 
main themes. The second author (JH) independently analyzed 25% of the interviews 
to ensure agreement on the relevance of the themes. In case of disagreement, we dis-
cussed until we reached consensus. Citations from the children are used to illustrate the 
themes.
ethical approval
The ethical committee of the VU Medical Center in Amsterdam (The Netherlands) evalu-
ated this study and indicated that there was no risk or discomfort associated with the 
interview, stating that this study was therefore exempt from obtaining approval under 
the Dutch law.
resULts
subjects
Children were recruited from seven different research studies (Table 2). Children with 
chronic conditions and healthy children were both included. We considered the children 
with cystic fibrosis (CF), Inflammatory Bowel Disease (IBD) and severe asthma as children 
with severe chronic conditions. Children with cashew allergy and mild asthma were 
considered as children with a mild chronic condition. One group of healthy children par-
ticipated in a study because they had atopic dermatitis as an infant. The other group of 
healthy children participated in an observational follow-up study because their mothers 
suffered from severe preeclampsia during pregnancy. These two groups of children were 
considered to be healthy now. The characteristics of the children included are shown 
in Table 3. A more detailed description of each child can be found in Appendix B. The 
majority had previous experiences with the procedures (Table 4) and with participating 
in research (85%) (Table 3). The parent(s) of the children were present during 85% of the 
interviews (N=39). The interviews ranged from 9.04 to 43.59 minutes (M=23.46 minutes).
In total, forty-eight children and their parents were approached to participate. The 
parents of two children declined to participate: one because the parents thought the 
interview would take too much of their time and a second because the parents thought 
the interview would be too burdensome for their child. They wanted to minimize the 
exposure of their child with CF to disease related events. The remaining 46 children ap-
peared to be a sufficient number to reach saturation.
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Clinical research procedures
The clinical research procedures that were performed on the children were 24 different 
research procedures, which included both invasive (such as needle-related procedures, 
provocation tests) and non-invasive procedures (such as pulmonary function tests, tak-
ing medical history, questionnaires). The research procedures are listed in Table 4.
Children’s discomforts related to clinical research procedures
We identified two main themes related to discomfort: physical discomfort and mental 
discomfort. These themes are elaborated on below.
Physical discomfort
The majority of the children experienced several physical discomforts. The ones men-
tioned most often were pain, nausea, shortness of breath, itchiness and feeling hungry.
Five of the 35 children who had an intravenous procedure, venipuncture or skin prick 
test (aged 7, 8, 15, 16, 17) indicated that the needle-related procedure was the worst 
part of the study because of the pain it caused (Note: some children had different needle 
procedures, and therefore the total of children who had a needle procedure is not equal 
to the numbers of the children undergoing a needle procedure in Table 4.). Three healthy 
children (aged 6 and 7), for whom venipuncture was part of the study, refused this 
procedure because of previous painful venipuncture experiences (Note: these children 
are not included in the 35 children undergoing needle procedures that are described in 
Table 4.). The forced oscillation technique and exhaled breath condensate test were also 
mentioned by almost all children as painful because of the uncomfortable mouthpiece 
and nose clip, and shortness of breath: “You get a nose clip and you cannot swallow and 
you almost have no air and your mouth is on some sort of piece and you get a dry throat” 
(boy #23, aged 11). For six out of 16 children these tests were considered the worst 
part of the study because of the pain and shortness of breath it caused. The sputum 
induction test was also painful for the children because they had difficulty coughing up 
secretions from their lungs, which caused pain because of a sore throat.
About half of the children who had to fast before the study (ca. 25% of all children) 
experienced this as discomfort, which was primarily related to feeling hungry “I did not 
like that [not being allowed to eat], because I was really starving. When I feel hungry, I just 
want to eat” (girl #17, aged 6). Two children with severe asthma felt short of breath 
because they were not allowed to use their medication on the morning of the study. For 
six children, fasting before the study was the worst part of the study because of these 
discomforts.
Other physical discomforts were related to allergic reactions when children under-
went a cashew provocation test or skin prick test which resulted in an itchy tongue, 
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nausea, shortness of breath and/or irritated airways: “It was itchy, and it tickled” (boy #25, 
aged 11).
Mental discomfort
Mental discomfort included anxiousness, tiredness, feeling bored, and embarrassed. 
Some of the healthy children and children with a mild chronic condition were somewhat 
anxious because they did not know what to expect from the procedures, the hospital 
environment and researchers: “The first time I was a little scared, because I did not know 
the people [i.e. researchers], now [that I know them] it is more pleasant” (girl #14, aged 7). 
Most children felt only anxious during the first time they underwent a procedure “For 
me it is quite normal [the MRI], I know how it works. The first time I was a little bit scared but 
now I’m used to it.” (boy #13, aged 15). On the other hand, some children reported that 
they felt anxious because of previous negative experiences, which were mainly related 
to needle-procedures: “The previous time I got a needle just above my elbow. It was quite 
painful, so this time I did not look forward to it. It actually did not hurt this time but I was a 
little anxious.” (girl #24, aged 12).
Boredom was also mentioned because of the length of the research procedures (such 
as lying in an MRI scanner for up to 60 minutes, the cashew provocation test that took 
approximately four to five hours, the cognitive capacity tests) or because of a lack of 
distraction during the research procedures or while waiting. “I think it [the study] took too 
long”(girl #22, aged 8). Children also became tired and bored after having undergone 
various consecutive research procedures for several hours. Having to go to the hospital 
instead of going to play with friends or going to school and travel time were other 
discomforting aspects, mentioned by the children with chronic conditions. For eight 
children who mentioned boredom as causing discomfort, it was the most burdensome 
part of the study “You’re sitting there for 10 minutes and it [exhaled breath condensation 
test] is really boring” (girl#34, aged 9).
Most of the children undergoing Tanner staging felt somewhat embarrassed that a 
researcher was to examine their developing bodies: “I was a little embarrassed when she 
was looking if I already started puberty” (boy #44, aged 12).
Willingness to participate in the study again
About two-thirds of the children (N=28) indicated that they would, participate in the 
same research study again; five children did not know and thirteen would not. The 
reasons of children who did not want to participate again were boredom because of 
the duration of the procedures (N=3) (mentioned by children who did the cashew 
provocation test) and (travel) time (N=4) (mentioned by children with CF and IBD): “I 
don’t want to do it [participate] again because I don’t want to travel so far” (boy #8, aged 6). 
The other children, who were all children with a severe chronic condition, did not want 
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to participate again because the research procedures caused pain (N=4) or because of 
disappointment in the planning of the research visits (N=2) (i.e. the researcher said that 
these children could combine the research visits with their regular medical check-ups at 
the hospital. In practice, this was not always possible).
Children’s suggestions to reduce discomfort
About half of the children gave suggestions to reduce discomfort. Some children recom-
mended to reduce the duration of both waiting and the lengthy procedures because 
these caused boredom and tiredness: “I would make the procedures shorter and make it a 
bit more of a game” (boy #16, aged 11), or recommended to provide distraction to make 
the procedures less discomforting and/or boring: “I did not like some of the procedures. 
During these, you need to have a distraction, so you can think of something else and you are 
not thinking ‘this does not feel pleasant’” (girl #31, aged 16). Suggestions for distraction 
were watching movies, making the procedure more like a game or listening to music. 
While most hospitals do have special playrooms for children, these rooms are predomi-
nantly designed for younger children; older children mentioned that: “The waiting room 
looks like fun, but for a twelve year old there is actually not much you can do, unless you 
bring something yourself” (boy #32, aged 12).
Children with a severe chronic condition mentioned that it would be convenient if 
the study’s test results could also be used for their regular check-up. They would then 
not have to go to the hospital twice and it would cause less physical and mental discom-
fort. In addition, they would prefer the study visits to be scheduled at a convenient time 
(after school or during a regular visit to the hospital), because they did not like missing 
school, whereas most of the healthy children did not mind going to hospital as they did 
not mind missing school.
Several children mentioned that the (written) information provided about the study 
should be made more ‘age-appropriate’ as it was often too difficult to understand, or did 
not include enough information on aspects they were interested in, such as whether an 
MRI is painful or what the liquid that the child has to drink before the MRI tastes like. The 
children believed that receiving better information would make them feel less anxious.
Some children said they would have liked to get a small gift as a token of apprecia-
tion (e.g. a gift card for the movies) for their participation in the research study. Younger 
children indicated that they would like to get a sticker or diploma, which would make 
them feel proud of having undergone a research procedure, particularly if it was painful.
45
Children’s discomfort in clinical research – interview study
3
DisCUssioN
Discomfort during research procedures from the child’s perspective
In addition to the discomforts reported in prior research, we also found that children’s 
discomforts during research procedures can be nausea, shortness of breath, itchiness, 
feeling hungry, feeling embarrassed and bored. On the other hand, concerns and wor-
ries about the safety of the procedures and/or uncertainty that comes with test results, 
found in previous research,17, 18 were not mentioned by the children we interviewed. The 
children we interviewed primarily participated in non-therapeutic studies and therefore 
the results of the research procedures may not have an important influence on their 
health, which may be an explanation why concerns and worries were not mentioned.
Differences in discomfort
Age
Having included children from a wide age-range, we explored whether there might be 
age-differences in their experiences. Some of the younger (healthy) children refused 
venipuncture, but no further salient age differences were found. In most literature on 
children’s experiences during medical care, however, younger children display more dis-
tress and report more pain than older ones,e.g. 7, 31, 32 which may be because older children 
usually have more experience with a certain procedure. In general, children with more 
experience with a medical procedure report less discomfort than children who are less 
experienced.33, 34
Medical condition
The healthy children seemed to mention fewer physically discomforting aspects than 
the children with a chronic condition. This is not surprising, as the healthy children we 
interviewed did not undergo physically invasive procedures (except for venipuncture). 
The healthy children often mentioned feeling anxious and bored (i.e. mental discomfort) 
as discomfort. This is probably because these children are often unfamiliar with a hos-
pital environment, and may therefore feel anxious about not knowing what to expect. 
They are also not used to spending a day or half a day in a hospital, which can make 
them feel bored. For children with a chronic condition the fact that they had to go to the 
hospital was in itself discomforting because they said they would have preferred to do 
other things such as go to school or go and see friends. This was usually not an issue for 
the healthy children.
Another difference we noticed was that all of the healthy children would participate 
again in the research studies, while the children who did not, were all children with a 
chronic condition. Most of them did not want to participate because of logistic incon-
veniences, such as travel time and poor planning of the research visits. Previous studies 
state that logistics are important factors that both parents and children consider when 
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making a decision for participating in a (hypothetical) study.e.g. 35, 36 It is valuable to know 
that although the logistical aspects were not a factor for the parents and children we 
interviewed for refusing to participate in the clinical research studies, the children who 
did not want to participate in similar research often mentioned logistics as a reason. 
This indicates that children may not be able to completely foresee what discomfort/
inconvenience the logistics of participating in a study will cause, or they may not be 
informed well enough about the discomforts related to logistics during the informed 
consent procedure.
suggestions to reduce discomfort
Most of children’s suggestions for reducing discomfort of the clinical research procedures 
should be easy to implement in many pediatric studies, such as providing distraction 
during lengthy procedures or while waiting, by showing a movie or making research 
procedures more like a game. Distraction has proven to be effective in reducing discom-
fort during medical procedures in children of all ages,e.g. 37 and it is also cost-effective 
because of the relatively low start-up and maintenance costs.38
We think it is also feasible to provide more age-appropriate information to the 
children during assent and during the research study. Many studies show that age-
appropriate information helps to reduce anxiousness,27, 28, 39 because children will be 
more prepared what will happen during the study. Researchers could do this by using 
the format of an information letter and assent form designed by Ford et al.40 This mate-
rial was designed in consultation with a group of children and provides the information 
about participating in research children are interested to know about, and leaves out all 
information not relevant according to them. Researchers can easily adapt this letter to 
their own study. To make the information about the study more appealing to children, 
researchers might think of other ways of informing children about their study. For in-
stance, in a recent study a comic strip was used to support children’s understanding 
of participating in research. Children enjoyed reading the material and liked it that the 
information was provided as a comic story format instead of plain text.41 When children 
like the way the information is presented, it may help to increase their understanding of 
what the study will be like.
In addition, it should be within reach of the researcher to give children a small gift, 
a sticker, or a diploma after the study. Giving children a small gift does not necessarily 
reduce discomfort, but it helps to give children the feeling that their participation is 
valued, especially children who do not directly benefit from the research study (i.e. non-
therapeutic research).
On the other hand, some of the children’s suggestions may be harder or even impos-
sible to implement, for instance, coordinating research visits with regular check-ups at 
the hospital. Although it is understandable from the perspective of the children with a 
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chronic condition, rooms are limited in hospitals and researchers have to adapt to the 
availability. Also, the children’s pediatricians are not always the same ones who perform 
the clinical research procedures, which makes it difficult to schedule research visits and 
regular visits consecutively. A possible solution could be for researchers and children’s 
health care staff to consult the hospital’s or department’s administration office before 
the start of the study to see if there are possibilities to combine research with regular 
visits.
Since each research study involves different research procedures, children’s sugges-
tions to reduce discomforts may differ across different studies. It is therefore important 
that all researchers ask children for suggestions to reduce discomfort during their stud-
ies. For instance, researchers could ask children in the pilot phase of the study about 
suggestions for reducing discomfort and incorporate the feasible ones at a later stage 
of the study.
Limitations
Although we interviewed a diverse group of children undergoing a wide range of clini-
cal research procedures, a limitation of our study is that we did not interview children 
who underwent severe invasive research procedures, such as bone marrow aspirations 
or biopsies. These procedures may be conducted in studies with children with acute 
life threatening conditions. The discomforts experienced by these children may include 
aspects not identified in this study.
recommendations
Additional research is needed for severe invasive research procedures, so as to identify 
possible other discomforts. Furthermore, we suggest that mental discomforts should 
be given more attention in the evaluation of discomfort in pediatric study protocols, 
which is in accordance with a previous study that children may be more focused on the 
immediate psychological discomforts than physical discomforts and risks.42
This qualitative study gives a broad view on children’s discomforts during clinical re-
search procedures, but does not provide numeric representativeness. Therefore, a next 
step is a quantitative study of the self-reported discomforts of children during clinical 
research procedures to get an insight into the number of children that experience these 
discomforts and the degrees of discomfort experienced by the children. Larger sample 
sizes make it also possible to investigate whether there are differences in discomfort 
between subgroups (e.g. healthy versus chronically ill children, younger versus older 
children, research procedures for therapeutic purposes versus non-therapeutic research 
procedures).
Kassam-Adams and Newman previously recommended systematically monitoring 
children’s experiences in research studies.13 We support their recommendation, and 
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suggest to take this a step further, and also ask children about discomforts during the 
specific research procedures of the studies. If children’s personal experiences during 
clinical research procedures are systematically monitored, IRBs and pediatric research-
ers have empirical information to guide them when evaluating the discomforts of the 
research procedures described in study protocols or when designing a study. Informa-
tion on experiences of children involved in previous studies may also help children and 
parents in future research with their decision-making concerning participation in clini-
cal research, or parts thereof. Additionally, if children are systematically asked for their 
suggestions for improvements, research procedures in future studies can be conducted 
with minimized discomfort.
Conclusion
Our study provides further insight into what discomforts children can experience during 
clinical research procedures, and it provides unique information on how discomforts of 
research procedures could be reduced according to the children involved. It is important 
that IRBs and pediatric researchers take into account that discomfort for children dur-
ing research procedures includes various physical discomforts (e.g. pain, shortness of 
breath, feeling hungry, itchiness) and mental discomforts (e.g. feeling anxious, bored 
and embarrassed).
Research is needed to investigate children’s possible discomforts in a greater 
number of research procedures and during more invasive procedures. IRBs can benefit 
from this knowledge when evaluating the discomfort of research procedures in study 
protocols. Information on the discomforts of children involved in previous studies, may 
also help children and parents in future research with their decision-making concerning 
participation in clinical research.
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APPeNDix A. iNterVieW sCHeDULe
General experiences
How did you feel about the study in general?
How did you feel before the study?
How did you feel afterwards?
Can you describe your experiences during the study?
Can you describe your experiences during procedure X?
experiences related to discomfort
Can you describe any discomfort you experienced in the study?
Is there any part of the study that you did not like? Which part? Why?
Can you describe any discomfort you experienced because of procedure X?
Worst experiences
What was/were the most burdensome/discomforting part(s) of the study? Which part? 
Why?
Preparation
Who prepared you for the study?
What information did you get about the study? Was this information sufficient?
Did you know what to expect of the study?
suggestions to reduce discomfort
Can you think of anything that would have made the study easier for you? If so, could 
you tell me about it?
Can you think of anything that will make procedure X less discomforting for you? If so, 
could you tell me about it?
Can you think of anything that will make procedure X more comfortable for you? If so, 
could you tell me about it?
future research
Would you participate in this research study again? Why (not)?
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APPeNDix B. DesCriPtioN of tHe iNCLUDeD CHiLDreN
iD Gender Age in years Health condition (non) therapeutic 
study
1. Girl 7 IBD Non-therapeutic
2. Boy 6 Healthy Non-therapeutic
3. Girl 6 Healthy Non-therapeutic
4. Boy 17 IBD Non-therapeutic
5. Boy 8 IBD Non-therapeutic
6. Boy 6 Healthy Non-therapeutic
7. Boy 17 IBD Non-therapeutic
8. Boy 6 Healthy Non-therapeutic
9. Girl 11 Asthma Non-therapeutic
10. Girl 11 CF Therapeutic
11. Boy 9 CF Therapeutic
12. Boy 14 IBD Non-therapeutic
13. Boy 15 IBD Non-therapeutic
14. Girl 7 Cashew allergy Therapeutic
15. Boy 6 Cashew allergy Therapeutic
16. Girl 17 IBD Non-therapeutic
17. Girl 6 Cashew allergy Therapeutic
18. Boy 8 Cashew allergy Therapeutic
19. Boy 6 Asthma Non-therapeutic
20. Boy 15 CF Therapeutic
21. Boy 17 CF Therapeutic
22. Girl 8 Asthma Non-therapeutic
23. Boy 11 CF Therapeutic
24. Girl 12 Cashew allergy Therapeutic
25. Boy 11 Cashew allergy Therapeutic
26. Boy 11 CF Therapeutic
27. Girl 11 IBD Non-therapeutic
28. Girl 13 Cashew allergy Therapeutic
29. Girl 16 IBD Non-therapeutic
30. Boy 13 CF Therapeutic
31. Girl 16 Asthma Non-therapeutic
32. Boy 13 Healthy Non-therapeutic
33. Girl 12 Healthy Non-therapeutic
34. Girl 9 CF Therapeutic
35. Boy 17 IBD Non-therapeutic
36. Boy 12 Healthy Non-therapeutic
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37. Girl 6 Healthy Non-therapeutic
38. Girl 12 Healthy Non-therapeutic
39. Boy 15 Healthy Non-therapeutic
40. Girl 15 IBD Non-therapeutic
41. Girl 12 Healthy Non-therapeutic
42. Boy 6 CF Therapeutic
43. Girl 12 Asthma Non-therapeutic
44. Boy 12 Healthy Non-therapeutic
45. Girl 16 Asthma Non-therapeutic
46. Boy 16 Asthma Non-therapeutic
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ABstrACt
Background. There is a need for data on children’s self-reported discomfort in clinical 
research, making the evaluations of discomfort by ethics committees evidence-based. 
Because there is no appropriate instrument to measure children’s discomfort, we aimed 
to develop a generic, short and child-friendly instrument: Children’s Discomfort during 
Research Procedures Questionnaire (CDRPQ).
methods. This article describes the six steps of the development of the CDRPQ. First, we 
updated a literature search on children’s self-reported discomfort in clinical research to 
get insight in what words are used to measure discomfort (step 1). Subsequently, we in-
terviewed 46 children (6-18 years) participating in research to get insight into important 
forms of discomfort for children (step 2), and asked them about their preferred response 
option for measuring discomfort (step 3). Next, we consulted nine paediatric experts 
from various backgrounds for input on the content and feasibility of the CDRPQ (step 4). 
Based on input from these previous steps, we developed a draft version of the CDRPQ, 
which we discussed with the experts. The CDRPQ was then pretested in 25 children to 
ensure face-validity from the child’s perspective and feasibility (step 5). Finally, validity, 
reliability and internal consistency were tested based on the scores of 418 children (step 
6).
results. The search update revealed several words used for measuring discomfort in 
research (e.g. ‘worries’, ‘unpleasantness’). The interviews gave insight into important 
forms of discomfort for children in research (e.g. ‘pain’, ‘boredom’). Children preferred 
a 5-point Likert scale as response option for the CDRPQ. The experts recommended 
a short, digital instrument involving different forms of discomfort, and measuring 
discomfort of individual research procedures. Pretesting of the CDRPQ resulted in a 
few layout changes, and feedback from the children confirmed the feasibility of the 
CDRPQ. Convergent validity and test-retest reliability were acceptable. Internal con-
sistency based on item-rest correlations and Cronbach’s alpha were low, as expected.
Conclusions. The CDRPQ is a generic, practical and psychometrically sound instrument 
for measuring children’s discomfort during research procedures. It contributes to make 
the evaluation of discomfort in paediatric research evidence-based. Therefore, we rec-
ommend including the CDRPQ as standard component of paediatric research studies.
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BACkGroUND
Institutional Review Boards (IRBs) estimate children’s discomfort in research but have 
little information on children’s self-reported discomfort during the research procedures 
to guide their decision-making.1 They therefore often have to rely on their own expertise 
and experience in paediatric care, which can give a biased view as literature shows that 
adults often perceive children’s discomfort in medical settings higher than the children 
themselves.2-4 In addition, a study by Shah et al. shows that among IRB chairs there is little 
consensus on the level of discomfort of research procedures.5 It is therefore important to 
take children´s own perspectives into account when evaluating discomfort of research 
procedures to make this evaluation evidence-based. This argument is reflected in dif-
ferent reports, stating that it is necessary to define and permanently monitor children’s 
discomforts during research procedures.6, 7 Moreover, it is reflected in Article 12 of the 
United Nations Convention on the Rights of the Child that children deserve to give their 
opinion in matters that concern them.8
The need to have self-reported data about the experiences of children in clinical 
research is seen, for instance, by the development of the Reactions to Research Par-
ticipation Questionnaire for Children (RRPQ-C)9 and the Pediatric Research Participation 
Questionnaire (PRPQ).10 Although these questionnaires give a general view of paediatric 
research participation (e.g. trust in the research team), they give limited insight into dis-
comfort, and do not address children’s experiences during the individual research pro-
cedures of a study. Since it is preferable that IRBs evaluate discomfort of the individual 
research procedures within a study,11, 12 the so-called component-analysis approach,13 it 
is important to have information on the discomfort of individual research procedures as 
well. Such information can be generalized across different research studies with similar 
procedures to estimate the level of discomfort that might be expected for children in 
future research with a given procedure.
In the absence of an appropriate instrument, we aimed to develop a questionnaire 
measuring children’s self-reported discomfort during research procedures. We aimed for 
a generic questionnaire that measures forms of discomfort relevant for all kinds of medi-
cal research procedures to enable comparisons between different research procedures, 
omitting aspects that are too specific (e.g. ‘feeling out of breath’ is only relevant for 
certain research procedures). We also aimed to use a very limited number of questions, 
as the questionnaire should be short and easy to complete, and we did not want our 
questionnaire to be an extra burden for research participation. This paper describes 
the step-by-step development of the questionnaire: the Children’s Discomfort during 
Research Procedures Questionnaire (CDRPQ).
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metHoDs
step 1. Literature search
To gain insight into children’s discomfort in clinical research, two of the authors (JH 
and JP) first reviewed the state of knowledge regarding children’s discomfort or risk of 
children and adolescents who participate in research.1 They searched literature from 
onset to December 2010. Inclusion criteria were: published in a peer-reviewed journal, 
empirical studies that addressed children’s self-reported experiences in clinical research, 
and written in English. Studies on parental burden, burden of illness, economic burden, 
non-empirical studies, and studies on the willingness to participate in medical research 
were excluded. They found eight articles concerning discomfort or risk. They concluded 
that studies on children’s self-reported discomfort in clinical research are scarce.
For the development of the CDRPQ we specifically looked at the words that these 
studies used to get insight into discomfort. We also carried out an update and extension 
of this search (Appendix A), for which PubMed, PsycINFO, Web-of-Science, Cochrane 
central, Medline and Embase were searched from onset to December 2012.
step 2. interview study
To incorporate the perspective of the children for item-generation, we conducted a 
qualitative study in 46 children (aged 6-18, M=11.9, SD=3.8) participating in different 
kinds of research studies (experimental, observational or follow-up studies) at two pae-
diatric academic hospitals. The aim of these interviews was to get insight into important 
forms of discomfort for children during research procedures, and what words they use 
to describe discomfort. A majority of these children (74%) was considered ill (asthma, 
cystic fibrosis, cashew allergy, Inflammatory Bowel Syndrome) and an approximately 
even number of boys and girls was enrolled. Twenty-four different research procedures 
were performed on the children, which included both invasive (such as needle-related 
procedures, provocation tests) and non-invasive procedures (such as pulmonary func-
tion tests, taking medical history, questionnaires). Children were interviewed directly 
after the study visit. The interview schedule is provided in Appendix B.
Audiotaped interviews were transcribed verbatim and imported into NVivo 10.0 
software.14 To ensure anonymity, all identifying information was removed from the 
transcripts. Data were analysed using ‘thematic analysis’, which was chosen to categorise 
important themes related to discomfort.15 The first author analysed the interviews and 
a supervising researcher independently analysed 25% of the interviews. Disagreements 
were discussed until consensus was reached.
step 3. Children’s preferred response option
The aim of this step was to measure the type of response option children prefer for our 
questionnaire measuring discomfort, because literature is inconclusive about the ‘best’ 
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response option for children to report their experiences in medical situations.16-21 After 
the interview, children were asked to answer five written questions about their experi-
ences with the research procedures. Forty-one of the 46 children (89%) of the previous 
step completed all five questions. These questions were based on input from literature, 
paediatricians, paediatric nurses and psychologists. Each question had three different 
types of response options: a 5-point Likert scale, a coloured numeric 100mm visual 
analogue scale (VAS) (ranging from green ‘no discomfort’ to red ‘extreme discomfort’), 
and a simple 100mm black line VAS. Children were asked to fill in all three response op-
tions for the five questions and at the end we asked them which option they preferred. 
We calculated Spearman correlations for the three different response options of each 
question to detect a possible discrepancy. We intentionally did not include a ‘faces’ 
scale because the reliability is often poor in older children,22 and we preferred to have 
a response option for children of all ages, without it coming across as being childish. 
Frequencies were used to determine children’s preference for a response option. We also 
determined whether there were preferences for a specific response option related to 
age differences by using a one-way ANOVA.
step 4. Consulting an expert panel
In order to develop a questionnaire that met the needs of paediatric healthcare profes-
sionals, we consulted an expert panel involving nine paediatric healthcare professionals 
from different backgrounds and disciplines: three paediatricians (one of which held a 
PhD in research ethics concerning paediatric research participation); one paediatric 
research nurse; one paediatric research coordinator at an academic hospital, who was 
also a member of an IRB; a chairman of a parent association for children with Duchenne 
muscular dystrophy; two psychologists, and a pedagogic. The aim of this phase was to 
incorporate the perspective of paediatric experts for item-generation and to discuss 
the practical implementation of the instrument. We presented the information that we 
had gathered from the literature, the interview study, the preference for a response op-
tion, and discussed about the content and layout of the questionnaire. The information 
gained from the previous steps and the input from the experts was used to develop a 
draft questionnaire of the CDRPQ. We then presented this draft questionnaire to the 
experts for additional review.
step 5. Pretesting the CDrPQ
The draft version of the CDRPQ was pretested on 25 children in clinical research to en-
sure feasibility and face-validity from the child’s perspective. The children were asked to 
comment on relevance and comprehensiveness of the items, whether they understood 
the questions, whether using the questionnaire on an iPad-mini led to practical issues, 
and whether the time needed to complete the CDRPQ was acceptable.
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step 6. Psychometrics of the CDrPQ
The final step of the development of the CDRPQ was testing its psychometrics, using 
the scores of 418 children (8-18 years, M=10.9 ± 2.1): 307 children in clinical research, 
61 in routine clinical care (ultrasound imaging, MRI scans, pulmonary function test) and 
50 children during dental check-ups. The latter two groups were included because of a 
research question for another study, but we also used them for validation purposes of 
the CDRPQ. The minimum age for the child’s participation in this study was eight years, 
because the questionnaire we used for measuring convergent validity is only suitable 
for children aged eight and older (Children’s version of the Impact of Event Scale,23 and 
because some of the children aged six or seven (step 3) had difficulties with answering 
the written questions. An approximate equal percentage of boys and girls participated. 
About 75% of the children were healthy (i.e. they did not have a known disease). All 
children completed the CDRPQ directly after undergoing the procedure.
Validity (convergent)
Event-related (traumatic) distress
For other research purposes, the Children’s version of the Impact of Event Scale 
(CRIES-13) was used:23 a self-report scale that measures the frequency of event-related 
(traumatic) distress. This gave us the possibility to compare the scores of the CDRPQ 
with those of the CRIES-13 as an indication of the convergent validity of the CDRPQ. 
The CRIES-13 consists of 13 items, which are divided into three subscales: avoidance 
(four questions, e.g. ‘Did you try not to talk about it?’), intrusion/re-experiencing (four 
questions, e.g. ‘Did pictures about it pop into your mind?’), and arousal (five questions, 
e.g. ‘Did you get easily irritable?’). Children have to rate each question on a 4-point 
Likert scale, with the following weights and categories: 0 = ‘not at all’, 1 = ‘rarely’, 3 = 
‘sometimes’, 5 = ‘often’. When a child has a total score of 30 or above on the CRIES-13, this 
child is considered to have clinically elevated stress response symptoms.24 The CRIES-13 
demonstrates satisfactory to good psychometric characteristics,25 and has good internal 
consistency for the total score (Cronbach’s α = 0.80). To measure the convergent validity 
of the CDRPQ, we calculated a Spearman correlation between the average discomfort 
score of the CDRPQ, which is based on the different forms of discomfort, and the total 
score of the CRIES-13.
Parents’ ratings
We asked parents to rate their child’s annoyance during the procedures in order to 
measure convergent validity. We compared the children’s scores on annoyance (one 
of the questions of the CDRPQ) with their parents’ ratings of annoyance by calculating 
the weighted kappa between these ratings.26, 27 The reason for choosing ‘annoyance’ is 
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that it reflects a general discomfort rather than a specific, and because we focused on 
children’s self-report rather than proxy reports.
Internal consistency
To evaluate the internal consistency of the CDRPQ, we calculated Spearman correlations 
between each of the forms of discomfort (e.g. nervousness) and the discomfort score 
averaged across the other forms of discomfort while correcting for self-correlation (i.e. 
item-rest correlations). As discomfort was shown to be a multidimensional construct 
(Step 2), it was expected that these correlations would be modest, as well as the Cron-
bach’s alpha which was calculated too.
Test-retest reliability
We measured discomfort of the procedures twice: directly after undergoing the pro-
cedure and after one month. Test-retest reliability of the CDRPQ was calculated with 
Spearman correlations of different forms of discomfort and the average discomfort 
score directly after the procedure and after one month. Additionally, to test the stability 
in level of discomfort over time, we analysed a possible difference between the two 
measurement moments with Wilcoxon’s signed rank tests.
resULts
A diagram of the different steps of the questionnaire development is presented in Figure 1.
step 1. Literature search
For the initial search 413 abstracts were identified of which eight were included that 
were focused on discomfort or risk. For item-generation of the CDRPQ, we identified 
‘discomfort’, ‘(un)comfortable’, ‘scared’, ‘worries’ and ‘(un)pleasantness’ as possible items 
based on the included articles. The extension and update of the search from onset until 
December 2012 revealed 2780 potential articles, but did not reveal new original empiri-
cal studies on children’s self-reported discomfort related to medical research procedures 
in addition to the initial search.
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figure 1. Scheme of the diff erent steps of the development of the CDRPQ
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step 2. interview study
The majority of the children experienced various forms of discomfort. Forms of discom-
fort that were frequently mentioned included feeling tired, having pain, feeling nervous/
anxious because of anticipated pain or not knowing what to expect from the research 
study, shortness of breath, nausea, itchiness, and feeling hungry, feeling frightened, 
feeling bored because of the duration and/or waiting, and feeling ashamed. These vari-
ous forms of discomfort suggest that discomfort is a multidimensional construct. The 
extensive description of the results of the interview study is published elsewhere.28
Half of the children, in particular the younger ones, did not know the meaning of 
‘discomfort’ or ‘burden’ or did not know how to describe the word. The most frequently 
mentioned description by the children who did understand the word said discomfort 
means ‘annoying’.
step 3. Children’s preferred response option
For each of the fi ve questions, the three diff erent response options (Likert scale, coloured 
numeric VAS, simple VAS) were strongly correlated (rho=0.76-0.99, p < 0.01). Twenty-
one children (51%) preferred the 5-point Likert scale, followed by 14 children (34%) 
preferring a coloured numeric 100mm VAS (Table 1). Two children (aged six and eight) 
spontaneously said they would have preferred a faces scale. There were no age-related 
diff erences for the preferred response option (p = 0.21).
table 1. Preference for response option
Number of children Percentage
5-point Likert scale 21 51.2%
Coloured 100mm VAS 14 34.1%
Plain 100mm VAS 2 4.9%
No preference 2 4.9%
5-point Likert scale or coloured 100mm VAS 1 2.4%
Coloured 100mm VAS or plain 100mm VAS 1 2.4%
Total 41 100.0%
step 4. Consulting an expert panel
During the expert panel meeting, the paediatric healthcare professionals gave practical 
suggestions for the development of the questionnaire. The most important suggestions 
are presented in Table 2.
In consultation with the experts we included the most frequently mentioned and 
relevant forms of discomfort, mentioned in Step 2, into the CDRPQ: ‘feeling nervous’, 
‘feeling annoyed’, ‘having pain’, ‘feeling frightened’, ‘feeling bored’, and ‘feeling tired’. 
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‘Annoyed’ was included because children frequently mentioned it as a synonym for 
discomfort, and moreover it represents a generic form of discomfort.
Although feeling ashamed/embarrassed, shortness of breath, nausea, itchiness, and 
feeling hungry are important forms of discomfort that were frequently mentioned by 
children as well, we decided not to include these as items, as these are only relevant for 
certain research procedures. In consultation with the experts, we did not use the forms 
of discomfort we found during literature search because the children did not mention 
these once during the interview study.
In addition to the questions about discomfort, we added three questions to the 
CDRPQ: 1) a question about ‘having fun’ because the experts mentioned that the CDRPQ 
should not only focus on negative experiences, 2) a question about suggestions on how 
to reduce discomfort related to the research procedure which can help researchers to 
improve their studies, and 3) a question whether children would undergo the research 
procedure in the future. We used Qualtrics© software to design a digital version of the 
CDRPQ, which we used on an iPad-mini tablet.
Based on the previous steps and the consultation with the expert panel, we de-
veloped a draft version of the CDRPQ in which we incorporated their suggestions. We 
discussed this draft version with the experts until we reached consensus on the content 
and the phrasing of the questions.
step 5. Pretesting the CDrPQ
Children during pretesting found it easy to complete the CDRPQ and reported that 
they experienced no discomfort or burden because of the CDRPQ. Instead, many said 
they liked filling in the CDRPQ. They understood the questions, most considered the 
table 2. Suggestions of the expert panel about the questionnaire
suggestions
1. The questionnaire should be administered digitally to make it more appealing to children and easier to 
distribute data to other researchers.
2. The questionnaire should be short, because children and parents are already loaded with questionnaires in 
research, e.g. about their health status. Questionnaires themselves are often perceived as a burden. They also 
indicated that the questionnaire should be short, so it does not interfere with their research studies.
3. Parents should also be asked to rate their child’s discomfort to study whether their ratings are similar.
4. The discomfort of individual research procedures should be measured because IRBs often evaluate the 
discomfort of the various research procedures of a study separately (i.e. component analysis approach).
5. Children do not like to fill in questionnaires that focus only on negative experiences. They should therefore 
also be asked about positive experiences (i.e. whether children liked the research procedures).
6. As children are the subjects who undergo the procedures, they probably have good ideas how to improve 
these. Therefore, children should be asked about improvements, which is useful for researchers to design 
the study to minimize discomfort
7. It is helpful to know whether children would undergo the research procedure in the future to get an 
impression of the child’s discomfort.
67
The development of the CDRPQ
4
questions were relevant for getting insight into their experiences during the research 
procedures, and said that they preferred an online questionnaire to a paper one, just 
as the expert panel had expected. However, the Internet connection failed sometimes 
(in three children), in which case the CDRPQ was administered on paper. Some children 
considered the question about ‘liking the research procedure’ irrelevant. They said that 
if they did not like the research procedure, it did not mean that they experienced the 
procedure as discomforting, and vice versa. The children said that they did not mind that 
the questions were primarily about negative experiences. Furthermore, the children 
provided some recommendations to improve the layout of the questionnaire (i.e. larger 
font, fewer questions on one page).
step 6. Psychometrics of the CDrPQ
Validity (convergent)
We observed a moderate Spearman correlation (r = 0.43; p < 0.001) between the average 
score on the CDRPQ and the total score of the CRIES-13. The weighted kappa between 
the rating of the parents and children on the child’s annoyance was 0.41, which is con-
sidered moderate.29
Internal consistency
Spearman correlations reflecting the contribution of the individual forms of discomfort 
on the average discomfort score are presented in Table 3. All the correlations were 
statistically significant (p < 0.05), but were low, implying that discomfort is determined 
by diverse non-overlapping aspects. This was also illustrated by a low Cronbach’s alpha 
(0.547).
Test-retest reliability
The test-retest reliability of the items of the CDRPQ, directly after the procedure and 
after one month, was high (Table 3). The retest scores did not differ significantly from the 
baseline scores for any of the items.
The final version of the CDRPQ is presented in Appendix C (Note: the CDRPQ was 
developed in Dutch and then translated to English for this manuscript). We removed 
two questions from the final version, namely: ‘Did you like undergoing procedure X?’ 
and ‘Would you undergo research procedure X again in the future?’. The first question 
was removed because, like the pretest, a considerable number of children regarded this 
question as irrelevant; they said they did not mind the CDRPQ focusing on negative ex-
periences. The latter question was removed because on further consideration, it did not 
give additional insight into the child’s discomfort over and above the other questions.
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DisCUssioN
This article describes the development of the CDRPQ, which was designed to measure 
discomfort of common medical research procedures in children (8-18 years) in order to 
make the evaluation of discomfort in clinical research evidence-based. Since there is no 
‘gold standard’ for measuring discomfort of research procedures (e.g. by self-report, by 
proxy, or by physiological measures such as cortisol levels), we focused on self-report 
because children’s self-reports are an important source of information that cannot be 
ignored and because we do not have much information on discomfort from children’s 
perspectives.
In general, we found that the CDRPQ is a reliable and valid questionnaire to measure 
generic discomfort related to medical research procedures, and can be easily completed 
by children between the ages of 8 to 18. The children themselves indicated that they 
liked completing the CDRPQ and did not experience it as being burdensome.
The moment of measurement (directly after the procedures versus after one month) 
did not significantly influence children’s answers, as there were no significant differences 
in discomfort between these measurement moments in our sample. This suggests that 
it is not necessary to complete the CDRPQ directly after the procedure. Children can 
complete it at a more convenient moment, for instance at home, which may be less 
burdensome for them.
Although the CDRPQ was developed to measure discomfort in clinical research, the 
questionnaire could be used for measuring discomfort in clinical care as well. The reason 
why we focused on research is because there are strict guidelines for the level of dis-
comfort, while these do not exist in clinical care. Although there are several instruments 
measuring children’s negative experiences in medical situations in clinical care,30-40 
limitations of these instruments are that these primarily focus on the measurement of 
table 3. Item-correlation with average discomfort score, test-retest correlations, differences in measure-
ment moment
Item-rest 
correlation with 
average score
N=418
p-value Test-retest
correlation
N=115
p-value1) Wilcoxon’s
Z
N=115
p-value
Nervousness 0.202 <0.001 0.665 <0.001 -0.011 0.991
Annoyed 0.401 <0.001 0.586 <0.001 -0.461 0.645 
Pain 0.262 <0.001 0.725 <0.001 -0.600 0.549 
Frightened 0.275 <0.001 0.525 <0.001 -0.209 0.835 
Bored 0.163  0.001 0.440 <0.001 -1.213 0.222 
Tired 0.248 <0.001 0.510 <0.001 -1.673 0.225 
Average discomfort score n/a  n/a 0.710 <0.001 -1.146 0.252 
1) p-values are one-sided
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pain or distress. The interviews with the children showed that discomfort is an umbrella 
term that also represents other forms of discomfort than pain and anxiety. Measuring a 
variety of forms therefore provides a more thorough measure of the child’s discomfort 
in clinical research.
strengths and limitations
A strength of the CDRPQ is that the content is based on literature, and input from children 
and paediatric healthcare professionals. It gives a good overview of discomfort experi-
enced by children during research procedures in a short time. The CDRPQ is a generic 
questionnaire that makes it possible to compare the discomfort caused by different 
research procedures. The CDRPQ helps to identify discomfort from a procedures-related 
approach rather than a study-related approach, and therefore provides crucial comple-
ment to existing instruments measuring children’s experiences in research, such as the 
RRPQ-C and PRPQ. Furthermore, the CDRPQ not only focuses on discomfort, but also on 
suggestions by children to reduce discomfort. This provides paediatric researchers with 
practical information to minimize discomfort of their studies, which is also a require-
ment of various ethical codes and regulations on paediatric research participation.41, 42
We administered the CDRPQ online, which has several advantages compared to 
paper-and-pencil questionnaires in terms of completeness of data (i.e. it can remind 
users that they skipped a question), less proneness to social desirability answering, and 
higher-cost effectiveness.43 In addition, the outcomes of an online questionnaire can be 
easily stored online, which can make it easy for children, parents, IRBs, and paediatric 
researchers to have access to this information.
The CDRPQ is limited in a way that for some procedures certain important forms 
of discomfort are not measured, which may give an incomplete view of the overall 
discomfort. For instance, for children during Tanner staging, embarrassment may be an 
important for of discomfort. It is time-consuming to measure all forms of discomfort for 
all kinds of research procedures, which is why we decided to develop a generic ques-
tionnaire, suitable to compare discomfort of different research procedures and between 
different groups of children.
The validation of the CDRPQ is limited. For instance, measuring convergent valid-
ity between parents’ and children’s scores was only based on one of the questions of 
the CDRPQ. Another limitation is the way ‘test-retest reliability’ is measured, which was 
based on retrospective recall. The situation during the retest is not equal to the first 
test, as time has passed since the research took place. A ‘real’ test-reliability would imply 
that the child would have to undergo the research procedure and the measurement of 
discomfort a second time, which is obviously unethical solely for the development of a 
questionnaire. However, assuming it has an equal effect on all children, the Spearman 
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correlation we used is considered adequate for this purpose, as it reflects the order of 
the responses, not the level.
future research
We are the first to validate the CDRPQ in Dutch children. Additional validation of the 
CDRPQ is needed, as is validation in other languages. It would be helpful to measure 
convergent validity based on all questions of the CDRPQ, reported by parents, research-
ers and children. Furthermore, future research is needed to investigate whether the 
CDRPQ can also be used in younger children (< 8 years).
future directions
The CDRPQ can help to establish the level of discomfort of research procedures (i.e. 
‘minimal’, ‘minor increase over minimal’, and ‘more than minimal’). As there is no clear 
description when a research procedure involves minimal discomfort, Westra et al. pro-
pose that “empirical data, expert opinions and/or the procedural characteristics suggest 
that at most a quarter of the persons (25%) concerned will experience considerable dis-
comfort”.44 Considerable discomfort could be conceptualized as children who reported 
“very” or “extremely” discomfort on the average score of the CDRPQ. Although it can be 
questioned whether 25% is a fair cut-off level, it gives IRBs and paediatric researchers 
guidance for the evaluation of discomfort and make it evidence-based.
In order to collect information on children’s discomfort during research procedures, 
it would be helpful if paediatric researchers include the CDRPQ as a standard compo-
nent to their studies, and IRBs explicitly recommend paediatric researchers to do this. 
The information ideally would be published online (anonymously), so that the whole 
field of paediatric research can benefit from this information.
CoNCLUsioNs
The CDRPQ is a generic, short and practical instrument for measuring children’s discom-
fort during research procedures. It contributes to make the evaluation of discomfort in 
paediatric research evidence-based. We recommend including the CDRPQ as a standard 
component of paediatric research studies to measure children’s discomfort.
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APPeNDix A. seArCH striNG to seArCH for LiterAtUre reLAtiNG to 
CHiLDreN’s exPerieNCes iN reseArCH
emBAse
((annoy* OR anxiet* OR bored* OR emotion* OR fear* OR feeling* OR frustrat* OR help-
less* OR irritat* OR mood* OR pleasure* OR regret* OR shame OR sorrow* OR coping 
OR cope OR coped OR stress* OR distress* OR burden OR perception* OR perceive* 
OR experience* OR comfort* OR discomfort*) NEAR/6 (procedure* OR technique* OR 
research* OR imaging* OR mri OR anesthe* OR anaesthe* OR intubat* OR surger* OR 
surgic* OR cannulat* OR infus* OR inject* OR ‘drug administration’ OR ‘x ray’ OR dialys* 
OR invasive OR noninvasive)):ab,ti AND (child/exp OR newborn/exp OR ‘child behavior’/
de OR ‘child psychology’/de OR ‘child hospitalization’/de OR (infan* OR newborn* OR 
(new NEXT/1 born*) OR baby OR babies OR neonat* OR child* OR kid OR kids OR tod-
dler* OR teen* OR boy* OR girl* OR minors OR underag* OR (under NEXT/1 ag*) OR 
juvenil* OR youth* OR kindergar* OR puber* OR pubescen* OR prepubescen* OR prepu-
bert* OR pediatric* OR paediatric* OR school* OR preschool* OR highschool*):ab,ti OR 
((adolescent/exp OR adolescence/exp OR adolescen*:ab,ti) NOT (adult/exp OR aged/exp 
OR ‘middle aged’/de OR (adult*):ab,ti))) AND (psychology/exp OR ‘psychological aspect’/
de OR (psychol*):ab,ti) AND (questionnaire/exp OR ‘self report’/de OR interview/exp 
OR ‘nonverbal communication’/exp OR observation/de OR ‘clinical observation’/de OR 
(questionnaire* OR ((self OR child*) NEAR/3 report*) OR interview* OR nonverb* OR (non 
NEXT/1 verb*) OR observ*):ab,ti)
medline in ovidsP
((annoy* OR anxiet* OR bored* OR emotion* OR fear* OR feeling* OR frustrat* OR help-
less* OR irritat* OR mood* OR pleasure* OR regret* OR shame OR sorrow* OR coping 
OR cope OR coped OR stress* OR distress* OR burden OR perception* OR perceive* 
OR experience* OR comfort* OR discomfort*) ADJ6 (procedure* OR technique* OR 
research* OR imaging* OR mri OR anesthe* OR anaesthe* OR intubat* OR surger* OR 
surgic* OR cannulat* OR infus* OR inject* OR drug administration OR x ray OR dialys* OR 
invasive OR noninvasive)).ab,ti. AND (exp child/ OR exp infant, newborn/ OR exp child 
behavior/ OR child psychology/ OR (infan* OR newborn* OR (new ADJ born*) OR baby 
OR babies OR neonat* OR child* OR kid OR kids OR toddler* OR teen* OR boy* OR girl* 
OR minors OR underag* OR (under ADJ ag*) OR juvenil* OR youth* OR kindergar* OR 
puber* OR pubescen* OR prepubescen* OR prepubert* OR pediatric* OR paediatric* OR 
school* OR preschool* OR highschool*).ab,ti. OR ((adolescent/ OR adolescen*.ab,ti.) NOT 
(exp adult/ OR (adult*).ab,ti.))) AND (exp psychology/ OR (psychol*).xs,ab,ti.) AND (exp 
questionnaires/ OR Interviews as Topic/ OR Interview, Psychological/ OR exp nonverbal 
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communication/ OR observation/ OR (questionnaire* OR ((self OR child*) ADJ3 report*) 
OR interview* OR nonverb* OR (non ADJ verb*) OR observ*).ab,ti.)
PsyciNfo in ovidsP
((annoy* OR anxiet* OR bored* OR emotion* OR fear* OR feeling* OR frustrat* OR help-
less* OR irritat* OR mood* OR pleasure* OR regret* OR shame OR sorrow* OR coping OR 
cope OR coped OR stress* OR distress* OR burden OR perception* OR perceive* OR ex-
perience* OR comfort* OR discomfort*) ADJ6 (procedure* OR technique* OR research* 
OR imaging* OR mri OR anesthe* OR anaesthe* OR intubat* OR surger* OR surgic* OR 
cannulat* OR infus* OR inject* OR drug administration OR x ray OR dialys* OR invasive 
OR noninvasive)).id,ab,ti. AND (100.ag. OR exp Child Attitudes/ OR child psychology/ OR 
(infan* OR newborn* OR new born* OR baby OR babies OR neonat* OR child* OR kid 
OR kids OR toddler* OR teen* OR boy* OR girl* OR minors OR underag* OR under ag* 
OR juvenil* OR youth* OR kindergar* OR puber* OR pubescen* OR prepubescen* OR 
prepubert* OR pediatric* OR paediatric* OR school* OR preschool* OR highschool*).
id,ab,ti.) AND (exp psychology/ OR (psychol*).ab,ti.) AND (exp questionnaires/ OR exp 
Interviews/ OR exp nonverbal communication/ OR (questionnaire* OR ((self OR child*) 
ADJ3 report*) OR interview* OR nonverb* OR non verb* OR observ*).id,tm,ab,ti.)
Cochrane central
((annoy* OR anxiet* OR bored* OR emotion* OR fear* OR feeling* OR frustrat* OR help-
less* OR irritat* OR mood* OR pleasure* OR regret* OR shame OR sorrow* OR coping 
OR cope OR coped OR stress* OR distress* OR burden OR perception* OR perceive* 
OR experience* OR comfort* OR discomfort*) NEAR/6 (procedure* OR technique* OR 
research* OR imaging* OR mri OR anesthe* OR anaesthe* OR intubat* OR surger* OR 
surgic* OR cannulat* OR infus* OR inject* OR ‘drug administration’ OR ‘x ray’ OR dialys* 
OR invasive OR noninvasive)):ab,ti AND ( (infan* OR newborn* OR (new NEXT/1 born*) 
OR baby OR babies OR neonat* OR child* OR kid OR kids OR toddler* OR teen* OR boy* 
OR girl* OR minors OR underag* OR (under NEXT/1 ag*) OR juvenil* OR youth* OR kin-
dergar* OR puber* OR pubescen* OR prepubescen* OR prepubert* OR pediatric* OR 
paediatric* OR school* OR preschool* OR highschool*):ab,ti OR ((adolescen*:ab,ti) NOT ( 
(adult*):ab,ti))) AND ( (psychol*):ab,ti) AND ( (questionnaire* OR ((self OR child*) NEAR/3 
report*) OR interview* OR nonverb* OR (non NEXT/1 verb*) OR observ*):ab,ti)
Web-of-science
TS=(((annoy* OR anxiet* OR bored* OR emotion* OR fear* OR feeling* OR frustrat* OR 
helpless* OR irritat* OR mood* OR pleasure* OR regret* OR shame OR sorrow* OR cop-
ing OR cope OR coped OR stress* OR distress* OR burden OR perception* OR perceive* 
OR experience* OR comfort* OR discomfort*) NEAR/6 (procedure* OR technique* OR 
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research* OR imaging* OR mri OR anesthe* OR anaesthe* OR intubat* OR surger* OR 
surgic* OR cannulat* OR infus* OR inject* OR “drug administration” OR “x ray” OR dialys* 
OR invasive OR noninvasive)) AND ( (infan* OR newborn* OR (new born*) OR baby OR 
babies OR neonat* OR child* OR kid OR kids OR toddler* OR teen* OR boy* OR girl* OR 
minors OR underag* OR under age* OR juvenil* OR youth* OR kindergar* OR puber* OR 
pubescen* OR prepubescen* OR prepubert* OR pediatric* OR paediatric* OR school* OR 
preschool* OR highschool*) OR ((adolescen*) NOT ( (adult*)))) AND ( (psychol*)) AND ( 
(questionnaire* OR ((self OR child*) NEAR/3 report*) OR interview* OR nonverb* OR (non 
verb*) OR observ*)))
Pubmed publisher
((annoy*[tiab] OR anxiet*[tiab] OR bored*[tiab] OR emotion*[tiab] OR fear*[tiab] OR 
feeling*[tiab] OR frustrat*[tiab] OR helpless*[tiab] OR irritat*[tiab] OR mood*[tiab] 
OR pleasure*[tiab] OR regret*[tiab] OR shame[tiab] OR sorrow*[tiab] OR coping[tiab] 
OR cope[tiab] OR coped[tiab] OR stress*[tiab] OR distress*[tiab] OR burden[tiab] 
OR perception*[tiab] OR perceive*[tiab] OR experience*[tiab] OR comfort*[tiab] OR 
discomfort*[tiab]) AND (procedure*[tiab] OR technique*[tiab] OR research*[tiab] OR 
imaging*[tiab] OR mri[tiab] OR anesthe*[tiab] OR anaesthe*[tiab] OR intubat*[tiab] OR 
surger*[tiab] OR surgic*[tiab] OR cannulat*[tiab] OR infus*[tiab] OR inject*[tiab] OR drug 
administration[tiab] OR x ray[tiab] OR dialys*[tiab] OR invasive[tiab] OR noninvasive[tiab])) 
AND ((infan*[tiab] OR newborn*[tiab] OR (new ADJ born*[tiab]) OR baby OR babies OR 
neonat*[tiab] OR child*[tiab] OR kid[tiab] OR kids[tiab] OR toddler*[tiab] OR teen*[tiab] 
OR boy*[tiab] OR girl*[tiab] OR minors[tiab] OR underag*[tiab] OR under ag*[tiab] OR 
juvenil*[tiab] OR youth*[tiab] OR kindergar*[tiab] OR puber*[tiab] OR pubescen*[tiab] 
OR prepubescen*[tiab] OR prepubert*[tiab] OR pediatric*[tiab] OR paediatric*[tiab] 
OR school*[tiab] OR preschool*[tiab] OR highschool*[tiab]) OR ((adolescen*[tiab]) NOT 
((adult*[tiab])))) AND ((psychol*[tiab])) AND ((questionnaire*[tiab] OR self report*[tiab] 
OR child report*[tiab] OR interview*[tiab] OR nonverb*[tiab] OR non verb*[tiab] OR 
observ*[tiab])) AND publisher[sb]
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APPeNDix B. iNterVieW sCHeDULe
General experiences
How did you feel about the study in general?
How did you feel before the study?
How did you feel afterwards?
Can you describe your experiences during the study?
Can you describe your experiences during procedure X?
experiences related to discomfort
Can you describe any discomfort you experienced in the study?
Is there any part of the study that you did not like? Which part? Why?
Can you describe any discomfort you experienced because of procedure X?
Worst experiences
What was/were the most burdensome/discomforting part(s) of the study? Which part? 
Why?
Preparation
Who prepared you for the study?
What information did you get about the study? Was this information sufficient?
Did you know what to expect of the study?
suggestions to reduce discomfort
Can you think of anything that would have made the study easier for you? If so, could 
you tell me about it?
Can you think of anything that will make procedure X less discomforting for you? If so, 
could you tell me about it?
Can you think of anything that will make procedure X more comfortable for you? If so, 
could you tell me about it?
future research
Would you participate in this research study again? Why (not)?
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APPeNDix C. CHiLDreN’s DisComfort DUriNG reseArCH ProCeDUres 
QUestioNNAire After eVALUAtioN
1. Were you nervous while undergoing procedure X?
¤  I was not nervous
¤  I was slightly nervous
¤  I was somewhat nervous
¤  I was very nervous
¤  I was extremely nervous
2. Was procedure X annoying?
¤  Procedure X was not annoying
¤  Procedure X was slightly annoying
¤  Procedure X was somewhat annoying
¤  Procedure X was very annoying
¤  Procedure X was extremely annoying
3. Was procedure X painful?
¤  Procedure X was not painful
¤  Procedure X was slightly painful
¤  Procedure X was somewhat painful
¤  Procedure X was very painful
¤  Procedure X was extremely painful
4. Were you frightened while undergoing procedure X?
¤  I was not frightened
¤  I was slightly frightened
¤  I was somewhat frightened
¤  I was very frightened
¤  I was extremely frightened
5. Were you bored while undergoing procedure X?
¤  I was not bored
¤  I was slightly bored
¤  I was somewhat bored
¤  I was very bored
¤  I was extremely bored
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6. Did you find procedure X tiring?
¤  It was not tiring
¤  It was slightly tiring
¤  It was somewhat tiring
¤  It was very tiring
¤  It was extremely tiring
7. Do you have any suggestions for making procedure X less annoying?
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ABstrACt
objectives. To describe children’s self-reported discomfort during research procedures 
and to get insight into how discomfort can be reduced. Secondary objectives were to 
compare discomfort in research to discomfort during dental check-ups, and to explore 
to influence of age, anxiety-proneness, gender, medical condition, previous experiences, 
purpose of the procedure (research versus clinical care) on discomfort.
methods. We enrolled 418 children (8-18 years). We measured discomfort due to six 
research procedures: buccal swabs, MRI-scans, pulmonary function tests, skin prick tests, 
ultrasound imaging and venipunctures.
results. Most children reported limited discomfort during the research procedures 
(means: 1.0-2.6 on a scale from 1-5). 60.3% suggested providing distraction by show-
ing movies to reduce discomfort. Only anxiety-proneness was positively related to 
discomfort. The purpose of the procedure affected discomfort differently between the 
procedures.
Conclusions. The findings of this study support the acceptability of participation of 
children in the studied research procedures, which stimulates evidence-based research 
practice.
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iNtroDUCtioN
There is a need to improve treatments and licensed medication for children by conduct-
ing pediatric research. For instance, it is estimated that 65% of all prescribed pediatric 
drugs are used off-label,1 which exposes children to an increased risk of medication un-
der- or overdose. Pediatric research, however, is complicated by the obligation to protect 
children against the risks and discomfort of research procedures. It is the responsibility 
of Institutional Review Boards (IRBs) to estimate the risks and discomfort of research 
procedures, and evaluate whether these are acceptable for the children. Primarily in case 
of discomfort, IRBs base this evaluation on their intuition and experiences, which may 
not necessarily give a representative view of children’s experiences.2-5 Consequently, this 
can lead to the rejection of studies when discomfort is expected to be excessive but is 
acceptable for the children, or to the acceptation of studies while discomfort is excessive 
for the children involved.
Unfortunately, there is a lack on data on children’s discomfort. In this study we 
therefore make a start in describing children’s self-reported discomfort during research 
procedures. These data are an important first step in providing an empirical basis for the 
evaluation by Institutional Review Boards (IRBs) and eventually providing benchmarks 
for the level of discomfort that might be expected for children with a given procedure.
We measured discomfort during research procedures instead of during a research 
study as a whole to make the results generalizable to children who undergo these pro-
cedures in future research and because IRBs often evaluate the research procedures of 
a study separately.6-8 By addressing research procedures, this study provides a crucial 
complement to previous studies that have measured children’s overall reactions to 
participation in research studies, such as the understanding of your rights of being a 
research participant.9-12 We compared the outcomes to discomfort of children during 
dental check-ups, which enabled us to compare discomfort experienced in research 
with a medical procedure most children encounter (‘reference level’). We exploratively 
compared whether the purpose of a medical procedure (research versus clinical care) 
influences discomfort. Furthermore, we explored whether age, anxiety proneness, 
gender, medical condition and previous experiences with the procedure were related 
to children’s discomfort. In addition, children were asked for suggestions to reduce 
discomfort.
metHoD
Participants
We used a convenience sample in which we aimed to include 50 children for each 
research procedure, or as much we could enroll within the timeframe of our study.13 
Children were eligible to participate if they met the following criteria: a) aged between 
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8-18 years, b) fluent in Dutch, c) no current psychological treatment for pain or anxiety 
disorders, d) no psychosocial problems as diagnosed in the Diagnostic and Statistical 
Manual of Mental Disorders at the time of enrollment, and e) accompanied by a parent 
or caretaker. This information was determined by consultation of parent(s) or the child’s 
medical record.
The children were recruited from research studies being conducted at three aca-
demic hospitals in the Netherlands. In addition, two other groups of children, for whom 
the same inclusion criteria applied, were included: 1) children without a known illness 
who had had a check-up visit to the dentist, and 2) children who had undergone a medi-
cal procedure during routine clinical care at one of these three hospitals. Children were 
enrolled between March 2014 and June 2015.
Procedure
First, the researchers conducting the research studies approached children and their 
parents if they were willing to participate in our study. Interested children and parents 
were provided with more information about the study by the first author or a research 
assistant. After agreement, written consent from parents and written child assent (>12 
years) were obtained. Children younger than twelve gave oral assent to participate. 
Directly after the research procedure, the children completed two questionnaires on 
an iPad mini tablet to measure discomfort and anxiety-proneness. Parents provided 
demographic information. All children received a gift card (€7.50) after completing the 
questionnaires.
measures
Discomfort
We developed the Children’s Discomfort during Research Procedures Questionnaire 
(CDRPQ) because no appropriate instrument existed for the aim of the current study. 
Instruments that measure children’s self-reported experiences in medical situations 
often focus on the measurement of pain, distress or anxiety. Discomfort, however, also 
involves other aspects than pain and distress, as was shown in an interview study we 
conducted.14 Measuring various forms of discomfort therefore provides a more thorough 
measure of the child’s discomfort. We aimed for an instrument that measures forms of 
discomfort that are applicable to all kinds of research procedures. Therefore the CDRPQ 
can be considered as a generic questionnaire.
The CDRPQ contains: 1) six questions about different types of discomfort (nervous-
ness, annoyance, pain, fright, boredom, and tiredness), which are measured using 
Likert scales ranging from 1=‘not discomforting’ to 5=‘extremely discomforting’, and 
2) one open question about suggestions for reducing discomfort (Appendix A. Note: 
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The CDRPQ was developed in Dutch and then translated to English for this manuscript). 
Validity and test-retest reliability were acceptable.15
Anxiety-proneness The influence of anxiety proneness on discomfort was measured 
using the Dutch translation of the trait scale of the State-Trait Anxiety Inventory for Chil-
dren (STAI-C),16 or the anxiety scale of the Child Behaviour Checklist (CBCL),16 depending 
on which questionnaire was already being used by the participating studies. Previous 
research shows that there are little differences in measuring anxiety by the trait scale 
of the STAI-C and the anxiety scale of the CBCL when parent-reported,17 and that these 
scales are highly correlated (r = 0.77).18 The trait scale of the STAI-C is self-reported and 
addresses the frequency and intensity of anxiety symptoms in general. It consists of 
20 items (e.g. “I worry about school”).19 The STAI-C trait scale has shown good internal 
consistency (Cronbach’s α > 0.80) and acceptable test–retest reliability (r > 0.65).20 The 
anxiety scale of the CBCL is parent-reported and includes six questions on anxiety prob-
lems (e.g. “fear of animals, situations or places”). The CBCL has shown good validity and 
reliability.16
Demographics
Parents provided information on demographics.
medical procedures
Research procedures
We measured children’s experiences during six research procedures: buccal swabs, MRI-
scans, pulmonary function tests, skin prick tests, ultrasound imaging and venipunctures 
(Table 1). The research procedures were selected based on the following criteria: no 
general anesthesia necessary, perceived by a consulted group of pediatric healthcare 
professionals as possibly causing discomfort, and performed in the participating hos-
pitals during the timeframe of our study. Almost all children underwent the research 
procedures for non-therapeutic research purposes, with the exception of the pulmonary 
function tests and some venipunctures.
Dentist
We measured the experiences of a group of children without a known illness during 
regular check-up visits to a general academic dental center (Table 1). Fifth-year dentistry 
students perform supervised dental check-ups on children at this academic dental cen-
ter.
Procedures in clinical care
We measured the experiences of children undergoing MRI-scans, pulmonary function 
tests or ultrasound imaging for diagnostic reasons (Table 1).
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statistical analysis
The data were analyzed using SPSS version 21. For each procedure, we calculated the 
means of the different forms of discomfort, the percentage who reported the research 
procedure as ‘very’ or ‘extremely’ discomforting, and an average discomfort score based 
on the six forms of discomfort. As most data were skewed, we used non-parametric 
statistics. A Kruskal-Wallis Test and Mann-Whitney U tests were used to explore differ-
ences between the procedures in the average discomfort score. We used Spearman 
correlations to explore the relation between the average discomfort score, and age 
and anxiety proneness. Mann-Whitney U tests were used to explore differences in the 
average discomfort score between children with and without an illness, boys and girls, 
children with and without previous experiences, and children in routine clinical care and 
research. We did a multivariate analysis to measure the variance in discomfort explained 
by the above-mentioned factors. The first author coded the question ‘What would you 
suggest to make [procedure X] less annoying?’ into categories. A supervising researcher 
checked these categories (JH), and disagreements were discussed until consensus was 
reached.
ethical approval
The IRB of the VU Medical Center in Amsterdam (The Netherlands) indicated that there 
was no risk or discomfort associated with this study (i.e. completing the questionnaires), 
and stated that it is exempt from requiring approval under Dutch Law (2014/010).
table 1. Description of the medical procedures
Procedure Description
Buccal swab test Taking mucosal epithelial cells from the inner cheek lining using a small brush.
MRI-scan Magnetic Resonance Imaging of different parts of the body, particularly of the head. 
The MRI-scans lasted between 30 and 60 minutes and were performed without 
sedation.
Pulmonary function test Regular pulmonary function test that lasted between 15 and 30 minutes.
Skin prick test Children were tested for 20 allergens. A droplet of each allergen was placed on the 
inner forearm and penetrated through to the skin using a specially modified lancet.
Ultrasound imaging Ultrasound imaging used for research purposes was an echocardiogram. For clinical 
care purposes, ultrasound imaging was particularly an echocardiography and in 
some cases ultrasounds were made of the lymph nodes, the head or the abdomen.
Venipuncture One to three 10ml tubes of blood were collected. In one of the two studies children 
could choose to have EMLA-cream applied before the venipuncture. None of the 
children had a local anesthetic.
Dental check-up During the dental check-up a general check was carried out, dental plaque was 
removed and children were given instructions on how to brush their teeth correctly. 
A new appointment was made for dental caries or other abnormalities.
87
Children’s discomfort in clinical research – questionnaire study
5
All parents and children older than eleven years who agreed to participate gave 
informed assent/consent for their participation and were aware that their data would 
be used for research purposes. Children younger than twelve years old verbally agreed 
to participate.
resULts
Participants
528 children were potentially suitable for participation in our study, of which 71 children 
(13.4%) did not meet the inclusion criteria (24 in research, 33 in clinical care and 14 
from the dental clinic): two children did not speak Dutch fluently, five children were 
not accompanied by a parent and 64 children were too young or too old. Of the 457 
children who were invited to participate, 418 children agreed to participate (91.5%). The 
most frequently mentioned reason for declining was lack of time of the parents (56%), 
followed by ‘no interest’ (26%). 307 children were enrolled from clinical research, 61 from 
clinical care, and 50 from an academic dental clinic. The majority of the children did not 
have a known illness (73.0%). Mean age was 10.9 years. Further characteristics of the 
children are presented in Table 2.
Discomfort during research procedures (CDrPQ)
Table 3 shows the discomfort children experienced: the mean of each form of discom-
fort, and the percentage of children who reported ‘very’ (score 4) or ‘extreme’ (score 5) 
discomfort. For almost all procedures, the mean scores on the different forms of dis-
comfort were low. Exceptions were: children undergoing the buccal swab test generally 
indicated that they were ‘slightly’ bored; most children felt the MRI-scan was ‘slightly’ 
tiring and 19% felt it was ‘very’ or ‘extremely’ tiring.
There were significant differences in discomfort between the procedures (p < 0.001). 
Compared to check-up visits to the dentist, discomfort of buccal swab tests, skin prick 
tests and ultrasound imaging were less discomforting (p = 0.002-0.007), while MRI-scans, 
venipunctures and pulmonary function tests caused a similar degree of discomfort (p = 
0.05-0.26).
suggestions to reduce discomfort
A large group of the children in clinical research (62.6%) suggested that distraction dur-
ing the research procedures, preferably in the form of a movie, would reduce discomfort 
(Table 4).
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table 2. Demographics
Demographics research (N=307) Clinical care (N=61) Dentist (N=50) total (N=418)
Gender (%)     
Boy 158 (51.5%) 30 (49%) 27 (54%) 215 (51.4%) 
Girl 149 (48.5%) 31 (51%) 23 (46%) 203 (48.6%) 
Age (%)     
Mean ± SD 10.5 ± 1.8 12.7 ± 2.8 10.8 ± 1.5 10.9 ± 2.1 
< 12 years 273 (88.9%) 26 (43%) 38 (76%) 337 (80.6%) 
≥ 12 years 34 (11.1%) 35 (57%) 12 (24%) 81 (19.4%) 
Procedure (%)     
Buccal Swab 25 (8.1%) - - 25 (6.0%) 
MRI 89 (29.0%) 16 (26%) - 105 (25.1%) 
Pulmonary function test 9 (2.9%) 20 (33%) - 29 (6.9%) 
Skin prick test 75 (24.4%) - - 75 (17.9%) 
Ultrasound imaging 77 (25.1%) 25 (41%) - 102 (24.4%) 
Venipuncture 32 (10.4%) - - 32 (7.7%) 
Check-up visit at dentist - - 50 (100%) 50 (12.0%) 
medical condition (%)     
ADHD/ADD 4 (1.3%) - - 4 (1.0%) 
Asthma - 20 (33%) - 20 (4.8%) 
Cystic Fibrosis 6 (2.0%) - - 6 (1.4%) 
Healthy (i.e. no known illness) 254 (82.7%) 1 (2%) 50 (100%) 305 (73.0%) 
Inflammatory Bowel Disease 36 (11.7%) 4 (7%) - 40 (9.6%) 
Metabolic disorder - 3 (5%) - 3 (0.7%) 
Nephrological condition - 3 (5%) - 3 (0.7%) 
Oncological condition 1 (0.3%) 8 (13%) - 9 (2.2%) 
Primary ciliary dyskinesia 4 (1.3%) - - 4 (1.0%) 
Other condition 2 (0.7%) 22 (36%) - 24 (5.7%) 
Previous experience with 
procedure (%)
148 (48.2%) 35 (57%) 50 (100%) 233 (55.7%)
trait-anxiety - stAi-C* N=82 N=61 N=36 N=179
Mean ± SD 29.3 ± 5.7 29.1 ± 6.2 28.9 ± 5.7 29.2 ± 5.9 
Range 20-44 20-48 22-42 20-48 
trait-anxiety - CBCL* N=192 N=0 N=0 N=192 
Mean ± SD 1.0 ± 1.4 - - 1.0 ± 1.4 
Range 0-6 - - 0-6 
* STAI-C = State Trait Anxiety Inventory for Children; CBCL = Child Behaviour Check List
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Potential influencing factors
There was no significant correlation between age and discomfort (p = 0.31), and 
discomfort and anxiety-proneness, measured with the STAI-C (p = 0.08) and CBCL (p 
= 0.22). There were no significant differences in discomfort between healthy children 
and children with a chronic condition (p = 0.78), boys and girls (p = 0.89), and children 
who had a previous experience or children who underwent the procedure for the first 
time (p = 0.31). Regarding the multivariate analysis, anxiety-proneness appeared to be 
significantly related to discomfort (β = 0.305, p < 0.001). The total model was significant, 
although it only explained 11.5% of the variance of discomfort.
Small differences were found between the experiences of children in research and 
clinical care. Children reported slightly more discomfort when undergoing a pulmonary 
function test for research purposes than for clinical care (mean = 1.8 versus mean = 1.3, 
p = 0.01). Undergoing an MRI-scan for research purposes caused less discomfort than 
for clinical care (mean = 1.6 versus mean = 2.1, p < 0.001). No significant difference was 
observed for ultrasound imaging (mean = 1.4 versus mean = 1.5, p = 0.20).
table 4. Suggestions to reduce discomforts
suggestion Number of children Percentage (%)
(Distraction total) (192) (62.6)
 - Movie 185 60.3 
 - Music 1 0.3 
 - Small talk 2 0.7 
 - Other form of distraction 4 1.3 
Less noise (MRI) 24 7.8
Fewer physical sensations 11 3.6
Warm gel (echoscope) 4 1.3
Warmer room temperature (MRI) 3 1.0
Shorter duration 1 0.3
Receiving present 1 0.3
Other 11 3.6
No suggestion 60 19.5
total 307* 100.0
* Only children in clinical research
DisCUssioN
This is the first large-scale study investigating children’s self-reported discomfort during 
research procedures. It is in line with the trend of actively involving children in express-
ing their experiences in medical and research situations. Our study shows that children 
experienced limited discomfort during the studied research procedures. Although chil-
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dren came from diverse backgrounds, the variation in their answers was limited, which 
supports the idea that our findings are generalizable.
Although the studied research procedures may not be the most invasive ones, it is 
important to have actual data on the discomfort children experience during these re-
search procedures rather than making assumptions. Besides, research shows that there 
are significant differences in the evaluation of discomfort of some of these research 
procedures among IRB members,21, 22 which supports the importance of self-reported 
data by children.
Looking at the different forms of discomfort, it is remarkable that the scores of the 
children in our study on being bored and tired are higher than the scores on the other 
forms of discomfort. Although a boring or tiring research procedure may not be consid-
ered by IRBs as unacceptable, these are important forms of discomfort for children and 
can be a reason for them to refuse undergoing this procedure (in the future). For this 
reason, we believe it is important that these forms of discomfort are explicitly taken into 
account when evaluating discomfort by IRBs.
In several ethics codes and guidelines, minimizing discomfort is a requirement for 
pediatric research.23, 24 According to the majority of the children in our study, distraction 
can help to achieve this. Distraction is proven to be (cost-)effective in reducing discom-
fort during medical procedures in children of all ages.25-30 While children preferred to 
be distracted by movies, during some procedures, it may be more feasible to distract 
children by providing music, toys, or decoration on walls and ceilings.
strengths and limitations
The outcomes of this study can help to establish benchmarks for the discomfort of 
research procedures in children, and thereby assist IRBs, pediatric researchers, parents 
and children in their estimation of the acceptability of the research procedures for par-
ticipation. Other strengths of the study are the multi-site enrollment for generalizability; 
the large number of children in some of the procedures; the comparison with a common 
‘everyday’ medical procedure (i.e. a dental check-up); the use of a specifically developed 
questionnaire to measure different forms of discomfort (CDRPQ); and the suggestions 
for reducing discomfort.
As we were dependent on the participating studies, we were unable to include the 
intended number of children for some procedures, because fewer children took part in 
these studies than expected, or were included at a later stage than initially planned. This 
has reduced the power of the outcomes of some research procedures (e.g. pulmonary 
function tests). On the other hand, the power of the outcomes of other procedures was 
enlarged because more children were included than planned (e.g. MRI-scans). Because 
of limited variation in children´s discomfort, we expect that our findings are generaliz-
able.
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We used different groups of children to compare discomfort in clinical research with 
dental check-ups. A design with paired measurements from the same child might have 
given a better estimation.
Furthermore, the degree of discomfort may be relative to the presence of other 
research procedures the children underwent in the studies. As there was little variation 
in their ratings of discomfort, we assume that the other research procedures did not 
have much influence on children’s reports.
All children included in our study assented to undergo the research procedures, 
which is why our study might be hampered by a selection bias (Note: this is applicable 
to many pediatric studies). It may be possible that highly anxious children declined to 
undergo the research procedures because of expected discomfort or anxiousness, or 
that they may not have been asked to participate for this reason. The fact that we did 
not have to exclude children with anxiety-disorders (i.e. one of the exclusion criteria) nor 
that children did have high scores on the anxiety-proneness measures, supports this. 
The findings of this study therefore cannot just be generalized to children in clinical care.
future research
For generalizability, future research should include larger numbers and more heteroge-
neous groups of children, in particular during pulmonary function tests. Future research 
is also needed to describe children’s discomfort during other (more invasive) research 
procedures. We therefore recommend pediatric researchers to include measures in their 
studies (e.g. CDRPQ) to investigate discomfort related to the research procedures in-
volved, and also disseminate these results (Note: recently in the Netherlands an addition 
to the law on research participation was accepted which requires to define and monitor 
discomfort in pediatric research (parliamentary meeting of October 25th, 2016). [https://
www.eerstekamer.nl/wetsvoorstel/33508_verrichten_van_medisch]).
For IRBs and pediatric researchers who evaluate the level of discomfort of (non-
therapeutic) research procedures, it is important to know which research procedures 
involve minimal, a minor increase over minimal discomfort, or more than minimal dis-
comfort. Unfortunately, there are no clear guidelines for this. Future research - in which 
IRBs, pediatric researchers, children and their parents are consulted - is therefore needed 
to determine cut-off levels for this.
Conclusion
Our findings support the acceptability of participation of children in the studied pro-
cedures for research purposes because children experienced limited discomfort. The 
results are an important first step in providing benchmarks for discomfort of research 
procedures in pediatric research, and contribute to the evidence-based evaluation of 
discomfort in research.
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APPeNDix A. CHiLDreN’s DisComfort DUriNG reseArCH ProCeDUres 
QUestioNNAire (CDrPQ)
1. Were you nervous while undergoing procedure X?
¤  I was not nervous
¤  I was slightly nervous
¤  I was somewhat nervous
¤  I was very nervous
¤  I was extremely nervous
2. Was procedure X annoying?
¤  Procedure X was not annoying
¤  Procedure X was slightly annoying
¤  Procedure X was somewhat annoying
¤  Procedure X was very annoying
¤  Procedure X was extremely annoying
3. Was procedure X painful?
¤  Procedure X was not painful
¤  Procedure X was slightly painful
¤  Procedure X was somewhat painful
¤  Procedure X was very painful
¤  Procedure X was extremely painful
4. Were you frightened while undergoing procedure X?
¤  I was not frightened
¤  I was slightly frightened
¤  I was somewhat frightened
¤  I was very frightened
¤  I was extremely frightened
5. Were you bored while undergoing procedure X?
¤  I was not bored
¤  I was slightly bored
¤  I was somewhat bored
¤  I was very bored
¤  I was extremely bored
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6. Did you find procedure X tiring?
¤  It was not tiring
¤  It was slightly tiring
¤  It was somewhat tiring
¤  It was very tiring
¤  It was extremely tiring
7. Do you have any suggestions for making procedure X less annoying?
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ABstrACt
objectives. We exploratively studied children’s long-term clinically relevant stress due 
to research procedures. We also explored whether age, anxiety-proneness, discomfort 
during research, gender, and medical condition were related to traumatic stress symp-
toms.
methods. We enrolled 100 children (8-18 years). The research procedures that children 
underwent were buccal swabs, MRI-scans, pulmonary function tests, ultrasound imag-
ing, or venipunctures. We used the Children’s Revised Impact of Event Scale (CRIES-13) to 
measure stress symptoms. A score of ≥30 on the CRIES-13 was seen as clinically relevant 
stress.
results. None of the children showed clinically relevant stress, except for one who 
underwent a venipuncture. Discomfort during research procedures, anxiety-proneness, 
and being a girl were significantly related to stress symptoms.
Conclusions. We cautiously conclude that for the studied procedures, Institutional Re-
view Boards (IRBs) do not need not be concerned about clinically relevant stress, since 
our study reveals that is it largely absent.
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iNtroDUCtioN
One of the conditions of pediatric research is that the risks are acceptable in relation to 
the benefits (i.e. in the case of therapeutic research), or should be minimal (i.e. in the 
case of non-therapeutic research). Study risks can be categorized into five categories: 
physical, psychological, social, legal, and economic risks.1 The risk estimation by ethics 
committees of clinical research is primarily based on the potential physical harm.2 While 
research participation typically does not pose economic, legal, or social problems to 
children, it can pose psychological risks.2 Psychological risk can be operationalized in 
various ways and is not acceptable in clinical research if it involves clinically relevant 
stress, meaning a psychological state for which professional help is needed. Studies on 
stress in routine pediatric care show that medical procedures can cause fear, phobia and 
sometimes even trauma in children, which in turn may lead to medical non-adherence 
and treatment refusal.3-6 In a recently published review, stress in relation to pediatric 
medical traumas was defined as “a set of psychological and physiological responses 
of children and their families to pain, injury, serious illness, medical procedures, and 
invasive or frightening treatment experiences”.7 This review indicates that research in 
pediatric medical situations has grown significantly, but this does not hold for studies 
looking at stress due to research participation. It is important to specifically have data 
on stress symptoms in pediatric research rather than generalizing data from pediatric 
clinical care because children in research differ from children in clinical care settings. 
Children in clinical research, who generally do not benefit from the study, make a delib-
erate decision for participating in clinical research, while children in clinical care often 
have no choice for undergoing medical procedures. Therefore a selection takes place 
in which the most vulnerable children generally will be excluded from clinical research.
Several articles discuss the psychological risks of research participation,e.g. 2, 8 but self-
reported data on the psychological risks of research on children are rare,9 particularly 
on long term risks. We only noted one small study that investigated the psychological 
impact of clinical research (examination for sexual development, intravenous insertion, 
blood draws and staying overnight in the hospital) on children.10 Approximately 10% 
of children were advised not to participate due to expected proneness for stress symp-
toms; none of the other children exhibited psychological problems after participating.
In this explorative study, we studied if children are at risk for clinically relevant stress 
in pediatric research one month and one year after undergoing a medical research pro-
cedure, using self-reported data on (long-term) stress symptoms. We explored whether 
age, anxiety-proneness, discomfort children experienced during the research procedure, 
gender and medical condition were related to clinically relevant stress symptoms.
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Participants
Data were collected as part of a study regarding children’s discomfort during medical 
research procedures.11 To be eligible, children had to be a) between 8 - 18 years old, b) 
fluent in Dutch, c) without current psychological treatment for pain or anxiety disorders, 
d) without severe psychosocial problems such as anxiety disorders and depression at 
the time of enrollment of the initial study, and e) accompanied by at least one parent 
or caretaker. We enrolled both children with and without a known illness. Children were 
recruited between March 2014 and June 2015 from research studies at three academic 
hospitals in the Netherlands.
Procedure
Written parental consent and child assent (≥ 12 years) were obtained. Children younger 
than twelve years orally agreed to participate. Children filled in two questionnaires di-
rectly after undergoing a research procedure: 1) Children’s Discomfort during Research 
Procedures Questionnaire (CDRPQ) and 2) State-Trait Anxiety Inventory for Children 
(STAI-C). Parents provided demographical information.
Parents received an email for their child after a one-month period. We could only 
send this email to a subsample due to possible interference with the outcomes/logistics 
of some of the medical research studies on which our study was ‘piggybacked’. This email 
contained an online link for the child to complete the Child Revised Impact of Event 
Scale (CRIES-13)12 for measuring long-term clinically relevant stress symptoms related 
to the research procedure. For evaluating stress symptoms after one year, we included 
an additional group of children one year after they underwent a research procedure. All 
children received a gift card (€7.50) after completing the questionnaires, which was sent 
to their home. We removed both email and personal addresses afterwards.
measures
Children’s Revised Impact of Event Scale (CRIES-13)
Clinically relevant stress due to research procedures was measured by the Dutch version 
of the CRIES-13,12 which is a child’s self-report scale about the frequency of event-related 
(traumatic) distress. The CRIES-13 consists of 13 items that are rated on a 4-point Likert 
scale: 0 = ‘not at all’, 1 = ‘rarely’, 3 = ‘sometimes’, 5 = ‘often’. The total score can range 
from 0 to 65. When a child has a total score of 30 or above on the CRIES-13, this child 
is considered to have clinically relevant stress symptoms.13 The CRIES-13 demonstrates 
satisfactory to good psychometric characteristics.14 It has good internal consistency for 
the total score (Cronbach’s α = 0.80).
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Children’s Discomfort during Research Procedures Questionnaire (CDRPQ)
Discomfort during the research procedure was measured using the CDRPQ. The CDRPQ 
contains questions about six different forms of discomfort (nervousness, annoyed, pain, 
fright, boredom and tiredness), which are measured using 5-point Likert scales ranging 
from 1 = ‘not discomforting’ to 5 = ‘extremely discomforting’. An average discomfort 
score can be calculated with these six forms of discomfort. The CDRPQ was developed 
based on literature, interviews with children about discomfort in clinical research,15 and 
in consultation with pediatricians, ethicists, psychologists, nurses and parents from 
patient associations. The CDRPQ was well received by the children. Convergent validity 
and test-retest reliability were acceptable.16
State-Trait Anxiety Inventory for Children (STAI-C)
We measured anxiety-proneness by the trait scale of the Dutch translation of the STAI-
C.17, 18 The STAI-C is a valid questionnaire, which measures state and trait anxiety. The 
trait scale addresses the frequency and intensity of anxiety symptoms in general, and 
consists of 20 items, e.g. “I worry about school”. The higher the scores on this scale, the 
more children tend to interpret situations as threatening. There is no official cut-off 
score for the STAI-C. In a Dutch norm population the STAI-C trait scale has shown good 
internal consistency (Cronbach’s α > 0.80) and acceptable test–retest (r > 0.65).17
The STAI-C is used for children between 8 - 15 years. We also used this questionnaire 
for older children (16 - 18 years) as it has been suggested that the child-version may be 
more useful for adolescent populations than the adult version (STAI), given that even 
older adolescents may have difficulty understanding some of the vocabulary of the 
adult version.19 Literature shows that the Dutch version of the STAI-C is reliable and valid 
for adolescents between 12 - 18 years old.20
medical research procedures
We measured clinically relevant stress in children in relation to five medical research 
procedures: buccal swab test, MRI-scan, pulmonary function test, ultrasound imaging 
and venipuncture. An elaborate description of the procedures is described elsewhere.11 
The research procedures were selected on the following criteria: no general anesthesia, 
pediatric healthcare professionals we consulted found that it possibly caused discom-
fort, and the availability of research procedures in the cooperating hospitals during the 
time frame of our study. Almost all children underwent the research procedures for 
non-therapeutic research purposes, except for pulmonary function tests and some of 
the venipunctures.
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statistical analysis
The data were analyzed using SPSS version 21. As the data were skewed, we used non-
parametric statistics. We determined the medians, interquartile ranges, and percentage 
of children who had clinically relevant stress (≥ 30 on the CRIES-13). We conducted a 
Kruskal-Wallis test respectively a Mann-Whitney U test to measure whether differ-
ences exist in stress symptoms between the different research procedures after one 
month respectively after one year. Spearman correlations were calculated between 
age, anxiety-proneness, and discomfort on the one hand and stress symptoms on the 
other hand. Discomfort was measured using the average discomfort score of the CDRPQ. 
Mann-Whitney U tests were used to evaluate differences in stress symptoms between 
children with and without an illness, and between boys and girls. A multivariate regres-
sion analysis was conducted to measure the variance explained in stress symptoms by 
age, anxiety-proneness, discomfort, gender, medical condition (with or without having 
a medical condition), and the time of measurement (one month versus one year after 
undergoing a research procedure). As stress symptoms scores had a non-symmetrical 
distribution, a log-transformation was applied first.
ethical approval
The Institutional Review Board of the VU University Medical Center in Amsterdam (the 
Netherlands) evaluated this study and indicated that there was no risk or discomfort as-
sociated with it (2014/010) and stated that the study was exempt from getting approval 
under Dutch Law.
All parents and children older than eleven years who agreed to participate gave 
informed assent/consent for their participation and were aware that their data would 
be used for research purposes. Children younger than twelve years old verbally agreed 
to participate.
resULts
Participants
A total of 100 children were included in this study. 66 children completed the CRIES-13 
one month after undergoing a medical research procedure, and an additional group of 
34 children filled out the CRIES-13 one year after undergoing an MRI-scan or venipunc-
ture for research purposes. The children’s demographics are described in Table 1.
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table 1. Demographics and characteristics of the children
Demographics After one month
(N=66)
After one year
(N=34)
Age (8-18 years)   
Mean ± SD 12.4 ± 2.7 12.4 ± 2.3 
< 12 years 35 (53%) 20 (58.8%) 
≥ 12 years 31 (47%) 14 (41.2%) 
Gender (%)   
Boy 35 (53%) 24 (70.6%) 
Girl 31 (47%) 10 (29.4%) 
research procedure  -
Buccal Swab 21 (31.2%) 17 (50%) 
MRI 13 (19.7%) - 
Pulmonary function test 6 (9.1%) - 
Skin prick test - - 
Ultrasound imaging 1 (1.5%) 17 (50%) 
Venipuncture (without EMLA) 25 (37.9%) 
Previous experience with 
procedure
56 (84.8%) 10 (29.4%)
Child’s medical condition   
ADHD/ADD 4 (6.06%) - 
Cystic Fibrosis 3 (4.5%) - 
Healthy 24 (36.4%) 34 (100%) 
Inflammatory Bowel Disease 30 (45.5%) - 
Oncological condition 1 (1.5%) - 
Primary ciliary dyskinesia 3 (4.5%) - 
Other condition 1 (1.5%) - 
trait-anxiety - stAi-C*
Mean ± SD 29.2 ± 6.1 30.7 ± 6.4 
Range 20-44 22-43 
* STAI-C = State Trait Anxiety Inventory for Children
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Clinically relevant stress symptoms (Cries-13)
After one month (N=66)
The total scores on the CRIES-13 in this group varied between 0 - 29 (median = 6; IQ 
range = 2-11). None of the children showed clinically relevant stress symptoms (total 
score ≥ 30) related to the research procedures (Table 2). A Kruskal-Wallis test showed 
that there were no significant differences in stress symptoms between research proce-
dures (p = 0.166).
After one year (N=34)
After one year, total scores on the CRIES-13 varied between 0 - 32 (median = 9; IQ range 
= 5.85-12) (Table 2). One child showed clinically relevant stress (score: 32) due to a veni-
puncture. A Mann-Whitney U test showed that children’s stress symptoms did not differ 
between research procedures (p = 0.986).
table 2. Medians and interquartile-ranges (IQ 25-75%) on the CRIES-13 after one month (N=66) and one 
year (N=34)
one month one year
Buccal swab 4 (1-6.5) -
MRI-scan 4.3 (1.5-10) 9 (6-12)
Pulmonary function test 9 (3.25-17.25) -
Ultrasound imaging 12 -
Venipuncture 7 (4-14) 9 (4.5-14)
Total 6 (2-11) 9 (5.85-12)
Potential influencing factors
As only one child had a clinically relevant stress score (CRIES-13 score ≥ 30), we describe 
the relation between several potential influencing factors and stress symptoms (instead 
of clinically relevant stress symptoms).
Anxiety-proneness was correlated with stress symptoms (r = 0.426, p < 0.001), indi-
cating that more anxiety-prone children experience more stress symptoms. Spearman 
correlations showed a moderate relation between discomfort and stress symptoms (r 
= 0.494, p < 0.001) (Table 3), indicating that the more discomfort children experienced, 
the more long-term stress they experienced. Examining the individual questions of 
the CDRPQ (i.e. different forms of discomfort), Spearman correlations showed weak to 
moderate positive relations between nervousness, feeling annoyed, pain, fright, and be-
ing tired (r = 0.257 - 0.419; p < 0.05). Boredom was not related to stress. Mann-Whitney 
U tests showed significant differences in stress symptoms between boys and girls (p < 
0.001), with girls having higher scores on the CRIES-13 than boys.
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Spearman correlations showed no relation between age and stress (p = 0.929). 
Mann-Whitney U tests showed no differences in stress symptoms between children with 
and without a known illness (p = 0.769).
table 3. Spearman correlations between discomfort (CDRPQ) and stress symptoms (CRIES-13) (N=100)
Nervous Annoyed Pain fright Bored tired Average discomfort score
Total score CRIES-13 .419** .365** .257* .360** -.056 .314** .494**
* p-value ≤ 0.05 ** p-value ≤ 0.001
Multivariate analysis
The regression analysis of the log-transformed CRIES-13 including the covariates age, 
anxiety-proneness, discomfort, gender, medical condition, and time of measurement 
had an R² of 35.1%. Discomfort experienced during the procedure (beta = 0.384, p < 
0.001), anxiety-proneness (beta = 0.265, p = 0.005), and gender (i.e. being a girl) (beta = 
0.225, p = 0.012) were significant and unique indicators of stress symptoms.
DisCUssioN
This is the first study to explore long-term clinically relevant stress symptoms in children 
due to medical research procedures. Our study shows that clinically relevant stress from 
the studied research procedures is almost absent. As these research procedures were 
found to be associated with low discomfort,11 these results did not surprise us. The 
positive relationship between discomfort during the procedure and long-term stress, 
and the results of the regression analysis in which discomfort appeared to be a good 
indicator for long-term stress, suggest that clinically relevant stress symptoms might be 
manifest as a result of more intrusive research procedures.
We found that more anxiety-prone children experience more stress symptoms, 
which is in line with previous studies.e.g. 21 Studies in medical settings often found that 
younger children (i.e. younger than approximately eight years) experienced more pain, 
anxiety, and distress during medical procedures than older children.22, 23 In our study, 
we did not find a relation between age and stress, which might be explained by the 
inclusion of relatively old children (> 8 years).
The research procedures appeared to cause more stress symptoms in girls than in 
boys. Other studies show that girls are more prone to posttraumatic stress than boys, 
while boys show behavioral symptoms.24 Girls are also more likely to report physical and 
psychological symptoms than boys, which can be explained by girls experiencing more 
symptoms or being more aware of these symptoms than boys, who are less supposed to 
express their emotions as it might be considered a sign of ‘weakness’.25
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We found no relation between medical condition and stress symptoms, which sug-
gests that children with a medical condition are not at higher risk for developing stress 
symptoms than healthy children (or vice versa).
Limitations and future research
A limitation of our study is the limited number of children in some research procedures, 
particularly during ultrasound imaging and pulmonary function tests. This is why we 
address this study as an explorative study. However, the limited variation in the reported 
stress symptoms indicates that the results are generalizable to other children undergoing 
these procedures in research settings. We therefore cautiously conclude that clinically 
relevant stress was largely absent as children reported relatively few stress symptoms.
As we only included children who had assented to undergo the research procedures, 
the study might be hampered by a selection bias (note: this applies to many research 
studies). It is possible that children who expect to experience stress symptoms did not 
participate in the research studies we cooperated with. Therefore, along with measuring 
clinically relevant stress symptoms caused by research participation, prescreening for 
expected psychological risk is also important. McCarthy et al. developed a screening 
protocol to identify children who are potentially at risk for stress symptoms during non-
therapeutic research participation.10 They identified that if trait-anxiety – which can be 
measured using the STAI18 - is considered high (i.e. more than one standard deviation 
above the mean of the study population), potentially provoking experiences such as 
invasive medical procedures may cause harmful stress reactions in children. They stated 
that children who have high trait-anxiety scores should not participate in non-thera-
peutic research as it may put them in potential anxiety-provoking situations needlessly.
In this study, only one child was considered to have clinically relevant stress one 
year after undergoing a venipuncture. It should be noted that this stress might not 
be caused by the research procedure. For future research, we therefore recommend a 
shorter interval than one year to measure stress after research participation. We also 
recommend repeated measurements in the same child to see the development of the 
stress symptoms over a longer period of time.
We are aware that the research procedures in this study are not the most invasive 
ones, thus it is expected that almost no clinically relevant stress was demonstrated. 
Our study shows that there is a significantly positive relation between discomfort and 
long-term stress symptoms, which justifies future research on clinically relevant stress 
symptoms in children who underwent more invasive research procedures, such as lum-
bar punctures. Also, stress symptoms of younger children (< 8 years) and children with 
life-threatening medical conditions in clinical research should be investigated, as they 
may be more prone to clinically relevant stress.
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Practical implications
The risk of clinically relevant stress symptoms from other (invasive) research procedures 
should be measured, and results disseminated by pediatric researchers, which in turn 
can facilitate IRBs’ decision-making on (psychological) risk. It would therefore be helpful 
if IRBs recommend pediatric researchers to measure clinically relevant stress due to the 
research procedures of their studies, and disseminate the findings to other researchers, 
IRBs, and parents and children.
Since our study showed that discomfort is related to long-term stress symptoms for 
children, minimizing discomfort (which is mandatory in many codes and regulations 
on research participation) may decrease the risk on clinically relevant stress symptoms. 
Pediatric researchers can minimize discomfort by incorporating practical suggestions of 
the children themselves, which we provided in a previous study.11
Conclusion
We cautiously conclude that children in clinical research are not at risk for clinically rele-
vant stress from the research procedures we investigated. As discomfort during research 
procedures and long-term stress symptoms were positively related, we recommend to 
investigate clinically relevant stress from more invasive research procedures.
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ABstrACt
Background. Conducting non-therapeutic research is ethically challenging because 
participation conveys risks and burden and no health benefit. In this paper we report 
the positive experiences of a diverse group of healthy and ill children (6-18 years) who 
participated in non-therapeutic research studies, and discuss whether these positive 
experiences can justifiably be viewed as benefits.
methods. We used semi-structured interviews from an earlier study about children’s 
experiences in clinical research and did a secondary analysis on the positive experiences 
of the children in the non-therapeutic studies (N=30). Interviews were analyzed using 
‘thematic’ analysis.
results. The interviewed children most frequently mentioned as positive experiences of 
non-therapeutic research participation: helping others and the gratification that comes 
with it, possible health benefits in the future, having fun, and new/increased knowledge 
about the human body, hospitals, and doing research. Less frequently mentioned were 
getting a present, not having to go to school and getting extra attention from health-
care staff.
Conclusion. Our study shows that children participating in non-therapeutic research 
have various positive experiences while taking part. We argue that some of these justifi-
ably could be taken into the risk-benefit analysis in certain situations, or maybe even 
as a standard part of this analysis. This may help to increase the number of (crucial) 
non-therapeutic studies with children.
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iNtroDUCtioN
Next to therapeutic research, non-therapeutic research is also necessary to improve 
healthcare for children. However, conducting non-therapeutic research is ethically 
challenging because children may experience burden and risks when participating, and 
these are not balanced by health benefits. Most guidelines and regulations therefore 
state that non-therapeutic studies are only acceptable if they convey minimal burden 
and risk.1-3 The debate on the risk-benefit analysis in pediatric research primarily focuses 
on the degree and nature of both burden and risk. During our study on the experiences 
children have during their participation in research, we stumbled upon the fact that chil-
dren who participate in non-therapeutic research also report many positive experiences. 
Can these positive experiences be seen as a benefit, to be weighed in the risk-benefit 
analysis of study protocols? If so, this could tip the scale. In the absence of benefits, risk 
and burden weigh heavily, but in relation to (certain) benefits they may be acceptable.
Almost fifteen years ago King argued that there should be a clearer description and 
definition of benefits in research because of the misconception about what a consti-
tutes a benefit in clinical research.4 According to King three categories of benefit can be 
identified: 1) direct benefit (i.e. health or medical benefit from receiving the intervention 
being studied), 2) collateral benefit (i.e. benefit from being in a study, e.g. a free physical 
exam, free medical care, personal gratification of altruism) and 3) aspirational benefit 
(i.e. benefit to society and to future patients, which arises from the results of the study).4 
However, in practice these distinctions are probably not applied. In a study into the 
appreciation of benefit by Institutional Review Boards (IRBs), it was shown that about 
60% of the IRB chairpersons considered added psychological counseling that was not 
necessary for research purposes, to be a direct benefit.5 Ten percent of the IRB chair 
respondents even considered participant payment as a direct benefit of research. This 
leads to the question, also raised by Cave,6 whether in addition to medical benefits, 
non-medical benefits (e.g. social, economic and emotional benefits) can qualify as direct 
benefits?
Few studies investigated the benefits children experience during research participa-
tion.7-10 These studies primarily focused on the quantitative measurement of benefits. Al-
though they give important information on the percentages of children that experience 
a certain benefit, these studies give limited insight into the variety of children´s benefits. 
Recently, Luchtenberg et al. conducted a qualitative study on the benefits adolescents 
experienced during their participation in clinical trials.10 The adolescents in their study 
positively valued helping others (e.g. future patients, their doctors and parents) and 
experienced personal benefits (e.g. improved health). Their study provides important 
additional information to the quantitative data of previous studies. Their study however 
primarily focused on adolescents in therapeutic studies. In this report we give insight 
into the positive experiences of a more diverse group of children (healthy and ill children 
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between 6 and 18 years) that participated in non-therapeutic research studies, and we 
will discuss whether these positive experiences can justifiably be viewed as benefits 
that can be taken into account into the risk-benefit analysis of IRBs in non-therapeutic 
research.
mAteriALs AND metHoDs
subjects
For this paper, we used a subsample of the interviews from an earlier study on children’s 
discomforts in clinical research.11 We purposefully selected a broad range of children 
(in age and medical condition) undergoing various types of medical research proce-
dures to assure a wide range of experiences, influences and attitudes.12 The children 
were enrolled until saturation was reached, i.e. until no new topics related to children’s 
experiences were mentioned during the interviews.13 For this analysis on the positive 
experiences, we only used the interviews of the children in the five non-therapeutic 
studies (mostly observational studies).
Procedure
The researchers of the cooperating studies first informed parents and children about our 
interview. Parents and children also received an information letter. Parents and children 
had an opportunity to ask questions about the interview in a face-to-face conversation 
with the interviewer, which was prior to the start of the study on the day of the child’s 
research visit. If willing to participate, written parent consent and child assent (children 
≥ 12 years) were obtained. Children younger than twelve years verbally agreed to par-
ticipate. All children received a gift card (€7.50) after the interview.
Interviews were conducted in a private room at the hospital, directly after the chil-
dren’s participation in the research studies by the first author (MSS), who has a degree 
in health psychology and was trained in interviewing children. Parents were present 
during most interviews, although they were kindly requested not to intervene in the 
interviews as the focus was on the child’s perspective.
instruments
The interviews were semi-structured and were focused on discomfort during clinical 
research. We also asked the children about general experiences during the studies. We 
did not specifically ask about positive experiences; children spontaneously mentioned 
these. The interview schedule can be found in Appendix A.
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Data analysis
Audiotaped interviews and field notes were transcribed verbatim. After initial tran-
scription by trained 3rd year psychology students, the first author (MSS) checked the 
transcripts for accuracy and analyzed the data using NVivo 10.0. For this report, we did a 
secondary analysis on a subsample of the interviews and specifically looked at children’s 
positive experiences during non-therapeutic research participation. We used ‘thematic 
analysis’ to identify themes related to positive experiences.14 The supervising author 
(SvdV) independently analyzed a third of the interviews to ensure agreement on the 
coding. Note: for additional information on the children and methods we used, we refer 
to the initial article.11
resULts
Participants
For this paper, we used the interviews of 30 out of a total of 46 children. These 30 chil-
dren (6-18 years; mean=11.9 years) participated in non-therapeutic research studies; 
the other 16 children all participated in therapeutic research. Among them were both 
children with mild or severe chronic conditions (60%), and healthy children (40%). An 
equal proportion of girls and boys participated: 15 girls and 15 boys. A description of the 
children is provided in Table 1.
Positive experiences
All children mentioned positive experiences, and we categorized these into seven differ-
ent types. Most frequently mentioned were ‘helping other children’ and the gratification 
that comes with it; having fun; (future) health benefits; and gaining new knowledge. 
Other, less frequently mentioned positive experiences were receiving a present; not 
having to go to school; and getting attention from healthcare staff and researchers.
Helping other children (altruism)
Children, and in particular the children with a severe chronic condition, frequently 
reported that they think it is important to help other children (with the same medi-
cal condition) to get better treatments in the future. “I don’t benefit from it myself […] 
for me it’s important that other children can benefit from it, that they can get the right 
medicines immediately and that they can live a normal life and in good condition […]. If it 
helps other children to suffer as less as possible, then for me it’s no issue to participate”(girl 
#4). Through helping others by participating in research, children reported to feel good 
about themselves “It gives you a good feeling when you participate”(girl #31).
The interviewed children for whom the research procedures and their normal care 
could be combined (e.g. extra blood samples, couple of minutes extra in the MRI for re-
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search purposes), said the researchers made it very easy for them to help others because 
it took minimal effort and time “It only takes five extra minutes in the MRI. Why wouldn’t 
I participate if I may help someone else? It takes minimal effort and for others it may be 
helpful”(boy #12).
table 1. Description of the children in non-therapeutic research
iD* Gender Age in years Health condition
01 Girl 7 IBD**
02 Boy 6 Healthy
03 Girl 6 Healthy
04 Boy 17 IBD
05 Boy 8 IBD
06 Boy 6 Healthy
07 Boy 17 IBD
08 Boy 6 Healthy
09 Girl 11 Asthma
12 Boy 14 IBD
13 Boy 15 IBD
16 Girl 17 IBD
19 Boy 6 Asthma
22 Girl 8 Asthma
27 Girl 11 IBD
29 Girl 16 IBD
31 Girl 16 Asthma
32 Boy 13 Healthy
33 Girl 12 Healthy
35 Boy 17 IBD
36 Boy 12 Healthy
37 Girl 6 Healthy
38 Girl 12 Healthy
39 Boy 15 Healthy
40 Girl 15 IBD
41 Girl 12 Healthy
43 Girl 12 Asthma
44 Boy 12 Healthy
45 Girl 16 Asthma
46 Boy 16 Asthma
* ID: Identification number of the initial study
** IBD: Inflammatory Bowel Disease
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Having fun
Many children mentioned ‘having fun’ during the research procedures, in particular the 
pulmonary function tests, MRI-scans, measuring blood pressure, and the cognitive ca-
pacity tests (Wechsler Intelligence Scale for Children, WISC) “There was a game I had to do 
[one of the tests of the WISC]. You get different cards and you have to make a story with these 
[...]in the right order as fast as you can. I found that the most fun part [of the study]”(boy 
#32). Children particularly enjoyed the research procedures that were framed as a game. 
For instance, during the pulmonary function test, children had to blow as hard as they 
could in order to virtually blow up a balloon “It [the cognitive test] has a scientific objec-
tive, but it was really fun to do!”(boy #32). The children who mentioned the MRI as fun 
said it was because it was exciting to them, and/or because they could listen to music 
or watch a movie.
Future health benefits
The majority of the chronically ill children positively valued possible health benefits 
in the (near) future. They hoped that better medicines were found, or that there will 
be increased knowledge about their diseases, so that they could benefit from these 
developments in the future “Well, if they find a better medicine by doing research, I’ll help 
others and maybe myself too”(girl #29). Additionally, the children indicated that they 
would like to know in detail how the results of the study can be used in the future. Some 
children reported that they considered having an extra medical check-up as a benefit of 
participating in research.
New or increased knowledge
About half the children, the healthy ones in particular, mentioned they enjoyed learning 
something about their physical and/or cognitive capacities, for instance how well their 
lungs work by undergoing pulmonary function tests or what level their blood pressure 
is. In most of the research studies, the children and parents received the individual out-
comes of research procedures, such as the test results on the pulmonary function test. 
The healthy children who underwent an MRI also received a picture of the child’s head.
A couple of children were interested in learning about hospitals, the medical proce-
dures, healthcare staff and doing research “I like to see what they [healthcare staff at the 
pediatrics department] are doing (…) because I want to become a pediatrician myself”(girl 
#38).
Receiving a present
Most children received some kind of present after their participation (e.g. crayons, 
coupon for the movies). The majority indicated that they very much appreciated this 
present, although they it was not an incentive for them to participate. In one study, the 
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parents of the children received money for their participation. The parents of one of the 
children promised their child that he could have the money. The child indicated that this 
was the most important reason to participate.
Not having to go to school
A couple of children, in particular the healthy children and children with a mild chronic 
condition, mentioned that they would rather participate in research than go to school 
“Tuesday is an annoying day at school. I’d rather do this”(boy #32).
Getting attention
A few chronically ill children mentioned getting (extra) attention from healthcare staff as 
something positive. The children who explicitly mentioned that the research team was 
friendly were in general more positive about the study they participated in than children 
who did not mention whether they liked the research team.
DisCUssioN
Our study shows that children (6-18 years) participating in non-therapeutic research 
have various kinds of positive experiences. We argue that three of these (learning, 
altruism and fun) can be justifiably qualified as benefits of research participation and 
can (conditionally) be used in a risk-benefit analysis. Exclusive focus on the potential 
risk and burden of participation tends to ignore the positive effects of participation, 
which our study shows is an important aspect for children. In general, researchers can 
sometimes be overly cautious when including vulnerable populations in their research 
because they think it will only burden them, while in fact these patients positively value 
the opportunity to contribute to society.15, 16
In our opinion, learning about yourself, medical procedures and/or doing research 
should certainly count as a benefit. A study that adds to children’s knowledge of the 
human body/medicine is ‘better’ than one in which children do not experience this. 
Previous research also shows that children want to be actively involved in research and 
are interested in the results of a study.10 We think learning something from participa-
tion (e.g. about science, biology or the human body) is a justified benefit that should 
be maximized. We therefore concur with Wendler’s view that educational benefits can 
justify non-therapeutic pediatric research.17
We also think that ‘helping other children’ is acceptable as a benefit for children as it 
indicates an altruistic attitude, which we value positively. Altruism has been document-
ed in previous studies about the experiences of children in (non-therapeutic) pediatric 
research,7-9, 18 and should be an important motivation for participating in any research 
(therapeutic and non-therapeutic). Adolescents (≥12 years) and chronically ill children 
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frequently mentioned altruism, and some younger children with a chronic condition 
also mentioned altruism. According to Piaget’s formal operations stage, children aged 
12 or over are able to understand ethics and morals, and would therefore be inclined to 
mention altruism.19 The younger children in our study who mentioned helping others 
as a positive experience, may be influenced by their parents.20 However, young children 
with a (chronic) illness may be more mature than their healthy peers concerning aspects 
of healthcare, and therefore show altruism in medical situations at an early age.
Having fun, which was mentioned in particular by the healthy children, can be seen 
as a benefit because it improves the experience of children in research. If children’s ex-
periences improve, children may be more likely to participate in future research, which 
in turn may increase participation rates.
However, not all the reported positive experiences are desirable benefits or even 
acceptable as a benefit from an ethical perspective. The benefit of ‘getting extra atten-
tion from healthcare staff’ is dubious from a moral viewpoint. Adults and children may 
feel that by participating in research they get attention they would otherwise not have 
received from the healthcare staff, but this should not be the case. Care should be taken 
to ensure that routine clinical care is sufficiently attentive and that there is no need for 
patients to feel that only participation in research would give them the care they need. 
We also regard receiving a present or money as a dubious benefit, especially when it is 
the primary benefit for participating. It could tempt researchers to give the child more 
money as compensation for a higher risk and burden level of their study.21 However, 
giving a small present as a token of appreciation may be acceptable, particularly if chil-
dren do not know this beforehand. This small gift may help children feel appreciated. 
Researchers however should make sure that the incentive is not the overriding reason 
to participate and it should never compensate for risk.
The future benefits that the children mentioned can be regarded as ‘hope’. In previous 
research, hope for (future) health benefits is often mentioned as a motivation or benefit 
of non-therapeutic research participation.10, 22 Hope can be interpreted as therapeutic 
misconception (i.e. blind optimism),23 or as therapeutic optimism (i.e. hope that does 
not result in despair).24 Based on the interviews, we assume that this hope for future 
health benefits can be categorized as therapeutic optimism, however, this is an assump-
tion and we do not know whether it may be (mixed with) therapeutic misconception. 
Although therapeutic optimism may be a reasonable and balanced form of optimism, 
we think ‘hope’ should not be incorporated into the risk-benefit analysis because there is 
a thin line between a therapeutic misconception and therapeutic optimism, and it may 
not be obvious which form of hope is experienced.
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should positive experiences be seen as benefits in all studies?
Knowing that children may experience (non-medical) benefits, and that the expectation 
of these benefits might and should motivate them to participate is one thing. The ap-
preciation of the positive side effects of research participation is in those cases a strictly 
personal choice. However, before they can make this choice, IRBs have to do a risk-benefit 
evaluation in order to decide whether the study as a whole is acceptable (and therefore 
open for individual appraisal by parents and children). That is an entirely different mat-
ter. Should IRBs take possible benefits into account, and weigh these against the risks 
and benefits of non-therapeutic studies? We propose two scenarios.
scenario 1. only in certain situations non-medical benefits should be taken into 
account
Research by Westra et al. shows that ethics committees can struggle with the minimal 
risk/discomfort threshold, and sometimes allow more than minimal risk/discomfort in 
studies that formally should be rejected.25 This is particularly the case when the studies are 
thought to be crucial, but the risks and burden are expected to be slightly above minimal. 
Weighing certain non-medical benefits in these situations can help to make exceptions 
for these crucial studies. The non-medical benefits could then be the factors tipping the 
balance to a favorable risk-benefit ratio. Including these benefits also helps to make the 
evaluation more transparent. Please note that the benefits we deem acceptable are classi-
fied by King as collateral or aspirational benefits.4 We thus accept that certain collateral and 
aspirational benefits are, in these exceptional cases, weighed into the risk/benefit analysis.
scenario 2. Non-medical benefits should always be taken into account
This would be a more general approach. The advantage of always taking into account 
certain non-medical benefits, is its simplicity: no need to decide whether in this particu-
lar case this is acceptable or not. Another argument in favor of this, is the fact that these 
non-medical benefits are, if present, always experienced by the research participant him/
herself, and are not - as is mostly the case with medical benefits - a benefit for a future 
child. The downside is that less crucial research, entailing more than minimal burden 
or more than negligible risks might be justified by these non-medical, and non-direct 
benefits. In fact this implies that the distinction between medical and non-medical (col-
lateral or aspirational) benefits becomes vacuous.
For both scenarios, there are several other considerations to take into account. 
Similar to the medical benefits, non-medical benefits cannot be guaranteed. In addi-
tion, the benefits are not applicable to all children. Children need to have the cognitive 
capacity to experience these benefits, which we estimate to be from approximately six 
years onwards (assuming that the child has no cognitive or psychological problems). 
Although we cannot draw any conclusions about differences between healthy and ill 
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children based upon our empirical work, it is likely that some positive experiences/
benefits are more important for certain groups of children, and less important for others. 
It might be argued that, once these groups are identified based on firm quantitative 
research, IRBs could and should take different benefits into account for different groups 
of participants. The same goes for different types of research studies. For instance, in 
non-therapeutic studies in ill children, altruism (and future benefits) are of importance, 
while in non-therapeutic research with healthy children ‘increased knowledge’ and ‘hav-
ing fun’ may play a more important role. We therefore have a preference for the first 
scenario, of selectively deciding to allow non-medical benefits to tip the scale, in order 
to avoid that non-medical benefits justify too much risk and burden.
recommendations
To better take into account non-medical benefits in non-therapeutic research participa-
tion, and in order to incorporate these benefits into the risk-benefit analysis, we have 
recommendations for several groups involved in pediatric research.
Institutional Review Boards
We recommend that IRBs take the non-medical benefits that we argued are justifiable into 
account when weighing the risk-benefit analysis of non-therapeutic research participation. 
We state a preference for the first, cautious scenario, where these benefits can tip the scale 
when crucial studies are at stake, but there are no medical benefits justifying the slightly 
over-minimal risks and burden. In those cases, IRBs should check whether the research set-
up is done in such a way that the possibilities for non-medical benefits are maximized.
Policy makers
Policy makers in the field of pediatric research participation can contribute to this discus-
sion by revising the regulatory framework to allow certain non-medical benefits into the 
risk-benefit analysis. This will support IRBs to incorporate non-medical benefits into the 
risk-benefits analysis in specific cases and make their evaluation justified and transparent.
Pediatric researchers
Based on the interviews with the children, there are two things for pediatric researchers 
to focus on. First, pediatric researchers could use empirical information on positive ex-
periences during the informed consent process. Information about the positive effects is 
often lacking in study protocols and patient information brochures. Researchers may be 
reluctant to provide information about possible non-medical benefits because they do 
not want to persuade parents and children to participate based on non-health benefits. 
We are of the opinion that all information, including that on positive experiences, is 
necessary to make a well-informed decision on whether to participate in research.
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Second, we advise pediatric researchers to improve children’s experiences and set up 
their study in such a way that non-medical benefits are maximized. Meeting the needs of 
children to learn new things during research (i.e. educational benefit) provides research-
ers with an opportunity to use non-therapeutic research to teach children about science, 
and thus to create more support for science among the general public. There are several 
ways in which this can be achieved, examples include giving the child-participants a 
booklet in which they can register the results of the research procedures in a way that 
appeals to them, or giving them feedback on the results of a study in an attractive way, 
or presenting the research procedures in the form of an interactive game.
Limitations and future research
We studied children’s positive experiences in a retrospective design following a secondary 
analysis of interviews that we conducted. Future research should specifically aim at explor-
ing the self-reported positive experiences of children during research participation in order 
to gain more in-depth information (i.e. directly asking children about their positive experi-
ences). We found that the emphasis of the positive experiences mentioned by the healthy 
children and by children with a chronic condition differed. Healthy children were more 
likely to mention ‘having fun’, ‘increased knowledge’ and ‘not having to go to school’ as a 
positive aspect of research participation, while the ill children mentioned ‘helping others’, 
‘future health benefits’ and ‘extra attention’ more often. Quantitative research is needed to 
establish whether this difference can be supported, as well as other differences between 
children (e.g. differences in age). The Reactions to Research Participation Questionnaires 
for Children (RRPQ-C) as well as the survey by Wendler et al. could be used to measure 
whether children experience certain benefits of research participation in a quantitative 
way.18, 26 Since we did not interview children with acute life-threatening conditions, we do 
not know whether our findings can be generalized to them.
Conclusion
In general, we argue that there is (too) much focus on the protection from risks and burden 
of children in non-therapeutic clinical research, and (too) little focus on the positive experi-
ences and benefits that are important for these children. Our study shows that children 
taking part in non-therapeutic research have various positive experiences during research 
of which some could justifiably be considered to be benefits of research participation.
ACkNoWLeDGemeNts
We would like to thank all children who were interviewed for this study. We gratefully 
acknowledge Krista Tromp for her suggestions for writing this article.
125
Positive experiences of children in non-therapeutic research 
7a
refereNCes
 1. Council for International Organizations of Medical Science. International Ethical Guidelines for 
Biomedical Research Involving Human Subjects (1st revision; original version 1993). Geneva, 
Switserland: CIOMS; 2002.
 2. European Union. Ethical considerations for clinical trials on medicinal products conducted with 
the paediatric population. Recommendations of the ad hoc group for the development of imple-
menting guidelines for Directive 2001/20/EC relating to good clinical practice in the conduct 
of clinical trials on medicinal products for human use. European journal of health law 2008. p. 
223-250.
 3. WMA General Assembly. Declaration of Helsinki - Ethical principles for medical research involv-
ing human subjects. http://www.wma.net/en/30publications/10policies/b3. Published 2013. 
Updated October 2013.
 4. King NM. Defining and describing benefit appropriately in clinical trials. Journal of Law, Medicine 
& Ethics. 2000;28(4):332-343.
 5. Shah S, Whittle A, Wilfond B, Gensler G, Wendler D. How do institutional review boards apply the 
federal risk and benefit standards for pediatric research? JAMA. 2004;291(4):476-482.
 6. Cave E. Seen but not heard? Children in clinical trials. Medical Law Review. 2010;18:1-27.
 7. Chu AT, DePrince AP, Weinzierl KM. Children’s perception of research participation: Examin-
ing trauma exposure and distress. Journal of Empirical Research on Human Research Ethics. 
2008;.3(1):pp.
 8. Kassam-Adams N, Newman E. Child and parent reactions to participation in clinical research. Gen 
Hosp Psychiatry. 2005;27(1):29-35.
 9. Newman E, Kaloupek DG. The risks and benefits of participating in trauma-focused research stud-
ies. J Trauma Stress. 2004;17(5):383-394.
 10. Luchtenberg M, Maeckelberghe E, Locock L, Powell L, Verhagen AA. Young People’s Experiences 
of Participation in Clinical Trials: Reasons for Taking Part. Am J Bioeth. 2015;15(11):3-13.
 11. Staphorst MS, Hunfeld JAM, van de Vathorst S, Passchier J, van Goudoever JB, Burden-group. 
Children’s self reported discomforts as participants in clinical research. Social Science & Medicine. 
2015;142:154-162.
 12. Marshall MN. Sampling for qualitative research. Fam Pract. 1996;13(6):522-525.
 13. Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research. New 
Jersey: Aldine Transaction; 1967.
 14. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 
2006;3(2):77-101.
 15. Prince-Paul M, Daly BJ. Moving Beyond the Anecdotal: Identifying the Need for Evidence-Based 
Research in Hospice and Palliative Care. Home Healthcare Now. 2008;26(4):214-219.
 16. Tromp K, Vathorst Svd. Gatekeeping by professionals in recruitment of pediatric research partici-
pants: Indeed an undesirable practice. The American Journal of Bioethics. 2015;15(11):30-32.
 17. Wendler D. A new justification for pediatric research without the potential for clinical benefit. Am 
J Bioeth. 2012;12(1):23-31.
 18. Wendler D, Abdoler E, Wiener L, Grady C. Views of adolescents and parents on pediatric research 
without the potential for clinical benefit. Pediatrics. 2012;130(4):692-699.
 19. Piaget J. The moral judgment of the child. New York: Harcourt, Brace, 1932.
 20. Scherer DG. The Capacities of Minors to Exercise Voluntariness in Medical-Treatment Decisions. 
Law Human Behav. 1991;15(4):431-449.
CHAPTER 7a.
126
 21. Friedman A, Robbins E, Wendler D. Which benefits of research participation count as ‘direct’? 
Bioethics. 2012;26(2):60-67.
 22. Vanhelst J, Hardy L, Bert D, Duhem S, Coopman S, Libersa C, et al. Effect of child health status on 
parents’ allowing children to participate in pediatric research. BMC medical ethics. 2013;14(1):1.
 23. Appelbaum PS, Roth LH, Lidz C. The therapeutic misconception: informed consent in psychiatric 
research. International Journal of Law & Psychiatry. 1982;5(3-4):319-329.
 24. Horng S, Grady C. Misunderstanding in clinical research: distinguishing therapeutic miscon-
ception, therapeutic misestimation, & therapeutic optimism. IRB: Ethics & Human Research. 
2003;25(1):11-16.
 25. Westra AE, Sukhai RN, Wit JM, de Beaufort ID, Cohen AF. Acceptable risks and burdens for children 
in research without direct benefit: a systematic analysis of the decisions made by the Dutch 
Central Committee. J Med Ethics. 2010;36(7):420-424.
 26. Kassam-Adams N, Newman E. The reactions to research participation questionnaires for children 
and for parents (RRPQ-C and RRPQ-P). Gen Hosp Psychiatry. 2002;24(5):336-342.
127
Positive experiences of children in non-therapeutic research 
7a
APPeNDix A. iNterVieW sCHeDULe
General experiences
How did you feel about the study in general?
How did you feel before the study?
How did you feel afterwards?
Can you describe your experiences during the study?
Can you describe your experiences during procedure X?
experiences related to discomfort
Can you describe any discomfort you experienced in the study?
Is there any part of the study that you did not like? Which part? Why?
Can you describe any discomfort you experienced because of procedure X?
Worst experiences
What was/were the most burdensome/discomforting part(s) of the study? Which part? 
Why?
Preparation
Who prepared you for the study?
What information did you get about the study? Was this information sufficient?
Did you know what to expect of the study?
suggestions to reduce discomfort
Can you think of anything that would have made the study easier for you? If so, could 
you tell me about it?
Can you think of anything that will make procedure X less discomforting for you? If so, 
could you tell me about it?
Can you think of anything that will make procedure X more comfortable for you? If so, 
could you tell me about it?
future research
Would you participate in this research study again? Why (not)?

CHAPTER 7b.
empirical data on benefits children experience 
in clinical research
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emPiriCAL DAtA oN BeNefits CHiLDreN exPerieNCe iN CLiNiCAL 
reseArCH
An important group is often excluded from taking part in discussions about benefits in 
pediatric research: the children themselves. Luchtenberg and colleagues (2015) rightly 
point out that previous studies investigated the benefits children experience in research; 
however, these studies are biased in that the researchers came up with the answer 
categories, instead of using input from the children to identify relevant topics. To get 
an idea of the benefits relevant to them, it is important to hear their voices and let the 
children indicate the benefits they actually experience. The authors took an important 
step forward and provided a broader picture of what we already know about benefits in 
pediatric research by interviewing children in clinical trials.1
reseArCH BeNefits exPerieNCeD BY otHer GroUPs of CHiLDreN
In an interview study focusing on the benefits children mention directly after participat-
ing in clinical research studies (N=46, 6–18 years), most of the benefits we found were 
similar to those in the target article.2 Our study provides additional information about 
the benefits children experience, because we targeted a different group: We studied 
children in various research studies, not only those in clinical trials.
Young children
The children interviewed in the target article were relatively old (11–23 years). It is inter-
esting that most of the benefits mentioned in the target article (helping other children, 
feeling good about oneself because of altruism, and personal health benefits) were also 
mentioned by the younger children in our study (22 of the 46 children interviewed in 
our study were between 6–11 years old). It is important to recognize that even children 
as young as 6 years are capable of reporting benefits they experience during research 
participation. Contrary to the development theory of Piaget in which young children 
generally are not considered to be capable of altruism or of feeling a moral duty,3 our 
findings indicate that young children participating in research, including 6-year-olds, 
think it is important to help other children. An explanation for this could be that sick 
children may be concerned about children with similar conditions and therefore their 
condition may have rendered them capable of altruism at a younger age than their 
healthy peers.
Healthy children
Luchtenberg and colleagues (2015) mentioned that they included both healthy and sick 
children in their study. However, only two of the children included were actually healthy. 
Interesting benefits mentioned by the healthy children in our study were “having fun” 
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and “learning about oneself” (N = 12). They often enjoyed undergoing research proce-
dures such as a magnetic resonance imaging (MRI) scan, intelligence tests (Wechsler 
Intelligence Scale for children), and even pulmonary function tests. These procedures 
were often passed off as a game, and the children thought they were fun. Another 
important benefit for the healthy children was to learn more about their cognitive and 
physical capacities. These children were interested in knowing how they would fare on 
a certain procedure, and what their anatomy looks like in an MRI. Although “having fun” 
and “learning about oneself” are not recognized as direct benefits of research in existing 
ethics guidelines, our study shows that these are important benefits for healthy children 
participating in research.
Children in non-therapeutic research
Although not explicitly stated by the authors, we deduce that most children in the target 
article participated in therapeutic studies. The majority of the children we interviewed 
participated in nontherapeutic studies, giving interesting information from the perspec-
tive of children who are not expected to benefit as defined by current ethics guidelines. 
Even though nontherapeutic research does not aim to provide health benefits, some sick 
children in these studies did mention health benefits such as extra medical checkups 
and better monitoring of their disease. In addition, almost all the children experienced 
benefits related to helping other children (and maybe even themselves in the future). 
The children with a chronic condition in particular thought it was really important to 
help other children. We therefore think that the term ‘network of exchange’, which the 
authors introduced when describing ‘helping others in general’, particularly concerns 
sick children.
HoW CAN ProfessioNALs iNVoLVeD iN PeDiAtriC reseArCH Use tHe 
exPerieNCes of CHiLDreN?
The target article and our own study show that both young children and adolescents,2, 4 
including healthy children and children in non-therapeutic research, experience a variety 
of benefits from research participation. Based on the findings of these studies, we think 
an important message for professionals involved in pediatric research is to recognize 
that non-health benefits also play an important role for children participating in a study, 
in therapeutic as well as nontherapeutic research.
Pediatric researchers
Pediatric researchers may be reluctant to mention benefits other than health benefits 
during the informed consent procedure because it may feel like pushing parents and 
children to participate. However, to obtain a complete picture of what participation in a 
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study will be like, it is important that parents and children be informed of the different 
kinds of benefits.1 Furthermore, if pediatric researchers are aware of important research 
benefits for children, they can try to maximize these benefits when designing their stud-
ies. For instance, they could make the study more fun for the children by making the 
procedures more like an interactive game. If researchers make an effort to make a study 
beneficial in the eyes of the children, this may help to increase patient participation.
institutional review Boards (irBs)
According to the definitions in existing ethics guidelines, research benefits are seen as 
health benefits. King (2000) argues that we should distinguish different kinds of ben-
efits: direct health benefits, collateral benefits, and aspirational benefits.5 According to 
King, many of the benefits found by Luchtenberg et al. (2015) and those in our own 
study would be categorized under collateral benefits (e.g. having fun, satisfying your 
curiosity, learning about oneself ). Shah et al. (2004) showed however that the chairs of 
IRBs sometimes perceive collateral benefits as direct benefits,6 which, according to the 
benefits that are important for the children, may actually be justified in some cases.
The findings of the target article and of our own study can help IRBs in recognizing 
what the benefits of a study are from the perspective of the children themselves. We 
would advise institutional review boards to also take the reported benefits in these stud-
ies into account when evaluating the risk–benefit ratio of study protocols. This supports 
Cave’s view that if research will not directly benefit the child’s health, other (collateral) 
benefits, such as altruism and having fun, can be viewed as direct benefits.7
fUtUre reseArCH oN CHiLDreN’s BeNefits iN CLiNiCAL reseArCH
Although both the target article and our own study give an insight into relevant benefits 
for children, it would be interesting to investigate in a larger sample size the percentage 
of children that experience certain benefits and whether the benefits for children de-
pend on the type of study (nontherapeutic vs. therapeutic) or the severity of the child’s 
condition (life-threatening vs. chronic condition vs. healthy).
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The need to protect children from discomfort and risks in clinical research outweighs 
the need for the development of evidence-based drugs and treatments. While children 
obviously need protection against discomforting research procedures, children’s dis-
comfort in medical settings can be overestimated,1, 2 which can lead to the rejection of 
important pediatric studies.
The aim to meet the need for more pediatric research3, 4 - leading to better pediatric 
healthcare - forms the basis of this thesis. We primarily focused on providing evidence-
based data on children’s discomfort during several common research procedures. For 
this, we developed an instrument for measuring discomfort of research procedures. 
Our eventual goal is to develop an online database with data on children’s self-reported 
discomfort, for which this thesis lays the foundation.
reseArCH QUestioNs
1. What is the degree of discomfort of common medical research procedures?
2. Do children experience clinically relevant stress symptoms due to common medical 
research procedures in the long-term?
3. Do age, anxiety-proneness, gender, medical condition and previous experiences 
with the procedures influence discomfort?
4. Are there differences in discomfort of the same medical procedures that are con-
ducted for research purposes versus clinical care?
5. What are children’s suggestions to reduce the discomfort of research procedures?
research question 1. Children’s self-reported discomfort during medical 
research procedures
In order to answer our main research question, we first needed to know what discomfort 
for children in clinical research means because there is no clear description (Chapter 3). 
A restricting factor was that most children did not understand the meaning of the word 
discomfort (‘belasting’ in Dutch). Therefore we had to change our approach slightly, and 
asked children about their experiences instead, focusing on the negative ones. What 
we learned from the interviews is that discomfort is not a one-dimensional but rather 
a multidimensional construct that involves different kinds of physical and mental ex-
periences. Although children came from diverse backgrounds and underwent different 
research procedures, their experiences were remarkably similar, for instance boredom, 
tiredness, nervousness.
The second step to get insight in children’s discomfort during research procedures 
was to standardize the measurement of it, for which we developed a questionnaire 
together with several pediatric healthcare professionals and input from literature: the 
Children’s Discomfort during Research Procedures Questionnaire (CDRPQ) (Chapter 4). 
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Since we aimed to develop an instrument that could be used for all kinds of research 
procedures, it was important to use forms of discomfort that are relevant to most re-
search procedures (i.e. a generic questionnaire). The final version of the CDRPQ involves 
six questions about children’s discomfort, with each question involving five levels of 
discomfort, and an open question about children’s suggestions for reducing discomfort.
For the final step, we asked children in clinical research to complete the CDRPQ. 
Given our restricted time and resources, we included six common research procedures: 
buccal swabs, MRI-scans, pulmonary function tests, skin prick tests, ultrasound imaging, 
and venipunctures (Chapter 5).
Children reported limited discomfort related to these procedures. These results may 
be not surprising as the procedures are quite common, which may be an indication that 
they are not (very) invasive and children may be familiar to undergoing these proce-
dures. On the other hand, there appears to be ambiguity about the degree of discomfort 
of some of these research procedures (e.g. some consider MRI-scans as minimal discom-
fort, while others view this procedure as more than minimal discomfort).5, 6
We were surprised by the relatively high scores on the questions about being bored 
and being tired, independent of the research procedures. Measuring children’s nega-
tive experiences in medical situations rarely seems to focus on these experiences. This 
indicates that boredom and tiredness may be underestimated forms of discomfort for 
children in medical settings.
research question 2. Psychological risk on clinically relevant stress
Literature shows that painful and distressing procedures can have a significant psycho-
logical impact on children, for which psychological help is required.7, 8 In Chapter 6 we 
showed that the risk on long-term clinically relevant stress due to common research 
procedures is almost absent. As children already experienced limited discomfort dur-
ing these research procedures (Chapter 5), these results did not surprise us. There is, 
however, a significant positive relation between discomfort during the procedures and 
long-term stress symptoms, suggesting that more discomforting research procedures 
may have a significant psychological impact on children. Measuring risk on clinically 
relevant stress is therefore of particular importance during very or extremely discomfort-
ing research procedures, which we think will be primarily used in therapeutic research, 
because there is no a priori upper limit for the level of discomfort as long as it is in 
proportion to the potential benefits.
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research question 3. factors influencing discomfort
Discomfort of a certain procedure may be experienced differently in different children 
and/or across different situations. We therefore explorativelyd studied the influence of 
several potential factors on discomfort (age, anxiety-proneness, gender, medical condi-
tion and previous experiences) to identify groups of children that are more prone to 
experience discomfort and consequently might need special precautions (Chapter 5). 
We focused on these specific factors because research in clinical care shows that these 
can influence children’s experiences, and ethics committees often take these factors into 
consideration when evaluating discomfort.
Except for anxiety-proneness, our results showed no relation between the above-
mentioned factors and discomfort. There are several explanations for this absence. First 
of all, children’s discomfort scores were relatively low, making it difficult to find a relation 
between these factors and discomfort. Second, we think the population of children in 
research differs from children in routine clinical care (in which the influence of these fac-
tors on discomfort was found). Contrary to the general pediatric population in routine 
clinical care, our study sample had a high percentage of healthy children, relatively old 
children (>8 years), and trait-anxiety levels were relatively low. Third, skewedness of some 
of the data (age and health condition) may have prevented to find a relation between 
these factors and discomfort. Since the explorative nature of this research question, it is 
needed to investigate the influence of these factors in larger study samples.
research question 4. research versus clinical care
It is important to know if children in research experience less discomfort during the 
medical procedures than children in clinical research. Children in research generally 
undergo medical procedures voluntary,e which is why they possibly experience less 
discomfort during the same medical procedure. If proven, this information can lead to 
more acceptability of children in clinical research. We therefore exploratively studied 
whether the purpose of a medical procedure (routine clinical care versus research) influ-
enced discomfort. The results were inconclusive. Significant differences were found for 
MRI-scans and pulmonary function tests, although the differences were small. Although 
we expected the procedures less discomforting in research, it may be (partly) depen-
dent of the procedures whether children experience it as less (or more) discomforting in 
research settings than in clinical care. More research is therefore needed.
d This was exploratively studied because our sample size was too small for a reliable outcome on the 
influence of factors on discomfort
e There are exemptions: sometimes children may not know that they are participating in a research 
study, and sometimes the parent makes the decision to enroll.
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research question 5. Children’s suggestions to reduce discomfort
Getting insight into children’s discomfort is one step; actually doing something to 
minimize this discomfort is a second one. Minimizing discomfort is even obligatory in 
several codes and regulations on pediatric research participation.9, 10 To help researchers 
reducing discomfort of the procedures in their studies, we described children’s sugges-
tions for reducing discomfort (Chapters 3, 5). Since we think these suggestions are an 
essential part of measuring discomfort, we added a question about reducing discomfort 
to the CDRPQ.
Distraction was, by far, the most mentioned suggestion to reduce discomfort, inde-
pendent of the research procedures. Distraction has proven to be effective in reducing 
discomfort of medical procedures in children of all ages,11-15 and it is also cost-effective 
because of the relatively low start-up and maintenance costs.16 It can be provided in 
different forms, such as showing short movies, listening to music or small talk. Our study 
shows that children prefer distraction by showing a movie.
Distraction is often provided during potential painful procedures, or when children 
are anxious. However, based on the relatively high scores on the CDRPQ on ‘bored’ and 
‘tired’, it is recommended to also provide distraction during lengthy procedures and 
extensive study visits.
streNGtHs
The debate on discomfort in pediatric research generally takes place from the perspec-
tive of adults, while the most important group is often excluded: the children them-
selves. This thesis aimed for hearing their voices about their experiences in research, and 
disseminating these data. This thesis is the first doing so on a relatively large scale, with 
respect to the number of research procedures and the number of children undergoing 
these procedures.
The necessity of getting insight into children’s self-reported experiences in clinical 
research is mentioned frequently. More than a decade ago, researchers like Kassam-
Adams developed instruments to map up children’s experiences in research. Unfortu-
nately, these initiatives never reached large-scale support by healthcare professionals. 
We were unable to find a clear reason for this. We believe it is because these researchers 
focused on discomfort of complete research studies, which makes it difficult to general-
ize the findings because studies are rarely similar. We therefore have chosen to focus 
on discomfort of research procedures, making it possible to generalize the findings of a 
certain procedure to children undergoing this same procedure in different studies.
It needs to be noted that – many years after the attempts by previous researchers17,18 
– our project benefits from recent Dutch and European developments within pediatric 
research. For instance, the Dutch government is promoting and subsidizing research on 
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the ethical, juridical and psychological aspects of children in research, and also invested 
in the development of a (ethics) guideline for pediatric researchers about the care of the 
children involved in their studies. Moreover, the Dutch government recently accepted 
a law that expands the possibilities for pediatric research, in particular for children in 
non-therapeutic research. This law largely follows recommendations by the Committee 
Doek4 for expanding the legislation on pediatric research and is in accordance with the 
renewal of the European regulation on clinical trials in children. Proof of the importance 
and relevance of this thesis is the fact that the law (Wet Medisch Wetenschappelijk 
Onderzoek met Mensen, WMO) now states that discomfort of children in research has 
to be defined and monitored. For this reason, we believe the time is ripe to measure 
children’s self-reported discomfort.
Furthermore, data on children’s self-reported discomfort and their suggestions for 
reducing discomfort provide useful information for those involved in pediatric research. 
The dissemination of this information will benefit the general area of pediatric research 
by providing an empirical basis for the evaluation of discomfort, facilitating cross-study 
comparisons of the impact of various procedures, and eventually helping to provide 
benchmarks for the level of discomfort that might be expected for children undergoing 
a given procedure. This thesis also offers an instrument (CDRPQ) for measuring children’s 
discomfort, which can help to establish these benchmarks.
LimitAtioNs
This thesis has several limitations to take into account. The most important ones are 
mentioned below.
Participants
Since we were dependent on the research procedures conducted at the participating 
hospitals, and the time given for our research project, we were unable to include the 
intended number of children (N=50) for some research procedures, because fewer 
children took part in these studies than expected, or were included at a later stage than 
planned. This has an effect on the power and generalization of the outcomes. Because 
of this and skewedness of the data (i.e. age and medical condition), no definitive con-
clusions can be drawn about the influencing factors on discomfort, such as whether 
younger children need special precautions in clinical research.
We only included children who had assented to undergo the research procedures; 
therefore the study might be hampered by a selection bias. It is possible that some 
children declined to undergo a research procedure because of expected discomfort. 
Unfortunately, we do not have information on the pool of children that was eligible 
for participation for the studies from which we recruited children, the sampling and 
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inclusion of these studies, and the percentage of children that actually participated (e.g. 
for some studies sampling is still ongoing). Studies on children’s motivations for (not) 
participating in clinical research could help to gain a general insight into the percentage 
of children that decline to participate because of the expected discomfort.19-22 However, 
selection bias basically is not only a problem for this thesis, but for many pediatric stud-
ies because selection takes place due to, for instance, gatekeeping by researchers and 
parents.
measuring discomfort
While the children mentioned various forms of discomfort, we only included forms 
of discomfort into the CDRPQ that were most frequently mentioned by the children 
and are applicable for all kinds of research procedures (e.g. ‘feeling short of breath’ is 
only relevant for certain procedures, while ‘boredom’ can be part of many). Hence, the 
CDRPQ should be seen as a generic questionnaire. This has advantages, such as making 
comparisons possible between discomfort of different research procedures, as well as 
disadvantages. It can give an incomplete view of the overall discomfort because impor-
tant specific forms of discomfort are not measured for some procedures.
A solution could be to develop a procedure-specific questionnaire on discomfort, 
involving the questions of the CDRPQ and additional questions about specific forms 
of discomfort related to a certain procedure. Of course, it is needed to validate this 
procedure-specific questionnaire first. It also needs to be noted that adding more ques-
tions will burden children more (an often heard criticism of research is the large amount 
of questionnaires) and therefore might influence the response-rate.
Children’s Discomfort during research Procedures Questionnaire (CDrPQ)
Next to the above-mentioned limitations about measuring discomfort, limitations of the 
CDRPQ are the - so far - limited psychometric analyses.
imPLiCAtioNs AND reCommeNDAtioNs for tHose iNVoLVeD iN 
PeDiAtriC reseArCH
Data on children’s self-reported discomfort and suggestions for reducing discomfort 
provide useful information for several groups involved in pediatric research. Below, we 
describe the relevance of the results of this thesis for each group and how these can be 
incorporated in practice.
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ethics committees
Evaluating discomfort
In Chapter 5, we describe the discomfort of some common medical research procedures, 
which helps make the evaluation of discomfort evidence-based. We encourage ethics 
committees to use these data when evaluating discomfort. We strive for information on 
the discomfort of other research procedures in the near future.
Recommending pediatric researchers to measure discomfort
To be able to use children’s self-reported information on discomfort, it is needed that 
these data are collected and disseminated. Ethics committees can play a key role in 
this by requiring these data as part of a study protocol and recommending pediatric 
researchers to register children’s experiences.
Evaluating benefits
Currently, only health benefits are taken into account in the risk-benefit analysis of pedi-
atric research. In our opinion, there are situations in which “increasing knowledge about 
the human body and doing research,” “having fun,” and “altruism” can also be taken into 
account as benefits in the risk-benefit analysis (Chapters 7a, 7b). These benefits can tip 
the scale when crucial studies are at stake, but when the medical benefits cannot justify 
the slightly over-minimal risks and discomfort.
Pediatric researchers
Measuring discomfort
We recommend that pediatric researchers routinely include a brief assessment of the 
impact of the research procedures of their studies by asking the participating children, 
for which the CDRPQ could be used (Chapter 4). To avoid overloading pediatric research-
ers with extra work and responsibilities during a study visit, it would be ideal if children 
can report their experiences directly on a website/app. As such, pediatrics researchers 
can limit their tasks to emphasizing the opportunity and importance of reporting these 
experiences to children (and their parents) and to refer them to this website/app.
Informed consent process
During the informed consent procedure, we encourage researchers to provide parents 
and children with information on expected discomfort of research procedures based on 
empirical data, in order to facilitate their decision-making for participation.
Reducing discomfort
It is important that discomfort in pediatric research is reduced as much as possible. This 
can be achieved by standard asking children - next to discomfort - for their suggestions 
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to reduce discomfort (i.e. one of the questions of the CDRPQ), and - if feasible - to apply 
these in their studies. As we showed in Chapters 3 and 5 many children undergoing 
different procedures suggested providing (more) distraction, for instance by showing 
short movies.
Maximizing positive experiences
When designing a study, pediatric researchers are encouraged to have an eye for the 
positive experiences that are important for the children, and are acceptable from an 
ethical point of view, such as their interest in science/human body (Chapters 7a, 7b). 
Improving the positive experiences may also improve participation rates, and maybe 
even awake an interest in science among children.
Children and parents
Facilitating decision-making
For children (and parents) who are approached for research participation, it can be 
helpful when they have access to information on discomfort of research procedures of 
children in previous research. It provides them with additional information on what to 
expect from undergoing research procedures from the perspective of their peers. This 
information can facilitate decision-making for (parts of ) research participation, as they 
will be better informed. For instance, if the majority of children do not experience a 
specific research procedure as discomforting, it may be a reason for others to agree with 
undergoing this procedure too.
Self-reported data on discomfort
The availability of children’s self-reported data on discomfort is dependent on the will-
ingness of children to report on their experiences during research participation. As we 
learned from the studies in this thesis, our experience is that most children are willing to 
report these experiences as long as it does not require much extra time. We think that 
it would be useful if children can report their experiences (anonymously) on a website 
(e.g. using the CDRPQ), which they could access without (extensive) registration to make 
it as easy as possible for them.
fUtUre DireCtioNs
implementation
It is important that the evaluation of ethics committees on discomfort is evidence-based. 
This thesis made a start in describing discomfort during research procedures. Additional 
research is needed to measure discomfort in larger and more heterogeneous sample 
sizes (e.g. more variation in age, medical condition), and related to other research pro-
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cedures. For this, we developed an implementation plan that is supported by several 
prominent stakeholders involved in pediatric research in the Netherlands (e.g. Dutch 
Society for Pediatrics, Dutch Society for Ethics committees, Nefarma, the Ministry of 
Health) and recently received financial support by ZonMw. In short, we plan to develop 
a website where children can report their experiences using the CDRPQ; the data on 
discomfort will be anonymously published in a database on this website. The website 
will be accessible for children, parents, ethics committees, researchers and others who 
are interested. To promote this website, we continue to work on the development of a 
network in which physicians, researchers, ethics committees, parents and children are 
involved. We aim for a network in the Netherlands first, and if proven successful, we will 
expand this to other countries as well.
Eventually, we hope the website can be used as a platform where data on discomfort 
are disseminated, experiences of research participation are shared, videos are showed 
in which children explain some essential concepts of participating in research, et cetera. 
The United Kingdom already established such a platform, which we see as an example 
for the Netherlands.
Child participation
We consulted children at different stages of our research project: during the interviews 
they were consulted about their experiences and were asked about the word discomfort; 
they were also asked about which response options they prefer; they provided feedback 
on the concept-version of the CDRPQ. When looking at Hart’s Ladder of Participation,23 
there are possibilities for improvements in child-participation in our project, leading to 
more empowerment of the children and thus to the successfulness of the project. As we 
cannot turn back time, we plan to more actively involve children during the follow-up 
project, for instance by setting-up a child-council (‘kinderraad’) who can help design the 
webpages for the children, who can test the website and provide feedback, who can 
advise us to expand the website to a platform, et cetera.
Levels of discomfort and their meaning
For ethics committees and pediatric researchers who evaluate the level of discomfort of 
(non-therapeutic) research procedures, it is important to know which research proce-
dures involve ‘minimal discomfort’. In this thesis, we provide data on different degrees 
of discomfort, but we do not provide which degree corresponds with the categories of 
discomfort used in legal documents and regulations (e.g. minimal discomfort, minor 
increase over minimal discomfort). One of the reasons why we did not do this is because 
the jurisdiction on the level of discomfort depends on the country where the research 
is being conducted. In Chapter 5 we discuss a recommendation by Westra et al., in 
which they suggest that minimal risk is when “at most a quarter of the persons (25%) 
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concerned will experience considerable risk”.24 Although this definition is meant for risk 
(involving both risk of harm and risk of discomfort), a cut-off level of 25% for minimal 
discomfort seems like a reasonable percentage. However, it is needed that future re-
search investigates if taking a percentage is indeed an acceptable way of determining 
different levels of discomfort, and if so, which percentage is an acceptable cut-off level 
according to ethics committees, researchers, and of course children and their parents.
Additional validation
Future research is needed for additional validation of the CDRPQ. For instance, it would 
be helpful to measure convergent validity based on all questions of the CDRPQ on the 
child’s discomfort. Also, the CDRPQ was developed in the Dutch language and then 
translated to English for this thesis. For using this questionnaire abroad, it is needed to 
validate the CDRPQ in other languages first. Furthermore, future research is needed to 
investigate whether the CDRPQ can also be used in younger children (< 8 years).
CoNCLUsioN
This thesis aimed for making the evaluation of discomfort in pediatrics research evi-
dence-based by providing information on children’s self-reported discomfort. It makes 
a start in reporting and disseminating children’s self-reported experiences, and lays a 
foundation for an online database on children’s discomfort in clinical research. With the 
recent additions in Dutch law to define and monitor children’s discomfort in research, 
aiming to increase the acceptability of children in clinical research, the time is ripe to 
build this database and make the evaluation of discomfort evidence-based.
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Summary
A
Chapter 1 introduces the topic of children participating in clinical research. Children’s 
health is at risk because of unlicensed and off-label medicines and other treatments (i.e. 
it is estimated that approximately 65% of treatments and medicines for children are unli-
censed and/or off-label). Clinical research is needed to get access to tested and licensed 
medication and treatment, yet children are restricted from participating because of the 
risks and discomfort it causes. It is striking that the guidelines for protecting children 
might actually bring their health at risk.
To find an optimal balance in conducting clinical research and protecting the child, 
it is necessary to have empirical data on children’s self-reported experiences in clini-
cal research. Until now, these data are scarce. The general aim of this thesis was to get 
insight into children’s experiences in clinical research, and make a start with collecting 
self-reported data on discomfort of children during medical research procedures. 
Although the focus is primarily on discomfort, positive experiences and benefits are 
addressed as well.
The studies described in this thesis were carried out at the Academic Medical Center 
in Amsterdam, VU University Medical Center in Amsterdam, Erasmus University Medi-
cal Center in Rotterdam, and the Academic Center of Dentistry in Amsterdam/Almere 
(ACTA).
The main research questions of the thesis were:
1. What is the degree of discomfort of common medical research procedures?
2. Do children experience clinically relevant stress symptoms due to common medical 
research procedures in the long-term?
3. Do age, anxiety-proneness, gender, medical condition and previous experiences 
with the procedures influence discomfort?
4. Are there differences in discomfort of the same medical procedures that are con-
ducted for research purposes versus clinical care?
5. What are children’s suggestions to reduce the discomfort of research procedures?
Chapter 2 describes the study protocol of a two-phase study measuring children’s 
self-reported experiences during research procedures. The first phase consisted of an 
interview study with a diverse group of children about their experiences during research 
procedures. In the second phase, the development of a questionnaire, measuring chil-
dren’s experiences during research procedures in a quantitative way, is described. This 
questionnaire is based on literature, input from pediatric healthcare experts and the 
interview outcomes of the first phase. Next, we measured the experiences of children 
during common medical research procedures using this questionnaire. Finally, we 
measured long term (clinically elevated) stress symptoms due to research procedures.
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Chapter 3 provides insight into children’s discomfort during clinical research proce-
dures and their suggestions to reduce possible discomforts. We interviewed a group of 
46 children (aged 6-18) participating in clinical research studies. The forms of discomfort 
of the interviewed children could be divided into two main groups: physical and mental 
forms of discomfort. The majority experienced physical discomforts during the research 
procedures: pain, shortness of breath, nausea, itchiness, and feeling hungry, which were 
often caused by needle procedures, some pulmonary procedures, and food provoca-
tion tests. Mental discomforts included anxiousness because of anticipated pain and 
not knowing what to expect from a research procedure, boredom and tiredness during 
lengthy research procedures and waiting, and embarrassment during Tanner staging. 
Children’s suggestions to reduce the discomforts of the research procedures primarily 
were providing distraction (e.g. watching a movie or listening to music), providing age-
appropriate information and shortening the duration of lengthy procedures.
In Chapter 4 we described the development of a generic, short and child-friendly instru-
ment to measure children’s self-reported discomfort during research procedures: the 
Children’s Discomfort during Research Procedures Questionnaire (CDRPQ). The CDRPQ 
is based on literature, the interviews we held with children and input from several pedi-
atric healthcare experts. It consists of six questions about different forms of discomfort 
children experience (nervousness, annoyance, pain, fright, boredom, tiredness) and an 
open question on how discomfort can be reduced. An average discomfort score can 
be calculated based on the six different forms of discomfort. Convergent validity and 
test-retest reliability were acceptable. Internal consistency was low, as expected given 
the variety in forms of discomfort. The CDRPQ was well received by the children.
In Chapter 5 we investigated children’s self-reported discomfort during research 
procedures and their suggestions how discomfort can be reduced, using the CDRPQ. 
We measured discomfort of six medical research procedures: buccal swabs, MRI-scans, 
pulmonary function tests, skin prick tests, ultrasound imaging and venipunctures. We 
compared the findings to children’s discomfort during dental check-ups, and explored 
whether age, anxiety proneness, gender, medical condition, previous experiences and 
the purpose of the procedure (research versus clinical care) affected discomfort.
For this study, we included 418 ill and healthy children (8-18 years): 307 from research, 
50 from dental care, and 61 from clinical care. Most children reported limited discomfort 
during the research procedures. When compared with dental check-ups, buccal swab 
tests, skin prick tests and ultrasound imaging were less discomforting, while MRI-scans, 
venipunctures and pulmonary function tests caused a similar degree of discomfort. Only 
anxiety-proneness was positively related to discomfort. It was inconclusive whether 
the purpose of the procedure (research versus clinical care) affected discomfort. The 
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majority of the children (ca. 60%) suggested providing distraction by showing movies 
to reduce discomfort.
Clinical research can cause different types of risk: physical, psychological, social, eco-
nomic and legal risks. In Chapter 6, the psychological risk that research procedures 
can have on children is investigated. We operationalized psychological risk as clinically 
relevant stress symptoms, measured with the Children’s Revised Impact of Event Scale 
(CRIES-13). A score of ≥ 30 on this scale was considered as clinically relevant stress. We 
measured stress symptoms of children (N=66) who underwent buccal swabs, MRI-scans, 
pulmonary function tests, ultrasound imaging and venipunctures after one month. We 
asked an additional group of 34 children about the stress symptoms caused by MRI-
scans and venipunctures after one year.
None of the children had clinically relevant stress symptoms, except for one child 
who reported to have clinically elevated stress symptoms one year after undergoing 
a venipuncture. Discomfort during research, trait-anxiety and gender (i.e. being a girl) 
were significantly positively related to long-term stress symptoms, indicating that chil-
dren who experience a considerable degree of discomfort during research, girls, and 
children with high trait-anxiety scores are more likely to experience long-term stress-
symptoms due to research procedures.
Contrary to the previous chapters on children’s discomfort, Chapters 7a and 7b address 
positive experiences and potential benefits of children in clinical research.
Recruiting children for non-therapeutic research is ethically challenging because par-
ticipation conveys risks and discomfort and no health benefit. In Chapter 7a we give 
insight into the positive experiences of a group of healthy and ill children (6-18 years) 
who participated in non-therapeutic research studies, and discuss whether these posi-
tive experiences can be viewed as benefits. We argue that helping others, having fun, 
and new/increased knowledge could justifiably be valued as benefits. We present two 
scenarios how ethics committees could incorporate these benefits into the risk-benefit 
analysis of study protocols. The first scenario discusses that these above-mentioned 
benefits should be incorporated in the risk-benefit analysis in studies that are thought 
to be crucial, but the risks and burden are expected to be slightly above minimal. In 
the second scenario, we propose that these benefits should be a standard part of the 
risk-benefit analysis.
Chapter 7b is based on the findings of Chapter 7a. It consists of an open peer commen-
tary on the article “Young people’s experiences of participation in clinical trials: reasons 
for taking part” by Luchtenberg et al. (2015). They conducted a qualitative study about 
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the benefits adolescents experience in clinical trials. In our commentary, we support 
the different benefits that Luchtenberg et al. found in their study, based on hearing the 
voices of the children in a more varied (in age, medical condition, and study types) study 
sample.
Chapter 8 constitutes a general discussion on the main findings of the studies presented 
in this thesis. This thesis aimed to make decisions in clinical research evidence-based 
by providing information on children’s self-reported discomfort during several research 
procedures. These data are a first step in providing benchmarks for discomfort of various 
research procedures in pediatric research.
Summarized, children experience limited discomfort and long-term stress symp-
toms during the investigated research procedures. This supports the acceptability of 
undergoing these research procedures.
Based on the findings of this thesis, recommendations and implications for differ-
ent groups involved in pediatric research are given (i.e. pediatric researchers, ethics 
committees, children and their parents). Also recommendations are given for future 
research. For instance, more data are needed on the discomfort of research procedures, 
in particular of research procedures not described in this thesis. For this, we designed 
an implementation plan to collect and disseminate these data, for which we recently 
received a grant by ZonMw.
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Samenvatting
A
In Hoofdstuk 1 wordt een toelichting gegeven op de deelname van kinderen aan 
wetenschappelijk onderzoek. De gezondheid van zieke kinderen loopt gevaar vanwege 
niet geregistreerde en niet goed onderzochte medicijnen en behandelingen. Weten-
schappelijk onderzoek is nodig om ervoor te zorgen dat kinderen toegang krijgen tot 
geteste medicatie en behandelingen, maar kinderen worden vaak uitgesloten van 
deelname vanwege de risico’s en belasting die het onderzoek met zich meebrengt. Het 
is opmerkelijk dat de regelgeving die (zieke) kinderen moet beschermen tegen weten-
schappelijk onderzoek, aan de andere kant hun gezondheid op het spel lijkt te zetten.
Om een optimale balans te vinden om wetenschappelijk onderzoek te kunnen doen 
én tegelijkertijd kinderen te kunnen beschermen tegen belasting (en risico’s) van het 
onderzoek, is het nodig om empirische data te hebben over de ervaringen van kinderen 
in wetenschappelijk onderzoek zoals kinderen die zelf rapporteren. Tot op heden zijn 
deze data nauwelijks beschikbaar. Het doel van dit proefschrift was daarom om inzicht 
te krijgen in de ervaringen van kinderen in wetenschappelijk onderzoek, en een start 
te maken om de belasting die kinderen ervaren tijdens medische procedures in weten-
schappelijk onderzoek in kaart te brengen. Hoewel de focus van dit proefschrift vooral 
op belasting is gericht, wordt ook ingegaan op de positieve ervaringen en voordelen die 
kinderen ervaringen tijdens onderzoek.
De studies die zijn beschreven in dit proefschrift zijn uitgevoerd bij het Academisch 
Medisch Centrum in Amsterdam, het VU Universitair Medisch Centrum in Amsterdam, 
het Erasmus Universitair Medisch Centrum in Rotterdam, en het Academisch Centrum 
voor Tandheelkunde in Amsterdam/Almere (ACTA).
De belangrijkste onderzoeksvragen van dit proefschrift waren:
1. Wat is de mate van belasting van veel voorkomende medische procedures in weten-
schappelijk onderzoek?
2. Ervaren kinderen klinisch relevante stress symptomen op de lange termijn vanwege 
medische procedures in wetenschappelijk onderzoek?
3. Beïnvloeden leeftijd, angst-predispositie, geslacht, medische conditie en eerdere 
ervaringen met een medische procedure de belasting van kinderen in wetenschap-
pelijk onderzoek?
4. Zijn er verschillen in belasting tussen een zelfde procedure die wordt uitgevoerd 
in het kader van wetenschappelijk onderzoek versus als deze wordt verricht voor 
diagnostiek- en behandeldoeleinden?
5. Wat zijn suggesties van kinderen om belasting van medische procedures in weten-
schappelijk onderzoek te verlichten?
In Hoofdstuk 2 wordt het studieprotocol van een twee-fase onderzoek over de 
zelf-gerapporteerde ervaringen van kinderen tijdens wetenschappelijk onderzoek 
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beschreven. De eerste fase van het onderzoek bestaat uit een interviewstudie waarin 
een diverse groep van kinderen over hun ervaringen tijdens medische procedures in 
wetenschappelijk onderzoek wordt gevraagd. In de tweede fase wordt de ontwikkeling 
van een vragenlijst beschreven waarmee de ervaringen van kinderen in wetenschap-
pelijk onderzoek kunnen worden gekwantificeerd. Deze vragenlijst is gebaseerd op 
literatuur, input van kindergeneeskundige experts, en de resultaten van de interviews 
uit de eerste fase van het onderzoek. Een volgende stap was om daadwerkelijk de er-
varingen van kinderen tijdens verschillende onderzoeksprocedures te meten, waarbij 
gebruik werd gemaakt van de bovengenoemde vragenlijst. Als laatste is gekeken naar 
stress symptomen van de kinderen op de lange termijn als gevolg van het ondergaan 
van onderzoeksprocedures.
Hoofdstuk 3 geeft inzicht in de belasting die kinderen ervaren tijdens wetenschappelijk 
onderzoek en hun suggesties om deze belasting te verminderen. We hebben hiervoor 
46 kinderen (6-18 jaar) geïncludeerd die meededen met een wetenschappelijke studie. 
De belasting die kinderen ervoeren, hebben we ingedeeld in twee hoofdcategorieën: 
fysieke en mentale belasting. De meerderheid van de kinderen ervoer fysieke belasting 
tijdens de onderzoeksprocedures, bestaande uit pijn, kortademigheid, misselijkheid, 
jeuk en honger hebben. Deze ervaringen werden met name veroorzaakt door naald-
gerelateerde procedures, longfunctiemetingen, en voedselprovocatietesten. Mentale 
belasting betrof met name het angstig zijn vanwege geanticipeerde pijn en omdat het 
kind niet wist wat het te wachten stond, zich vervelen en moeheid tijdens langdurige 
procedures en wachten, en schaamte tijdens puberteitsonderzoek. Kinderen gaven aan 
dat de belasting van de onderzoeksprocedures verminderd kon worden door afleiding 
(bijvoorbeeld naar een film kijken of naar muziek luisteren), het geven van leeftijds-
adequate informatie over het onderzoek en het verkorten van langdurige procedures.
In Hoofdstuk 4 wordt de ontwikkeling beschreven van een generieke, korte en 
kindvriendelijke vragenlijst om de zelf-gerapporteerde belasting van kinderen tijdens 
medische procedures in wetenschappelijk onderzoek te meten: Children’s Discomfort 
during Research Procedures Questionnaire (CDRPQ). De CDRPQ is gebaseerd op liter-
atuur, interviews met kinderen en input van verschillende kindergeneeskundige profes-
sionals. De vragenlijst bestaat uit zes vragen over verschillende vormen van belasting 
(zenuwachtig, vervelend, pijn, eng, saai, moe) en een open vraag over hoe de belasting 
verminderd kan worden. Een gemiddelde score kan worden berekend op basis van de 
zes vragen over belasting. De convergente validiteit en test-hertest betrouwbaarheid 
waren acceptabel. Interne consistentie was - zoals verwacht - laag, vanwege de variëteit 
in vormen van belasting. De CDRPQ werd goed ontvangen door de kinderen.
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In Hoofdstuk 5 hebben we de zelf-gerapporteerde belasting van kinderen tijdens 
wetenschappelijke onderzoekprocedures onderzocht en de suggesties van kinderen 
om deze belasting te verminderen. We hebben hierbij gebruikt gemaakt van de door 
ons ontwikkelde vragenlijst: de CDRPQ. We hebben de belasting gemeten van zes 
onderzoeksprocedures: wangslijmvliesafnames, MRI-scans, longfunctietesten, allergiet-
esten, echoscopieën en bloedafnames. De belasting van deze procedures hebben we 
vergeleken met de belasting die kinderen tijdens een controle-afspraak bij de tandarts 
ervaren. Ook hebben we exploratief gekeken of de leeftijd van de kinderen, angst-
predispositie, geslacht, medische aandoening, eerdere ervaringen met de procedures, 
en het doel van het onderzoek (wetenschappelijk onderzoek versus zorg) van invloed 
waren op de belasting tijdens het onderzoek.
Voor deze studie hebben we 418 zieke en gezonde kinderen geïncludeerd (8-18 jaar 
oud), waarvan 307 kinderen meededen met wetenschappelijk onderzoek, 50 kinderen 
die een controle bij de tandarts ondergingen en 61 kinderen werden geïncludeerd 
vanuit de klinische zorg. De meeste kinderen rapporteerden een beperkte mate van be-
lasting tijdens de wetenschappelijke procedures. Wanneer we de belasting vergeleken 
met die van de kinderen tijdens de tandartscontroles waren de wangslijmvliesafnames, 
allergietesten en echoscopieën minder belastend, terwijl MRI-scans, bloedafnames en 
longfunctietesten een vergelijkbaar niveau van belasting lieten zien. Verder was alleen 
angst-predispositie positief gerelateerd aan belasting. Het was onduidelijk wat voor 
invloed het doel van de procedure (wetenschappelijk onderzoek versus zorg) had op de 
belasting. De meerderheid van de kinderen (ca. 60%) gaf als suggestie om voor afleiding 
te zorgen tijdens de onderzoekprocedures, met name door middel van het kijken naar 
films.
Wetenschappelijk onderzoek kan verschillende soorten risico met zich mee brengen: 
fysieke, psychologische, economische en juridische risico’s. In Hoofdstuk 6 hebben we 
gekeken naar de psychologische risico’s voor de kinderen in wetenschappelijk onder-
zoek. We hebben psychologisch risico geoperationaliseerd als klinische relevante stress. 
Deze hebben we gemeten met de Children’s Revised Impact of Event Scale (CRIES-13). 
Een score van ≥ 30 op deze vragenlijst werd gezien als klinisch relevante stress. Na één 
maand, hebben we de stress symptomen van 66 kinderen die een wangslijmvliesaf-
name, MRI-scan, longfunctietest of bloedafname ondergingen gemeten. Een additio-
nele groep van 34 kinderen hebben we één jaar na het ondergaan van een MRI-scan of 
bloedafname gevraagd naar hun stress symptomen.
Geen van de kinderen rapporteerde klinisch relevante stress, met uitzondering van 
één kind dat een jaar daarvoor een bloedafname had ondergaan. Belasting gedurende 
het onderzoek, angst-predispositie en geslacht (meisje) hadden een significant posi-
tieve relatie met lange-termijn stress symptomen. Kinderen die aanzienlijke belasting 
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tijdens het onderzoek ervaren, meisjes en kinderen die van nature angstig aangelegd 
zijn, lijken meer kans te hebben om lange-termijn stress symptomen te ervaren door 
deelname aan wetenschappelijk onderzoek.
In tegenstelling tot de voorgaande hoofdstukken over belasting, gaan Hoofdstukken 
7a en 7b over de positieve ervaringen van kinderen in wetenschappelijk onderzoek en 
de mogelijke voordelen die zij ervaren van onderzoekdeelname.
Het includeren van kinderen voor niet-therapeutisch wetenschappelijk onderzoek is een 
uitdaging omdat deelname risico’s en belasting met zich meebrengt, maar tegelijker-
tijd geen gezondheidsvoordelen voor het deelnemende kind biedt. In Hoofdstuk 7a 
geven we inzicht in de positieve ervaringen van een groep zieke en gezonde kinderen 
(6-18 jaar) die deelnemen aan niet-therapeutische studies. We bediscussiëren of deze 
positieve ervaringen gezien kunnen worden als voordelen van onderzoekdeelname, en 
als zodanig in de besluitvorming een doorslaggevende rol kunnen spelen ten gunste 
van deelname aan medisch onderzoek. We beargumenteren waarom het helpen van 
anderen, plezier hebben en het verwerven van nieuw en verbeterde kennis hiervoor 
in aanmerking komen. We presenteren twee scenario’s hoe ethische commissies deze 
voordelen mee kunnen nemen in de “risk-benefit” analyse van onderzoeken. In het 
eerste scenario wordt beschreven dat de bovengenoemde voordelen alleen moeten 
worden meegenomen in deze analyse wanneer het gaat om een cruciale studie waarbij 
de risico’s en belasting iets meer dan minimaal zijn. In het tweede scenario pleiten we er-
voor om deze voordelen mee te nemen in de risk-benefit analyse van alle onderzoeken.
Hoofdstuk 7b is gebaseerd op Hoofdstuk 7a. Het betreft een commentaar op het 
artikel “Young people’s experiences of participation in clinical trials: reasons for taking part” 
door Luchtenberg et al. (2015). De auteurs van het stuk geven aan dat zij een kwalitatief 
onderzoek hebben gedaan naar redenen voor kinderen om deel te nemen aan weten-
schappelijk onderzoek en de voordelen die zij ervaren van onderzoekdeelname. In ons 
commentaar onderschrijven wij de voordelen die Luchtenberg et al. noemen, waarbij 
wij ons baseren op ons eigen onderzoek met een meer gevarieerde onderzoekspopu-
latie (meer variatie in leeftijd, medische aandoeningen en studie types).
Hoofdstuk 8 bevat een discussie over de belangrijkste bevindingen van de studies in 
dit proefschrift. Dit proefschrift had als doel om de beslissingen over deelname aan 
wetenschappelijk onderzoek evidence-based te maken door informatie te verschaffen 
over de zelf-gerapporteerde belasting van kinderen tijdens onderzoeksprocedures. 
Deze gegevens vormen een eerste stap voor een referentiepunt van de belasting van 
onderzoeksprocedures in kindergeneeskundig onderzoek.
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Samenvattend kan worden gezegd dat kinderen weinig belasting en lange-termijn 
stress ervaren door de door ons onderzochte procedures in wetenschappelijk onderzoek. 
Deze resultaten onderstrepen dat het - in het algemeen – aanvaardbaar is om kinderen 
deze procedures te laten ondergaan in het kader van wetenschappelijk onderzoek.
Verder staan in dit hoofdstuk aanbevelingen en implicaties voor verschillende groe-
pen die betrokken zijn bij kindergeneeskundig onderzoek, zoals onderzoekers, ethische 
commissies, kinderen en ouders. Ook worden aanbevelingen gegeven voor toekomstig 
onderzoek. Zo is er meer onderzoek nodig over de belasting van de onderzoekspro-
cedures, met name over de belasting van onderzoeksprocedures die niet beschreven 
zijn in dit proefschrift. Wij hebben een implementatieplan opgesteld om deze gegevens 
te verzamelen en te verspreiden, en hebben hier recent een subsidie van ZonMw voor 
ontvangen.
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Claartje, José, Kerime, Mariette, Marlou, Nicoletta en Sarina: dank voor jullie hulp bij het 
afnemen van de vragenlijsten. Zonder jullie was ik nu nog steeds data aan het verzame-
len! Kerime, jou wil ik in het bijzonder bedanken voor je lieve briefjes en chocola; een 
welkome afleiding tijdens het schrijven!
Lieve oud-collega’s van het Erasmus MC: jullie hebben mijn eerste jaren op de arbeids-
markt tot een bijzondere tijd gemaakt, waar ik met veel plezier op terug kijk. Dank voor 
alle gezelligheid, interesse én vooral ook jullie hulp de afgelopen jaren. Een paar mensen 
wil ik in het bijzonder bedanken. Benno, ik ben je erg dankbaar dat je mij destijds hebt 
aangenomen als docent bij de Medische Psychologie. Met veel genoegen kijk ik terug 
op onze gesprekken over onderwijs, muziek en kunst. Annemerle en Noor, wat fijn om 
twee van die toppers als kamergenoten te hebben gehad. Het ‘support’-filmpje dat jullie 
voor mij hebben gemaakt, heb ik vaak bekeken. Sintyha, dank voor je hulp bij allerlei 
onderwijszaken, maar nog meer voor de gezellige shopsessies, etentjes en natuurlijk 
alle bara’s die je voor me mee hebt genomen. Hanneke, mijn mede-Amsterdammer 
in Rotterdam, ik kijk met veel plezier terug naar onze roadtrips en uitstapjes door het 
land. (Ex-)junior onderzoekers van de MPP, dank voor alle steun, jullie gezelschap, jullie 
hulp en natuurlijk ook het delen van promovendus-perikelen. Wilfred, mijn onderwijs-
partner-in-crime, ik kijk met veel plezier terug op de leuke lessen die wij samen hebben 
gegeven. Ik wil je ook bedanken voor je hulp om mij in contact te brengen met artsen/
onderzoekers in het Sophia. Jouw advies ‘kaftje er omheen’ heeft zijn vruchten afgewor-
pen; daarna lag het proefschrift (relatief ) snel bij de drukker! Maya, bedankt voor je hulp 
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om de lessen te verzetten als ‘er weer eens iets belangrijks tussen was gekomen voor 
mijn onderzoek’. Hetty, dank voor jouw helpende hand bij allerhande logistieke zaken.
Divisie Vrouw-Kind van het AMC: hartelijk dank voor de gastvrijheid om ook bij jullie aan 
mijn proefschrift te kunnen werken.
Mijn collega’s van het Julius Centrum (UMC Utrecht), met name kamer Str 7.101, wil ik 
bedanken voor de interesse en steun bij de laatste loodjes van mijn onderzoek. Wat 
heerlijk om zulke fijne collega’s te hebben.
Iwona, dank voor de prachtige omslag van mijn proefschrift.
Lieve vrienden, vriendinnen en familie, dank voor jullie oprechte belangstelling in mijn 
onderzoek, jullie positiviteit en de welkome afleiding naast mijn onderzoek.
Lieve Bibi, ik vind het heel bijzonder dat jij aan mijn zij staat bij de verdediging van mijn 
proefschrift. Sinds we samen in Leiden psychologie zijn gaan studeren, ben jij een be-
langrijk persoon in mijn leven. Je bent een goede vriendin, studiegenoot, clubgenoot, 
oud-huisgenoot, schoonzus, en nu ook paranimf!
Lieve Annette, Mark en Willem, en de rest van de Stalen en Van Driellen, bedankt dat 
jullie mij zo liefdevol hebben opgenomen in jullie familie. Dank voor jullie interesse in 
mijn onderzoek en de nodige ontspanning.
Lieve Irene, mijn lieve bommetje, waar zou ik zijn zonder jou? Door jou leer ik dingen los 
te laten, te relativeren en - niet geheel onbelangrijk - voor mijzelf op te komen. Jij houdt 
mij een spiegel voor waar dat nodig is en bent mijn rots in de brandig. Ik ben ontzettend 
blij dat jij mijn lieve zus en paranimf bent!
Lieve papa en mama, jullie hebben mij de vrijheid gegeven om mijn eigen keuzes te 
maken in het leven en hebben mij het vertrouwen gegeven dat ik meer kan dan dat ik 
zelf denk. Bedankt voor al jullie onvoorwaardelijke liefde, geduld en support. Papa, dank 
voor al je wijze adviezen. Lieve mama, dit proefschrift draag ik op aan jou.
Lieve Rogier, woorden schieten te kort als ik moet beschrijven hoe dankbaar ik jou ben. 
Jij bent degene die er altijd voor mij is; wat ben ik blij dat jij en ik samen wij zijn. Ik houd 
van jou!
